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ABSTRACT OF DISSERTATION

Circadian rhythms orchestrate physiological, behavioral and cognitive processes in
order to anticipate and adapt organisms to key environmental cues. These endogenously
driven oscillations are generated by a network of interlocked auto-regulatory
transcriptional-translational feedback loops driven forward by the Bmal1/Clock
heterodimer transcription factor. Given the ubiquitous and dynamic quality of circadian
rhythms, the identification of factors involved in the coordination and regulation of the
endogenous oscillations is central in broadening our understanding of biological timing
systems. In an examination of gene expression in the mammalian central circadian
pacemaker, the hypothalamic suprachiasmatic nucleus (SCN), revealed a previously
unreported rhythmic expression of runt-related transcription factor 2 (Runx2). The goal
of the research described in the present dissertation was to determine the mechanistic
basis of rhythmic Runx2 expression as well as determine whether Runx2 interacts with
the core molecular machinery of the circadian clock. First, rhythmic gene expression
Runx2 in the SCN, olfactory blub (OB) and paraventricular nucleus (PVN) of adult mice
was demonstrated using quantitative real-time polymerase chain reaction and
immunohistochemistry served to show rhythmic Runx2 protein expression in the SCN.
Second, using SCN tissues from Bmal-/- mice or by transiently silencing BMAL1
expression in vitro it was shown that Runx2 expression is dependent on a functional core
molecular clock network, namely the transcriptional activity of Bmal1. Chromatin
immunoprecipitation was used to demonstrate that BMAL1 directly interacted with its
putative binding sites within the RUNX2 promoter suggesting that the core clock
machinery directly regulates its rhythmic gene expression. Next, Runx2 haplodeficient
iii

mice and transient silencing of RUNX2 expression in vitro revealed that decreases in
Runx2 expression leads to a dampened amplitude of rhythmic Bmal1 expression and a
lengthening of the period of molecular as well as running wheel behavioral rhythms.
Finally, RUNX2 was found to interact with a putative binding site identified in the
BMAL1 promoter suggesting that the influence of RUNX2 on the amplitude of BMAL1
expression was at least in part based on direct regulation at the gene level. Together,
these findings serve to establish the foundational framework of the reciprocal relationship
between the Runx2 transcription factor and the molecular network underlying circadian
rhythms.

KEYWORDS
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CHAPTER I:
INTRODUCTION

1

1.1 – Biological clocks are a central feature of life

Timing of physiological, behavioral and cognitive processes is orchestrated by
endogenously generated oscillations, termed circadian rhythms. Present throughout the
phylogenetic tree, biological timing systems function to anticipate and adapt an organism
to changes occurring within its environment. The evolutionary benefits of such a timing
system are broad. Some examples include avoidance of predators, enhanced energy
storage (Hut & Beersma, 2011), increased efficiency of metabolic processes (Roenneberg
& Merrow, 2002), circadian regulation of cell cycle progression and DNA damage
responses to prevent deleterious mutations and cancers (Homma & Hastings, 1989; Carre
& Edmunds, 1993; Merrow & Roenneberg, 2004; Nagoshi et al., 2004; Simons, 2009;
Sancar et al., 2010).

The length of a circadian cycle, known as the circadian period, is approximately
24h (varying from 23-25h between species) corresponding to the length of one day. In
fact, the term ‘circadian’ is derived from the Latin words ‘circa’ meaning ‘around’ and
‘diem’ or ‘dies’ meaning day together translating to ‘approximately one day’. This
relationship between day length and mammalian circadian period is not coincidental.
Over 3.5 billion years ago, the ability to associate the timing of molecular activity to
environmental events evolved in prokaryotic cells to optimize survival on Earth. The
continuous rotation of the Earth around its axis results in predictable cycles of the most
potent environmental zeitgeber, or timing cue, light. Daily rhythms in photosensitive
proteins timed to occur with the availability of light served to protect early single celled
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life forms (i.e cyanobacteria) from the harmful effects of ultraviolet radiation while
increasing the metabolic efficiency of photosynthetic pathways (Golden et al., 1997).
This example of adaptation and anticipation of an environmental event is relatively
simple compared to the multifaceted and dynamic circadian rhythms systems known to
be ubiquitous in mammalian physiology.

The existence of an endogenous timing system in plants and animals that is
sensitive and adaptable to environmental cues was first postulated by the scholar Jean
Jacques d’Ortous deMairan in 1729. His postulation was founded on the observation that
the red flowers of the Kalanchoe bloss feldiuna plant continued to open on a circadian
basis without exposure to daily sunlight due to an endogenous process. Despite
deMairan’s early observations of intrinsic rhythmicity in plant leaf movement, academic
interest in chronobiology did not begin to blossom until the mid-twentieth century
(DeCoursey, 2004). In 1960, J.W Hastings and B.M. Sweeney reported daily rhythms in
bioluminescence observed in the unicellular algae Gonyaulax polyedra (now known as
Lingulodinium polyedrum) persisting in the absence of environmental stimuli (Hastings
& Sweeney, 1960). Fellow pioneer in chronobiology, plant pathologist Erwin Bünning
was the first to show that photoperiodic time was in fact orchestrated by an endogenous
timing system and postulated the adaptive value of such biological rhythms (Bunning &
Moser, 1969). The foundation of the modern day field of chronobiology was formally
laid at the first international symposium on biological clocks in 1960 at Cold Spring
Harbor Laboratory. At this occasion, Colin S. Pittendrigh, a rhythms researcher,
presented the unifying concepts and key principles of biological rhythms he developed
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along with a fellow chronobiologist, Jügen Aschoff. Our understanding of the biological
timing system in mammals has expanded exponentially since the stage was set by these
chronobiology pioneers, and continues to grow on a daily basis.

1.2 – Making the biological clock tick: Molecular mechanisms of cell level
oscillations

1.2.1 Core molecular clock network

Cell autonomous oscillations are driven by networks of interconnected transcriptionaltranslational auto-regulatory loops (TTL) whereby the protein product of core clock
genes feedback to influence their own gene expression as well as that of other clock
genes (Reppert & Weaver, 2001). The genetic network of core clock components can be
represented in a diagram consisting of multiple interconnected loops having either
positive or negative impact on gene expression (Figure 1.1). In mammals, the positive
arm of the primary loop consists of the basic helix-loop-helix transcription factors Bmal1
(brain-muscle-ARNT-like protein 1) and its binding partner, Clock (circadian locomotor
output cycle kaput, or Npas2 in extra-SCN brain tissue), driving the expression of the
core clock Period genes (Per1, Per2 and Per3) and Cryptochrome genes (Cry1 and Cry2)
(Shearman et al., 1997; Gekakis et al., 1998; Kume et al., 1999; Okamura et al., 1999;
Vitaterna et al., 1999; Shearman et al., 2000; Reick et al., 2001). Per and Cry mRNAs
are translated in the cytoplasm and proteins form multimeric complexes that translocate
into the nucleus. Once in the nucleus, the Per/Cry protein heterodimers act to negate their
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Figure 1.1. A molecular network of transcriptional-translational feedback loops is
the basis of the mammalian circadian timing system. Image modified from Ko, C. H.
and Takahashi, J. S. Molecular components of the mammalian circadian clock. Hum Mol
Genet, 2006, 15 Spec No 2: R271-7 (Ko & Takahashi, 2006).
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own transcription by impinging on the activity of the Bmal1/Clock complex (Kume et al.,
1999). In contrast to this negative auto-regulation, Per2 appears to have a positive
transcription effect on Bmal1 (Shearman et al., 2000). In turn, the positive drive exerted
by PER2 feedback is important to the overall regulation of core clock genes.
In addition to the primary core loop, an auxiliary loop serves to promote the
precision and robustness of cellular oscillations. As with the forward arm of the primary
loop, the Bmal1/Clock heterodimer promotes expression of auto-regulatory genes; in this
instance, retinoic acid-related orphan nuclear receptors, Rev-erbs and Retinoid-related
orphan receptor (ROR; α, β, and γ). The protein product of each of these genes is capable
of binding to retinoid-related orphan receptor elements (RORE) found within the Bmal1
and Clock (and NPAS2) promoter region to influence their transcription. RORs exert a
positive effect on gene expression by RORE binding. In contrast, binding of Rev-Erb to
the ROREs block transcription of genes (Preitner et al., 2002; Sato et al., 2004; Crumbley
et al., 2010; Crumbley & Burris, 2011; Cho et al., 2012). This auxiliary loop is further
interconnected to the primary loop via Per2, which interacts with Rev-Erbs to
synchronize the negative and positive limbs of these TTLs (Schmutz et al., 2010).

1.2.2 Post-transcriptional, post-translational and epigenetic regulation of circadian
rhythms

The core components of the molecular circadian clock network have been defined
as genes whose protein products are necessary for the generation, regulation and
maintenance of endogenous rhythms within individual cells (Takahashi, 2004). Beyond
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the core clock loops described above, a number of additional factors contribute to the
stability, robustness and precision of molecular oscillations.

Immediately following expression, circadian transcripts are targeted by
microRNAs and/or RNA-binding protein complexes that contribute to their stability
and/or degradation (see (Pegoraro & Tauber, 2008) for review). Post-translational
modifications of circadian proteins regulate the subcellular localization and half-life and
are a crucial component of the circadian clock machinery. Casein kinase 1 epsilon
(CK1ɛ) was the first kinase identified based on the fact that hamsters harboring a
mutation in this gene exhibit a shortened circadian period, known as the tau mutation
(Ralph & Menaker, 1988; Lowrey et al., 2000). CK1ɛ phosphorylates Per proteins,
obstructing their translocation into the nucleus leading to their retention in the cytoplasm,
destabilizes proteins and induces its degradation (Lowrey et al., 2000). The effects of this
phosphorylation are muted if Per is bound to a Cry protein (Vielhaber et al., 2000; Eide et
al., 2005). In the absence of CK1ɛ, Per proteins accumulate and translocate into the
nucleus at an accelerated pace than in the presence of CK1ɛ. Once in the nucleus, Per
inhibits the Bmal1/Clock transcriptional drive leading the circadian cycle to restart thus
shortening the circadian period as observed in tau mutant animals (Ralph & Menaker,
1988; Reppert & Weaver, 2001). Discovery of a number of kinases and phosphatases
involved in the circadian clockwork reveal that these post-translational modifications
serve to regulate the pace; timing and function of clock elements (see (Reischl & Kramer,
2011) for review).
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Epigenetic regulation of the circadian rhythms adds another layer of complexity
to the molecular clock network. A role for epigenetic modifications started with the
revelation that Clock is a histone acetyltransferase able to induce epigenetic changes to
facilitate transcription at DNA binding loci (Doi et al., 2006). Histone modifications by
Clock are counteracted by Sirt1, a member of the sirtuins family of histone deacetylases
(Asher et al., 2008; Nakahata et al., 2008).Interestingly, the activity of Sirt1 is modulated
the intracellular NAD+ to NADH/H+ ratio thus serving as a metabolic sensor feeding back
onto the clock network (Asher et al., 2008; Nakahata et al., 2008). Advances in our
understanding of epigenetic regulation will surely shed light on the complexity of the
control of circadian oscillations at the DNA level.

1.2.3 Clock-controlled genes

In parallel with clock genes, genes involved in rhythmic biological processes outside the
core clock mechanism are directly regulated by Bmal1/Clock activity and the TTL. These
genes are rhythmically expressed and driven by the central clock but are not, by
definition, essential for circadian rhythms generation (Reppert & Weaver, 2001). By
regulating the rhythmic expression of these clock-controlled genes, the molecular clock
regulates rhythmic physiological processes at both cellular and tissue levels. Moreover,
clock-controlled genes can feed back onto the clock mechanism to communicate the
status of the internal environment of the organism illustrating that the clock output can
itself influence the clock. Expression of clock genes and clock-controlled genes is
modulated by cis-regulatory elements found in the gene promoter regions. The central
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elements are the E-box (5’-CACGTG-3’) and E-box like sequence, or E’-box, (5’CACGTT-3’) recognized by the Bmal1/Clock transcriptional complex. A number of
clock-controlled genes are also indirectly regulated by the core clock by transcription
factors under control of Bmal1/Clock activity. Transcriptional activation by the nuclear
receptors

(ROR,

Rev-Erbs)

through

nuclear

receptor

elements

(NRE:

5’-

(A/T)A(A/T)NT(A/G)GGTCA-3’) has been documented to occur in the evening phase
(Harding & Lazar, 1993; Preitner et al., 2002) while expression driven by D-box binding
protein (DBP) binding to D-box (5’-TTATG(T/C)AA-3’) sequences occur during the day
(Harding & Lazar, 1993; Falvey et al., 1996; Preitner et al., 2002; Ueda et al., 2005).

1.3 – Regulate globally, act locally: Hierarchical organization of the mammalian
circadian system

Evolution from photoreceptive single celled organisms to multi-cellular and multi-organ
beings necessitated the development of complex networks to coordinate circadian
activities. In addition to synchronizing these processes to the surrounding ecosystem,
organisms with multiple tissue systems required a circadian system able to synchronize
physiological processes within and between the various organs. The circadian timing
system in mammals evolved to have a hierarchical organization with centralized
pacemaker to coordinate oscillations in multiple tissue systems and maximize the
efficiency of an organism’s ability to adapt to its ever changing environment.

9

1.3.1 The suprachiasmatic nucleus of the hypothalamus

In mammals, the central circadian pacemaker is localized to the suprachiasmatic nucleus
of the hypothalamus (SCN). At the top of the hierarchy, the SCN coordinates oscillations
of endogenous peripheral clocks to occur at biologically relevant intervals. The SCN
consists of a pair of nuclei composed of ~20, 000 neurons located in the anterior region
of the hypothalamus along the midline of the brain immediately dorsal to the optic
chiasm and bilateral to the third ventricle (Figure 1.2) (Van den Pol, 1980; Guldner,
1983). Each unilateral nucleus of the SCN is composed of two anatomical subdivisions:
the predominantly non-rhythmic ventrolateral “core” region which is most proximal to
the optic chiasm and receives retinal innervations and the rhythmic dorsomedial “shell”
which partially envelops and receives synaptic inputs from neurons in the core (Moore,
1996).
The neurons of the SCN are relatively small compared to those of other brain
regions, measuring ~10 µm in diameter, and have simple dendritic arbors (Van den Pol,
1980). The neurons of the SCN are subdivided into distinct populations of neurons based
on the neuropeptides they express, whether or not they express core clock genes in a
rhythmic manner and when peak neuronal activity is observed during the circadian
period. The cells of the SCN shell display oscillations in core clock gene expression and
are phenotypically defined by their expression of arginine vasopressin (AVP), which
represents approximately 20% of SCN neurons (Hamada et al., 2001; Hamada et al.,
2004). Moreover, these neurons have also been shown to co-express angiotensin II and
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Figure 1.2. Anatomy of the suprachiasmatic nucleus. A) Coronal section of the mouse
brain including the suprachiasmatic nucleus (SCN). Black circle: unilateral SCN nucleus.
Scale bar: 838 µm. Inset: Enlargement showing the bilateral nuclei of the SCN (black
circle). Scale bar: 419 µm. 3V: third ventrical; oc: optic chiasm; PVN: paraventricular
nucleus. Image modified from the Allen Brain Atlas online reference (http://www.brainmap.org/). B) Innervation of the ventrolateral ‘core’ of the SCN by the
retinohypothalamic tract in the mouse brain. Image modified from Colwell, C.S. Linking
neural activity and molecular oscillations in the SCN. Nat Rev Neurosci. 2011. 12(10):
553-569 (Colwell, 2011).
11

met-enkephalin (Abrahamson & Moore, 2001). The central neuropeptide expressed
within the core of the SCN is vasoactive intestinal peptide (VIP), shown to be important
for coupling activity of neurons within the core and core neurons with the shell
populations (for review see (Vosko et al., 2007)). In addition to VIP, neurotensin, and
gastrin releasing peptide are also present in cells within the core region of the SCN (van
den Pol & Tsujimoto, 1985; Abrahamson & Moore, 2001). The functional and
peptidergic heterogeneity of neurons housed within the SCN highlight the complex and
broad functions of the central pacemaker. Despite broad chemical and structural
descriptions, the anatomy and neuropeptide composition of the SCN vary dramatically
across species emphasizing the notion that the SCN is a multifaceted structure.

1.3.1.1 The SCN as the central circadian pacemaker

A variety of strong and compelling evidence supports the notion that the SCN serves as a
master conductor of the circadian orchestra. Among the most convincing evidence is that
circadian rhythms can be abolished by bilateral SCN-specific lesions, and then reinstated
by transplantation of whole graft or dispersed cell suspensions of fetal SCN tissues
(Moore & Eichler, 1972; Stephan & Zucker, 1972; Lehman et al., 1987; Silver et al.,
1990). The period reinstated by the transplant is characteristic of the donor rather than
that of the host period prior to SCN lesioning (Ralph et al., 1990). These studies form the
foundation for the hypothesis that the circadian period of rhythmic characteristics
measured at the whole-organism level is a reflection of the intrinsic properties of the
network of SCN neurons.
12

1.3.1.2 Rhythmic properties of the SCN network of neurons

A number of studies have demonstrated rhythmic electrical activity occurring in the SCN
when intact, isolated from the brain or its neurons are dissociated from one another. In
contrast, rhythmic electrical activity recorded from extra-SCN brain regions persisted
only in the presence of the SCN (Inouye & Kawamura, 1979). The endogenous nature of
SCN neurons was further demonstrated when the tissue or dispersed neurons isolated
from the SCN maintained molecular and electric rhythms both in vivo and in vitro (Green
& Gillette, 1982; Groos & Hendriks, 1982; Welsh et al., 1995). Although the individual
neurons of the SCN can generate and sustain endogenous oscillations, the coupled
network of cells within the SCN allows for robust and stable rhythm generation that is
resistant and more resilient than that seen in a single cell. Evidence for this view stems
from studies conducted using SCN neurons isolated from animals harboring mutations in
clock genes (Liu et al., 2007). Dispersed neurons from animals lacking functional
expression of Per1 or Cry1 genes generated only weak, intermittent and rare rhythmicity
such that only 5-10% of cells had detectible rhythms when sampled for 7 days (Liu et al.,
2007). In contrast, SCN slices cultured from these same mutants displayed robust
rhythmicity demonstrating that the multicellular network of neurons in the SCN instills
its resilience to genetic perturbations.
The period of intact SCN structure is more precise than the period measured from
dissociated SCN neurons. Early multi-electrode recording studies found that dispersed
SCN cells had a substantially broader range of circadian periods (21 - 26h) than that of
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intact SCN cultures or that of running wheel rhythms in mice (Liu et al., 1997; Herzog et
al., 1998; Honma et al., 1998; Nakamura et al., 2001). In a comprehensive study
investigating the relationship between animal behavior and SCN circadian rhythms,
Herzog and colleagues (2004) found that precision of the period established by running
wheel activity was dramatically more precise than that of SCN slice cultures; similarly,
both mice and slice recordings provided more precise measures of period than dispersed
neurons (Herzog et al., 2004). Therefore, the properties of the intact SCN network are
crucial for a robust, accurate timekeeping and precise synchronization of biological
rhythms (i.e. behavior).

1.3.1.3 Afferent connections

The observed intrinsic rhythm of SCN neurons is entrainable to environmental cues or
zeitgebers which serve to synchronize the endogenous pacemaker to the outside world.
For most mammals, light is the most potent zeitgeber and is considered the most
important external cue regulating of circadian rhythms. In mammals, photic information
is communicated to the neurons of the SCN both directly and indirectly via a
monosynaptic neural pathway projecting from intrinsically photoreceptive retinal
ganglion cells (ipRGCs) called the retinohypothalamic tract (RHT) (Moore & Lenn,
1972; Morin & Cummings, 1981; Moore & Speh, 1994). Terminals from the RHT form
synapses onto a small subset of SCN neurons, where they release two excitatory
neurotransmitters implicated in photic signalling from the retina to the SCN: glutamate
and pituitary adenyl cyclase activation peptide (PACAP) (Castel et al., 1993; Hannibal et
14

al., 1997). Lesioning the RHT results in a loss of entrainment of behavioral rhythms to
light-dark cycles, while activation of the RHT by stimulation of the optic nerves or
applications of glutamate and/or PACAP to cultured SCN slices can induce shifts in the
phase of rhythmicity similar in direction and magnitude of light exposure in vivo
(Johnson et al., 1988; Shibata & Moore, 1993; Franken et al., 1999). Together, these
studies demonstrate the necessity of the signals transmitted through the RHT for photic
entrainment of SCN (Johnson et al., 1988).

In addition to the RHT, the SCN receives inputs from many non-retinal afferents
hypothesized to influence circadian rhythms. The SCN is directly innervated by NPYcontaining

terminals

from

the

intergeniculate

leaflet

(IGL)

known

as

the

geniculohypothalamic tract (GHT) (Harrington et al., 1985; Card & Moore, 1989).
Lesions studies have demonstrated that the GHT plays a role in circadian responses and
entrainment to photic stimuli, and these are attributed to RHT innervations of the IGL
(Swanson et al., 1974; Hickey & Spear, 1976; Frost et al., 1979; Harrington et al., 1985;
Harrington & Rusak, 1986; Pickard et al., 1987; Pickard, 1989). Similar studies have also
implicated the IGL in mediating circadian responsiveness to non-photic stimuli such as
brief exposure to novel running wheel activity and serial arousal (Biello et al., 1994;
Maywood et al., 1997). Serotonergic neurons originating from the dorsal and median
raphe nuclei projecting to the SCN and IGL can shift behavioral rhythms and attenuate
SCN activation in response to light stimulation (Dudley et al., 1999; Meyer-Bernstein &
Morin, 1999). The SCN also receives cholinergic projections from the midbrain and basal
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forebrain and cortical projection from the infralimbic cortex have also been described
(Bina et al., 1993; Bina & Rusak, 1996; Moga & Moore, 1997).

1.3.1.4 Efferent connections

Anterograde and retrograde tracers have been used to map brain nuclei which are efferent
targets of the SCN: the paraventricular nucleus, the medial preoptic area, the supraoptic
nucleus, the dorsomedial hypothalamus, the arcuate nucleus, the anterior hypothalamic
area, the bed nucleus of the stria terminalis, the subparaventricular zone, the amygdala,
the periventricular nucleus of the thalamus, the ventral lateral septum and the
intergeniculate leaflet (Watts & Swanson, 1987; Morin, 2007). Evidence for humoral
output signals in addition to neural efferents were initially derived from SCN lesion and
transplant studies; behavioral rhythms of SCN-lesioned animals were restored by SCN
tissue grafts encapsulated to prevent restoration of synaptic connections to the host neural
tissue while allowing diffusion of humoral signals (Silver et al., 1996). Despite restoring
locomoter rhythms, rhythmicity in endocrine functions cannot be restored by such grafts
and likely require efferent connections from the SCN for rhythmic control of these
biological processes.

Information regarding timing and environmental signals integrated at the level of
the SCN needs to be conveyed to peripheral tissues in order to adapt and synchronize
16

clocks throughout the entire body. The SCN transmits information most directly by
autonomic neural connections and hormones, although body temperature and feeding
behavior can also act as synchronization cues directed by the SCN (Balsalobre et al.,
2000; Damiola et al., 2000; Le Minh et al., 2001; Stokkan et al., 2001; Brown et al.,
2002; Nakamura et al., 2008; Vujovic et al., 2008).

1.3.1.5 Entrainment of circadian rhythms

In the absence of an environmental timing cue, the endogenous period of an organism’s
central circadian clock (SCN) will govern its daily rhythm in behavior and physiology.
Since most organisms have an internal clock period that is not exactly 24 hours, timed
biological events will appear to ‘drift’ each day in accordance to the organism’s ‘freerunning’ rhythm. An animal with a slightly longer endogenous period will display an
activity phase onset later each passing day thus drifting to the right (Figure 1.3A). In
contrast, an animal with a slightly shorter endogenous period will display its activity
phase earlier and earlier each passing day thus appearing to drift to the left (Figure 1.3B).
If both these animals were subjected to a 12h: 12h light-dark cycle, their circadian
rhythms would entrain to the light and dark (Figure 1.3). In the case of one or several
mutations in the genes of core clock elements, external cues such as light may be required
for circadian timing. This becomes evident in an environment devoid of a daily timing
cue, such as in constant darkness, in which an animal harboring clock gene mutations
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would display arrhythmicity of rhythmic biological processes such as sleep-wake cycles
(Figure 1.3C).

To efficiently study the circadian clock, chronobiologists developed a
nomenclature to define time of day under an entrained stimulus (i.e. light) or by
endogenous rhythm in the absence of a daily stimulus. Under conditions of entrainment,
circadian phase is indicated by ‘zeitgeber time’ (ZT). Under constant conditions lacking
any timing cues and in which the circadian clock is said to ‘free-run’, circadian phase is
defined by ‘circadian time’ (CT). For example, under a 12:12h light-dark cycle ZT0 is the
start of the light phase and ZT12 defines the start of the dark phase. In contrast, when
rhythms are governed solely by the endogenous rhythm of the SCN time is measured in
CT wherein CT12 represents the onset of a biological phase marker, such as activity.

The effects of light on rhythmicity of the SCN are time-of-day dependent. Photic
stimuli presented during the early night (ZT/CT 13-15) induce a subsequent phase delay
in the onset of activity while photic stimuli presented in the late night (ZT/CT 20-23)
causes an advance in the phase of rhythmicity. Photic stimulation during the subjective
day does not impact the phase of rhythms in the SCN. The effect of a stimulus (i.e. light)
on the subsequent phase of the circadian period is plotted as a phase response curve to
display the impact of the stimulus over the course of the circadian cycle (Figure1.3D).

Non-photic cues such as social interaction, induced activity (wheel running), dark
pulses, food availability and sleep deprivation can also entrain the circadian clock
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Figure 1.3. Examples of entrained and endogenous circadian rhythms under a
12h:12h light-dark cycle and constant darkness. Each actogram represents a circadian
rhythm initially entrained to a 12h:12h light-dark cycle. When entrained, all three
subjects display nocturnal behavior which begins (lights off; ZT12) and ends (lights on;
ZT0) at the same time each day. In constant darkness, subject (A) displays an endogenous
circadian rhythm longer than 24h, with the rhythm starting later each day; subject (B)
displays an endogenous circadian rhythm shorter than 24h with the rhythm starting earlier
each day; and subject (C) displays an arrhythmic circadian rhythm, lacking predictable
activity onset. D) Schematic of a phase response curve (PRC) for a photic stimulus. A, B,
and C modified from Golombek, D.A and Rosenstein, R.E. Physiology of Circadian
Entrainment. Physiol. Rev. 2010; 90: 1063-1102 (Golombek & Rosenstein, 2010).
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(Stephan et al., 1979; Boulos et al., 1980; Mrosovsky, 1988; Reebs & Mrosovsky, 1989;
Antle & Mistlberger, 2000). In contrast to photic stimuli which induce changes in
circadian phase when presented during the subjective night, non-photic stimuli affect
phase when presented during the subjective day. The above mentioned examples of nonphotic zeitgebers have been shown to induce phase advances during the subjective day.
(Stephan et al., 1979; Boulos et al., 1980; Mrosovsky, 1988; Reebs & Mrosovsky, 1989;
Antle & Mistlberger, 2000). The mechanisms through which these factors phase shift
SCN rhythms are not as well characterized as photic cues and this remain an active area
of research in the field of chronobiology.

1.2.1.6 Summary

Altogether, the SCN embodies the hallmark features of a circadian timing system: 1) the
ability to perceive environmental cues; 2) integrate time-related information into the
central circadian pacemaker; 3) transmit that information to peripheral tissues in order to
adapt metabolic and physiological processes to timing and environmental conditions,
and; 4) integrate feedback information from periphery regarding internal state of the
organism (Eskin, 1979).
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1.3.2 Peripheral clocks

It has long been appreciated that rhythmic processes occur in the cells of tissues outside
of the SCN. The growing understanding of the molecular basis of circadian oscillations
(described in Section 1.2) enabled the identification of extra-SCN tissues that contained
the necessary elements for rhythms generation. Rhythmic expression of core molecular
clock components has been identified in multiple neural tissues including the retina, the
thalamus, hypothalamus, amygdala, hippocampus and cerebellum (reviewed in (Guilding
& Piggins, 2007). Beyond the brain, molecular oscillations can be found in most if not all
cells of peripheral tissues. The core molecular timing mechanisms are similar in
endogenously oscillatory cells of the SCN and peripheral tissues.

An early hypothesis postulated that only neurons of the SCN are self-sustained
and peripheral clocks are dependent on SCN-directed signal such that rhythms would
dampen after several cycles when isolated from the SCN. Several animal models were
developed to visually investigate circadian dynamics in peripheral tissues by coupling the
promoter of a core clock gene (i.e. Per1 or Per2) to the luciferase gene. Cultured tissues
from these transgenic animals revealed robust autonomous circadian oscillations in
isolated tissues of the olfactory bulb and neuroendocrine nuclei such as the
paraventricular nucleus, arcuate nucleus and pituitary gland (Abe et al., 2002; Yoo et al.,
2004). In peripheral tissues, the liver and lung had robust and persistent rhythms,
displaying rhythmic oscillations in Per2::Luciferase-driven bioluminescence for
approximately 3 weeks in culture (Yoo et al., 2004). Moreover, peripheral tissues
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cultured from animals with lesioned SCN displayed persistent oscillations with a period
similar to that of tissues from unlesioned host animals (Yoo et al., 2004). These findings
demonstrate that circadian oscillators are capable of persistent circadian rhythms in the
absence of SCN influence. However, the phase of rhythms in these tissues differs from
the SCN in that they lag in phase behind the SCN both in vivo and in vitro (Zylka et al.,
1998; Yamazaki et al., 2000; Abe et al., 2002; Yoo et al., 2004). Therefore, the SCN acts
as a master conductor of peripheral clocks orchestrating their timing based on its
autonomous circadian rhythms.

A number of extra-SCN neural (supraoptic nucleus, periventricular nucleus of the
thalamus) and peripheral tissues (kidney) have dampened rhythms in cultures when
isolated from the SCN (Abe et al., 2002; Yoo et al., 2004). Differences between robust
and attenuated rhythmicity may be attributed to differences in the stability of the
endogenous molecular clock or to the reduced efficiency of synchronizing rhythms
between neurons within a nucleus under culture conditions. In vivo, the SCN appears to
play a role in promoting and synchronizing circadian rhythms in nuclei and tissues which
have weak intrinsic molecular clocks and poor coupling between cells within a tissue. For
example, cultures of mouse embryonic fibroblasts display robust endogenously generated
rhythms (Pando et al., 2002). However, over time, the phase and period of rhythms
between cells differs and eventually the culture appears to be arrhythmic despite each cell
having stable oscillations. Despite the lack of synchrony as a population, these cells were
synchronized to the host period upon transplantation (Pando et al., 2002). Thus, rather
than driving rhythms in diverse tissues, the SCN appears to be the conductor of the

22

physiological orchestra synchronizing circadian rhythms among tissues within an
organism as well as contributing to synchrony among cells within tissues.

1.4 – Runt-related transcription factor 2 (Runx2) and the circadian clock network

The core molecular clock mechanism has been well studied in the SCN and several
peripheral oscillators, yet new components of this network, such as Dec genes, are only
now starting to be characterized (Hastings et al., 2003a; Hastings et al., 2003b; Filipski et
al., 2004; Guo et al., 2005; Guo et al., 2006). To gain insight on rhythmic genes within
the SCN, our laboratory conducted a microarray analysis to reveal previously
unidentified rhythmic genes in the SCN of adult, male Syrian hamsters housed in the
absence of light cues. This screen revealed rhythmic expression of the runt-related
transcription factor-2 (Runx2), a key factor in osteogenesis and a mediator of signal
transduction pathways regulated by a number of factors including cytokines, hormones
and specific signalling receptors. The functional significance of Runx2 rhythmicity was
not yet known and is the central focus of the studies of this dissertation.

1.4.1 Circadian regulation of bone homeostasis

Most homeostatic physiological processes are governed by the circadian clock;
maintenance of skeletal bone mass is no exception. Bone remodeling is a dynamic
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phenomenon which occurs in a sequential and balanced manner: resorption of preexisting mineralized bone by osteoclast cells and de novo bone formation by osteoblast
cells. In addition to their role in bone formation, osteoblasts regulate the differentiation of
precursor cells into osteoclasts making them pivotal players in homeostasis of the skeletal
system (for review see (Karsenty et al., 2009)).

Anecdotally, it has been well recognized that human bone growth occurs at night
while that of nocturnal animals such as mice and rats occurs during the day, both
representing times of rest. Most recently in 2004 Noonan and colleagues demonstrated
that 90% of bone growth occurred during rest and sleep period in immature lambs
(Noonan et al., 2004). Early observations in diurnal variation in the synthesis of two main
bioproducts of osteoblasts, type I collagen and osteocalcin, provided the first hints that
elements of the skeletal system may be under circadian regulation (Simmons & Nichols,
1966; Gundberg et al., 1985). More recent studies have described circadian oscillations in
human serum levels of osteocalcin and alkaline phosphatase, osteoblast bioproducts, as
well as c-telopeptide, a marker of osteoclast activity (Gundberg et al., 1985; Nielsen et
al., 1991; Bollen et al., 1995; Aoshima et al., 1998; Heshmati et al., 1998; Qvist et al.,
2002). Moreover, DNA synthesis showed circadian rhythmicity in bone cells (Russell et
al., 1983). Despite detectable temporal regulation of skeletal metabolism, mechanisms
governing circadian oscillations in bone growth and homeostasis remained unclear.

To elucidate the role of the circadian clock on bone development and
homeostasis, researchers have begun to focus on the functional expression of core
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molecular clock genes in osteoblasts and osteoclasts. Initial studies investigated the
skeletal phenotype of animals harboring mutations in key clock genes. The first
description of a circadian gene mutation causing bone anomalies was in mice lacking
functional expression of Bmal1 (Bunger et al., 2005). In addition to a number of
circadian and physiological anomalies, these animals developed severe progressive noninflammatory arthropathy distinguished by ossification of the ligaments and tendons
(Bunger et al., 2005). The abnormal increase in ossification leads to immobility of joints
and overall decrease in activity levels. Animals lacking functional expression of Per or
Cry genes had markedly increased bone mass, a parameter not seen in Bmal1 mutants (Fu
et al., 2005). Regardless of whether animals lacked Per, Cry or Bmal1 functionality, each
mutation resulted in an increase in the observed number of osteoblasts (Fu et al., 2005).
These findings were attributed to the role of the molecular clock occurring locally in
progenitor cells to balance bone formation by inhibiting the proliferation of osteoblasts
(Fu et al., 2005). However, these findings were not sufficient to support the notion of the
potential capacity of independent circadian rhythms in bone cells as observed in other
peripheral tissues.

Rhythmic gene expression of mouse calvarial bone was assayed by microarray.
From the total expression profile (22,690 genes), 26.6% of genes displayed rhythmic
expression pattern including seven core circadian genes (Bmal1, Npas2, Per1, Per2,
Per3, Rev-Erbα and β) (Zvonic et al., 2007). This is a large spectrum, given that the
average tissue’s transcriptome is composed of approximately 2-13% clock-controlled
genes (Duffield, 2003). A similar study using human osteoblasts described similar results
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of rhythmic circadian clock gene expression (Grundberg et al., 2008). Rhythmic activity
in bone has been visualized in vivo using mice expressing the firefly luciferase gene
under promoter control of the osteocalcin gene which displayed a periodicity of
approximately 24h based on real-time measures of bioluminescence (Gafni et al., 2009).
Rhythmic molecular activity has been observed specifically in cultured osteoblasts from
mice harboring the Period2::Luciferase gene, displaying cycles in bioluminescence with
a period of approximately 24h (Maronde et al., 2010).

1.4.2 Runt-related transcription factor 2 (Runx2) and the circadian clock

Runt-related transcription factor 2 (Runx2) is one of three members (Runx1-3) of the
mammalian family of transcription factors harboring a Runt domain, a highly conserved
DNA-binding sequence first described in Drosophila melanogaster (Nusslein-Volhard &
Wieschaus, 1980; Gergen & Wieschaus, 1986; Duffy & Gergen, 1991). In mammals,
Runx2 is crucial to proper embryonic development and necessary for osteoblast lineage
specification from mesenchymal precursors (Komori et al., 1997; Otto et al., 1997; Lu et
al., 2001; Geoffroy et al., 2002; Byers & Garcia, 2004). Since its critical role in
osteogenesis, most research to date has focused its functions in osseous cell types. From
such studies, it is known that Runx2 haploinsufficiency or gene mutation(s) leading to
reduced Runx2 function is the crux of the human disease cleidocranial dysplasia, whose
phenotype can be mimicked by mice harboring similar deficits (Komori et al., 1997; Otto
et al., 1997; Zhang et al., 2009; D'Alessandro et al., 2010). Conversely, several animal
models designed to over-express the Runx2 gene display osteopenia and multiple bone
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fractures attributed to an increased number of osteoblasts but also impaired bone
mineralization and reduced number of osteocytes (Choi et al., 2001; Geoffroy et al.,
2002). The broad spectrum of observations obtained from human and animal studies
with various gene dosages of Runx2 demonstrate that its role in embryogenesis and postnatal development is non-redundant among its family members, Runx1 and 3 (Komori et
al., 1997; Otto et al., 1997; Zhang et al., 2009; D'Alessandro et al., 2010).

Recent studies point to a putative interaction between Runx2 and the circadian
clock network in osteogenesis and bone homeostasis (Karsenty, 2008; Komori, 2008): a)
animals harboring genetic mutations altering function of core clock genes display
elevated indices of bone formation and increased numbers of osteoblasts, a cell type
whose differentiation from progenitors requires Runx2 (Fu et al., 2005; Maronde et al.,
2010); b) Runx2 expression is rhythmically expressed in bone (Nielsen, 1994); and c)
circadian rhythms in core clock gene expression is detectable in bone and cultured
osteoblasts (Maronde et al., 2010; Smith et al., 2011). Since Runx2 expression is also
detectable in non-osseous tissues including pituitary, gonads and the brain (Jeong et al.,
2008; Breen et al., 2010; Park et al., 2010), these findings suggest that Runx2 may be a
clock-controlled gene in multiple tissues.
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1.5 – THESIS RATIONALE AND OBJECTIVES

1.5.1 Rationale
A growing body of research highlights the influence of the circadian timing system on
osteogenesis and bone homeostasis (Simmons & Nichols, 1966; Nielsen et al., 1991;
Nielsen, 1994; Fu et al., 2005; Zvonic et al., 2007; Grundberg et al., 2008; Maronde et
al., 2010; Smith et al., 2011). The bone forming cells, osteoblasts, are at the center of
these processes. Runx2 is an essential transcription factor involved in the differentiation
of progenitor cells into osteoblasts, an event that is unbalanced in animal models
harboring mutations to core circadian genes (Bunger et al., 2005; Fu et al., 2005). Taken
together with evidence suggesting Runx2 expression is rhythmically coordinated in bone
(Zvonic et al., 2007), these observations suggest an interlocked relationship between
elements of the circadian clock and Runx2. Recently, a microarray study performed in
our laboratory revealed a previously unidentified rhythm in Runx2 expression in the
rodent SCN. This was an intriguing finding given the limited knowledge of Runx2 acting
outside the skeletal system (Jeong et al., 2008; Vladimirova et al., 2008; Takarada &
Yoneda, 2009). While its activity and regulation has been extensively studied in regards
to bone osteogenesis and bone homeostasis, the mechanisms associating it to, and its
regulation by the molecular clock network remain largely unknown. Furthermore, any
effects of Runx2 on the functioning of the circadian clock at the cellular or behavioral
level have not yet been explored. Therefore, the central goal of the studies presented in
the current dissertation is to elucidate the relationship of Runx2 and the molecular
clockwork, and determine its functional role in cellular and behavioral rhythms.
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1.5.2 Hypothesis
The molecular network of the circadian clock mediates rhythmic expression of Runx2 in
the central pacemaker, the SCN, as well as in peripheral oscillatory tissues. In addition to
being a clock-controlled gene, Runx2 acts as a modulator of the circadian rhythms by
feeding back onto the primary elements of the molecular clock in order to influence their
expression and/or activity.

1.5.3 Objectives

1. To determine whether Runx2 expression is under circadian regulation in the adult
murine brain and whether it contributes to the expression of molecular and/or
behavioral rhythms (Chapter II).
2. To demonstrate that Runx2 gene expression is directly regulated by components
of the core circadian clock (Chapter III).
3. To demonstrate that Runx2 regulates circadian clock gene expression and
interacts with the BMAL1 gene (Chapter IV).
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CHAPTER II:

The Transcription Factor Runx2 is Under Circadian Control in the
Suprachiasmatic Nucleus and Functions in the
Control of Rhythmic Behavior

Research article: Meghan E. Reale, Ian C. Webb, Xu Wang, Ricardo M. Baltazar, Lique
M. Coolen, and Michael N. Lehman (2012). Accepted by PLoS One; manuscript number
PONE-D-12-30032R1.
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2.1 – INTRODUCTION

The mammalian timekeeping system that drives rhythmic processes occurring on a 24
hour cycle is organized by a hierarchy of oscillators whose phase is coordinated by the
suprachiasmatic nucleus of the hypothalamus (SCN) (Buijs & Kalsbeek, 2001; Buijs et
al., 2003). In individual SCN cells, as in peripheral cellular oscillators, circadian rhythms
are driven by networks of transcriptional-translational auto-regulatory loops (TTL)
having a cycle lasting approximately 24 hours. The basic helix-loop-helix transcription
factor Bmal1 (brain and muscle ARNT-like 1) and Clock (circadian locomotor output
cycle kaput) heterodimerize and drive transcription of core clock genes Period (Per1,
Per2 and Per3) and Cryptochrome (Cry1 and Cry2) genes by binding E-box elements
within gene sequences (Zhang & Kay, 2010). Per and Cry proteins accumulate in the
cytoplasm where they form heteromultimeric complexes with other proteins and
translocate into the nucleus to inhibit the activity of Clock/Bmal1. As the levels of Per
and Cry expression and protein concentration decrease, the inhibitory complexes are
degraded thus restarting the cycle. In addition to core clock factors, genes involved in
basic cellular events are also tightly regulated by the TTL (for examples, see (Hamaguchi
et al., 2004; Kawamoto et al., 2004; Teboul et al., 2008; Ward et al., 2010)). By
regulating the rhythmic expression of these clock-controlled genes (CCGs), the circadian
system coordinates rhythmic physiological processes at both cellular and tissue levels.

Runt-related transcription factor 2 (Runx2) is one of three members (Runx1-3) of
the mammalian family of transcription factors harboring a runt domain, a highly
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conserved DNA-binding sequence first described in Drosophila melanogaster (NussleinVolhard & Wieschaus, 1980; Gergen & Wieschaus, 1986; Duffy & Gergen, 1991).
Recent studies point to a putative interaction between Runx2 and the circadian clock
network in osteogenesis and bone homeostasis (Karsenty, 2008; Komori, 2008): a) clock
gene mutant mice show deregulated bone formation parameters largely attributed to
increased numbers of osteoblasts, a cell type whose development from its precursors is
highly dependent on Runx2-mediated events (Fu et al., 2005; Maronde et al.); b) Runx2
expression and several of its downstream gene targets are rhythmically expressed in bone
(Nielsen, 1994); and c) oscillations in molecular clock genes are detectible in bone and in
cultured osteoblasts (Maronde et al., 2010; Smith et al., 2011). Since Runx2 expression is
also detectable in non-osseous tissues including pituitary, gonads and the brain (Jeong et
al., 2008; Breen et al., 2010; Park et al., 2010), these findings suggest that Runx2 may be
a CCG in multiple tissues.

In this study, we first examined temporal expression of Runx2 mRNA and protein
in the SCN and other brain regions known to be rhythmic, and compared its circadian
profile to that of the core clock genes Per1, Per2 and Bmal1. Second, we determined
whether Runx2 was under control of the circadian clock by examining its expression in
the SCN of Bmal1-null mice. Third, we compared molecular rhythms between SCNs
cultured from Runx2+/+, Runx2+/- and Runx2-/- mice in real-time by crossbreeding
Runx2+/-

mice

with

mice

harboring

the

circadian

reporter

gene

construct,

mPeriod2::Luciferase (mPer2Luc). Finally, we examined activity rhythms in Runx2+/mice to determine whether Runx2 has a role in regulating behavioral clock outputs.
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Taken together, the findings from these experiments provide insight to the relationship
between Runx2 and the circadian system including evidence for clock gene-mediated
rhythmic expression of Runx2, and the functional role for Runx2 in regulating circadian
period at the level of the SCN and behavior.

2.2 – MATERIALS AND METHODS

2.2.1 Animals

All animal care and experimental procedures were approved by the Canadian Council of
Animal Care and the Animal Use Subcommittee of the University of Western Ontario
(Appendices E & F).

All mice strains, including mutants, were generated on a C57BL/6 background.
Adult, male C57BL/6 mice (8-10 weeks old; Charles River Laboratories, Montreal,
Canada) were used for gene and protein expression studies. Male Bmal1 knockout mice
(Bmal1-/-) mice were generated by breeding Bmal1+/- mice (Bunger et al., 2000)(founder
mice generously provided by Dr. C. Bradfield, University of Wisconsin Medical School,
Madison, WI). Offspring genotyping was performed similar to the methodology
previously described. However, a non-multiplex PCR approach was used in place of
multiplex PCR since the mutant allele is expressed at lower levels than the wild type
allele, which can lead to competitive primer binding during multiplex PCR resulting in
instances of false negative genotyping results. Primers used for genotyping PCR:
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OL2646,

5’-CCACCAAGCCCAGCAACTCA-3’;

OL2647,

5’-ATTCGG-

CCCCCTATCTTC-TGC-3’; and OL278, 5’-TCGCCTTCTATCGCCTTCTTGACG-3’.
The wild-type allele is amplified by primers OL2647 and OL2646 (WT primer set),
which produce a 400bp PCR product. The gene knock-in product (600bp) is amplified by
the neomycin-specific primer set OL278 and OL2646 (M primer set) since the region
targeted by OL2647 is deleted from the mutant Bmal1 gene. In brief, PCR reactions for
each animal were performed using genomic DNA isolated from tail biopsies with 2X
PCR buffer (10μl; Promega) supplemented with 2.5 mM MgCl2 and either WT or M
primer sets (1mM of each primer). PCR reaction conditions consisted of 40 cycles of
95°C for 15 s; 60°C for 15 s; 72°C for 1 min. PCR products were separated by
electrophoresis on a 1% agarose gel in 1X TAE buffer [40mM Tris; 19mM Acetic Acid
(EMD Biosciences, San Diego, CA)]. Two PCR reactions were performed for each
animal, one for each primer set, to determine which alleles were present.

Runx2 deficient (Runx2+/-) mice were generated by breeding Runx2+/- mice (Otto
et al., 1997)(founder mice generously provided by Dr. S. Mundlos, Max Planck Institute
for Molecular Genetics, Berlin, Germany). Offspring genotyping was conducted by PCR
using the following primers (sequences provided by Dr. S. Mundlos): Neo5-neu2, 5’GATGATCTGGACGAAGAGCATCAGG-3’;
GGGTGACCAGTCTCTTACCTTG-3’;

Cbfa11-neu,

MCBFA3-korr,

5’-

5’-AGCGACGTGAG-

CCCGGTG -3’. In brief, multiplex PCR reactions for each animal were performed using
genomic DNA isolated from tail biopsies with 2X PCR buffer (10μl; Promega)
supplemented with 2.5 mM MgCl2 and 2.5mM of each primer. The wild-type allele
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produced a 350 bp PCR product while the mutated Runx2 (neomycin knock-in) gene had
a 600bp amplification product. PCR reaction conditions consisted of 35 cycles of 94°C
for 1min; 59°C for 1min; 72°C for 1 min. For both transgenic strains, WT (Bmal+/+,
Runx2+/+) littermates were used for experimental control groups.

Mice homozygous for the mPeriod2::Luciferase fusion protein gene (mPer2Luc;
Jackson Laboratory, Bar Harbor, ME) were crossbred with Runx2+/- mice to generate
mPer2Luc/Runx2+/- mice for in vitro bioluminescence recording experiments. Offspring
genotyping was conducted for mPer2Luc as previously described (Yoo et al., 2004). In
brief, multiplex PCR reactions were performed using 250 ng of genomic DNA isolated
from tail biopsies with 2X PCR buffer (10μl; Promega) supplemented with 2.5 mM
MgCl2 and 2.5mM of each primer. Primers used for genotyping PCR: P1, 5’CTGTGTTTACTGCGAGAGT-3’; P2, 5’-GGGTCC-ATGTGATTAGAAAC-3’; P3, 5’TAAAACCGGGAGGTAGATGAGA-3’. The wild-type allele is amplified by primers
P1 and P2, which produce a 230 bp PCR product. The luciferase knock-in allele PCR
product (680bp) is amplified by primers P1 and P3. PCR reaction conditions consisted of
35 cycles of 95°C for 45s; 55°C for 45s; 72°C for 1 min. Genotyping for Runx2 was also
performed, as described above. Crossbreeding Runx2+/-/mPer2Luc+/+ produced litters with
predicted Mendelian ratios for the three possible genotypes: Runx2+/+, Runx2+/- and
Runx2-/- . Brain and liver were cultured in random order without prior knowledge of
Runx2 genotype; overall, viability of tissues in culture was similar regardless of genotype
and did not correlate with the order in which tissues were collected from the uterine sac.
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Transgenic breeding colonies were group housed and kept under a 12:12h light:
dark

(LD)

cycle

until

experimental

manipulations

were

conducted.

During

experimentation, animals were individually housed at constant room temperature and
humidity in cages equipped with running wheels (MiniMitter, Bend, OR) and food and
water available ad libitum. Running wheel activity was monitored and recorded
continuously in 5 min intervals using VitalView software (MiniMitter). Actograms,
periodograms and activity levels were analyzed using CLOCKLAB software (Actimetrics,
Evanston, IL).

For studies of diurnal and circadian rhythms in gene and protein expression,
animals were housed in LD until running wheel activity was observed to be stably
entrained (10-14 days) and subsequently either maintained in LD (7-10 days) or housed
under constant dim red illumination (lux < 5; DD) until stable free-running behavior was
established (10-14 days). For animals housed in LD, by convention, lights ON is
designated as zeitgeber time 0 (ZT0) and lights OFF as ZT12. For animals housed in DD,
the daily onset of wheel running was used to estimate circadian time 12 (CT12).

2.2.2 Tissue collection

Animals housed in running wheel cages were sacrificed at six defined times of day under
either LD following stable entrainment or DD after stable free-running behaviour was
established: ZT and CT 1, 5, 9, 13, 17 and 21, respectively (n = 12 per time of day). For
Bmal1-/- mice, animals were transferred into DD at ZT12 and sacrificed at 17 h and 29 h
later, reflecting ZT5 and ZT17 in the following circadian cycle. True circadian time
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cannot be established in these animals because behavior reflects their inherent molecular
arrhythmicity in the absence of a daily light cue. Since photic stimulation of the SCN
may itself stimulate expression of Runx2, animals were sampled within the first day
without photic stimulation in order to sample tissues prior to the breakdown of entrained
rhythms.

For tissue collection for gene or protein expression analyses, animals were
overdosed with sodium pentobarbital; brains were rapidly removed and deeply frozen
under sterile RNase-free conditions. Microdissections of distinct brain regions were
performed by isolating tissue from frozen coronal sections using a sterilized blunt-end
needle. Brain regions included olfactory bulb, suprachiasmatic nucleus (SCN),
paraventricular nucleus of the hypothalamus (PVN) and hippocampus (HP). Tissue
punches were stored at -80°C until further processed.

For immunohistochemistry analyses, animals were deeply anaesthetized with
sodium pentobarbital and perfused transcardially with 50 mL of 4% paraformaldehyde in
0.1M phosphate buffer. Brains were removed, post-fixed in 4% paraformaldehyde for 4h
at 4°C and then stored in 20% sucrose in 0.1M sodium phosphate buffer (PB) with 0.01%
sodium azide. Brains were cut using a freezing microtome into 4 parallel series of 25 µm
thick coronal sections and stored at -20ºC in cryoprotectant (Watson et al., 1986).

2.2.3 Total mRNA isolation and real-time polymerase chain reactions
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RNA samples were produced by pooling tissue isolated from three mice in the same
treatment group to generate a total of n = 4 per time point. Tissue samples were
homogenized and total RNA isolated using TriZol reagent (Invitrogen, Burlington, ON).
Reverse transcription of total RNA was performed using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems Inc., Foster City, CA) according to the
manufacturer’s instructions. Confirmation of gene expression in the SCN was performed
by qualitative RT-PCR conducted in triplicate using 1µg cDNA, 15µL of QuantiFast
Probe PCR Kit Master Mix (Qiagen, Mississauga, ON) and 3µL of each forward and
reverse primer for a total PCR reaction volume of 30µL. Sequences of forward and
reverse primers: Runx2 forward: 5’-CCGCACGACAACCGCACCAT-3’ and reverse: 5’CGCTGGGGCCCACAAATCTC-3’ amplifies 289 bp product; Runx1 forward: 5’CATCCGGTCTCCACTCAGTT-3’ and reverse: 5’-TGGCTTATGGGTCTTCCTTG3’amplifies 612 bp product; Runx3 forward: 5’-CAGGTTCAACGACCTTCGAT -3’ and
reverse: 5’-GAGGTAGGTGTGGTGGAAGC-3’ amplifies 517 bp product; Osteocalcin
forward:

5’-CTCACCCTGTCCCCTAAGC-3’

and

reverse:

5’-

CCGTAGATGCGTTTGTAGGC-3’ amplifies 489 bp product (OligoCore, The
University of Western Ontario, London, ON, Canada). Reactions were preceded by an
initial denaturation step (5 min) followed by 35 amplification cycles of 45s denaturation
at 95ºC, 45s annealing at 60ºC and 1 min elongation at 72ºC with a final 10 min
elongation. PCR products were separated by electrophoresis on a 1% agarose gel in 1X
TAE buffer. Gels were visualized and images captured using the MultiImage Light
Cabinet (Alpha Innotech Corporation, Santa Clara, CA). The genomic identity of
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amplified sequences having predicted lengths were confirmed by molecular sequencing
(Robarts Research Institute, the University of Western Ontario, Canada).

For quantitative analysis of gene expression, real-time qRT-PCR reactions were
performed using 2µL of cDNA, 10µL of TaqMan Universal PCR Master Mix 2X
(Applied Biosystems), 0.8µL of 25mM MgCl2 (Invitrogen), 6.2µL DEPC and 1µL of
TaqMan gene expression assay solution for the gene of interest. QRT-PCR reactions
were performed for Bmal1 (Mm00500226_m1), Per1 (Mm00501813_m1), Per2
(Mm00478133_m1), Runx2 (Mm00501578_m1), Runx1 (Mm01213404), Osteocalcin
(OC; Rn01455285_g1), Osteopontin (Mm01611440_mH) and Glyceraldehyde-3phosphate dehydrogenase (GAPDH; Rn99999916_s1). Triplicate reactions for each
sample were performed using a Rotor-Gene RG-6000 thermocycler and software (Corbett
Life Sciences, San Francisco, CA). Each reaction was performed using the following
PCR conditions: hold at 50ºC for 2 min and 95ºC for 10 min, 40 cycles of 95ºC for 15 sec
and 58ºC for 1 min. The cycle threshold (Ct) values were determined from an optimal
threshold line generated from standard curve dilutions for each gene analyzed. In brief, a
series of 5-log dilutions of cDNA reverse transcribed from RNA isolated from the brain
region of interest was used to perform qPCR reactions for each probe to be used for
analyses. Standard curves were deemed optimal when the line of best fit through the Ct
values of the dilutions had a R2 > 0.99 and an efficiency value between 0.8-1. The Ct of
each experiment sample was determined from the intersection between the baseline
subtracted amplification curve of the sample and the threshold line established by the
optimal standard curve. The gene of interest levels of expression within a sample was
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normalized to their respective levels of the expression of the housekeeping gene,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), within each sample; this value
corresponds to the ΔCt value. In the current study, the ΔΔCt value represents the
difference between gene expression in an individual sample at a given time of day and
the overall average level of gene expression measured at all-time points sampled rather
than a comparison to a control group as typically performed (ΔCt(average) - ΔCt(sample)

=

ΔΔCt). Relative mean fold changes for each sample were calculated relative to the
average ΔΔCt across samples at all times of day sampled with the value 1 representing a
baseline level of expression. One-way Anovas and two-tailed t-tests were conducted to
identify significant daily rhythms of each gene within each brain region, with
significance levels of <0.05.

For analyses of SCN tissues from Bmal1 mutant mice, data were normalized to
GAPDH levels and are represented as a relative mean fold change from the average gene
expression detected at both time points with the value 1 representing a baseline level of
expression. One-way Anovas and two-tailed t-tests were conducted to identify significant
daily rhythms. Values were considered significantly different with p < 0.05.

2.2.4 Total protein isolation and western blotting

Protein samples were generated by pooling tissue isolated from three mice in the same
treatment group to generate a total of n = 4/time point (CT9 and CT21). Methodology
applied for protein isolation, preparation of protein lysates, PAGE, electrophoretic
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blotting and immunodetection of proteins of interest has been previously described
(Webb et al., 2009). In brief, protein samples of equal volume and concentration were
loaded on a 10% polyacrylamide gel and separated under reducing conditions (Webb et
al., 2009). All samples were run in duplicate and balanced by time point and genotype
across individual gels. Precision Plus Protein All Blue Standards (Bio-Rad Laboratories
Ltd.) were used as molecular weight markers. Following protein transfer onto Millipore
Immobilon-FL polyvinylidene difluoride membranes (Millipore, Billerica, MA),
membranes were individually incubated for 16 h on a shaker at 4ºC with an antibody
raised against the loading control protein, GAPDH (mouse anti-GAPDH; 1:20,000;
MAB374, Chemicon International, Temecula, CA), and one of the following rabbit antiRunx2 (mouse) antibody M-70 (1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA);
and rabbit anti-Bmal1 (1:200; PA1-523, Affinity BioReagents, Golden, CO. The
following secondary antibodies were used to visualize immunolabeled blots: IRDye
800CW-conjugated polyclonal goat anti-mouse (1:20,000; LI-COR Biosciences, Lincoln,
NE); Alexa 680-conjugated polyclonal goat anti-rabbit (1:5000; Invitrogen); and IRDye
800CW-conjugated polyclonal donkey anti-mouse (1:20,000; LI-COR Biosciences).
Images were captured using an Odyssey 2.1 scanner (LI-COR Biosciences).
Quantification of protein concentration was performed by determining ratios of protein of
interest/GAPDH intensity levels for each lane and averages of the duplicates were
calculated for each protein sample. The overall fold change in protein across the day was
determined by normalizing the ratios for each sample to the overall mean at CT9 of the
control (WT) groups. Post hoc Tukey analyses were performed where appropriate to
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determine time of day effects and values were considered significantly different with p <
0.05.

All primary antibodies resulted in single bands of immunoreactivity at their
respective expected molecular weights. Labeling of western blots of protein isolated from
calvarial bone and SCN tissue with the Runx2 antibody resulted in labeling of a single
band at the predicted molecular weight for Runx2 (~60kDa; Figure 2.1B) further
confirming the specificity of the antibody recognition over Runx1 (~50kDa) and Runx3
(~45kDa).The specificity of the Runx2 antibody used in the current study has been
previously documented (Luppen et al., 2003; Barski & Frenkel, 2004; Gutierrez et al.,
2004).

2.2.5 Immunohistochemistry

For immunohistochemical analyses, a series of sections throughout the forebrain,
including sections containing the SCN and PVN, from perfused tissue was processed for
Runx2. Immunostaining was performed at room temperature, with gentle agitation of the
free-floating sections, and with extensive rinses with 0.1M phosphate buffered saline,
(pH 7.35; PBS) between incubation steps. First, sections were incubated for 10 min in 1%
H2O2 and for 1h in incubation solution (PBS containing 0.4% Triton-X100 (PBSTX;
Fisher Scientific, Inc.; Ottawa, Canada) and 0.1% bovine serum albumin fraction V
(BSA; Fisher Scientific)). Sections were then incubated in rabbit antibody raised against
mouse Runx2 (1:200 in incubation solution; M-70, Santa Cruz Biotechnology) for 16h, in
biotinylated goat anti-rabbit secondary antibody (1:500 in PBSTX + BSA; Vector,
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Burlington, ON) for 1h and in ABC-elite (1:1000 in PBS; Vector) for 1 h. Reaction
product was visualized

with 3,3’-diaminobenzidine (0.2mg/ml in 0.1M PB; Sigma

Oakville, ON; dissolved in PB supplemented with 0.0004% H2O2 for 10 min. Sections
were mounted onto positively charged glass slides (Fisher Scientific), dehydrated in an
increasing ethanol gradient, delipidated with CitriSolv (Fisher Scientific) and coverslipped with DPX mounting medium (Electron Microscopy Sciences, Hatfield, PA).

For immunofluorescence, sections were incubated in rabbit antibody raised
against mouse Runx2 (1:200 in PBSTX + BSA) for 16h, in biotinylated goat anti-rabbit
(1:500 in PBSTX + BSA; Vector, Burlington, ON) for 1h, in ABC-elite (1:1000 in PBS;
Vector) for 1h, in biotinylated tyramine (PerkinElmer, Waltham, MA; 1:250 diluted in
PBS with 3% H2O2) for 10 min, and in Alexa 488-conjugated streptavidin (1:200 in PBS;
Molecular Probes) for 30 min. Sections were next incubated in mouse anti-NeuN (1:1000
in PBSTX + BSA; MAB377, Chemicon International) for 16h and Alexa 555-conjugated
goat anti-mouse (1:100 in PBSTX + BSA; A-21424, Molecular Probes) for 30 min.
Sections were mounted onto positively charged glass slides, dried and cover-slipped with
an

aqueous

mounting

medium

(Gelvatol)

containing

anti-fading

agent

1,4-

diazabicyclo(2,2)octane (DABCO; 50 mg/ml, Sigma-Aldrich, St. Louis, MO).
Immunohistochemical controls included the omission of individual primary antibodies
resulting in absence of specific immunolabeling for the corresponding antigen.

2.2.6 Histological analysis
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To determine the global distribution of Runx2, a qualitative analysis was performed of
Runx2 immunoperoxidase labeled sections of wild type mice (n = 4 at CT5 and CT9
each). Optical density analyses of Runx2 immunoperoxidase labeled sections were
conducted using images of the SCN and PVN that were captured with a Leica DFC420
camera connected to a Leica DM5000B microscope (Leica Microsystems, Wetzlar,
Germany). All images (2-3 images per animal/area of interest) were captured using
identical microscope and camera settings. Density analyses of immunolabeled cells were
conducted using ImageJ software (NIH, Bethesda, MD) with fixed threshold settings and
were expressed as the area above threshold. Mean areas above threshold (± SEM) were
calculated for each area in individual animals and used to calculate the mean over all
animals (± SEM) for each brain region at a given time of day (CT1, 5, 9, 13, 17, and 21).
The data were expressed as the mean fold change relative to the overall mean across
times of day analyzed (± SEM; 6 time points). Anova analyses were performed to
determine the overall effects of time of day followed by Tukey post hoc tests for pairwise comparisons between each time of day when appropriate. Values were considered
significantly different when p < 0.05.

2.2.7 Confocal Microscopy

Cortical tissues were imaged and captured from coronal slice of adult mouse brain (25
μm) using a Zeiss LSM-510 ConfoCor laser scanning confocal microscope system (Carl
Zeiss MicroImaging GmbH, Göttingen, Germany). Alexa 488 fluorescence (green) was
imaged with a 505-530 nm band pass filter and Argon laser and Alexa 555 fluorescence
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(red) with a 560-615 nm band pass filter and a HeNe1 laser. Z-stack images of 1.0 µm
thick optical sections through sampled sections were captured with x63 oil immersion
objective. Images were used for qualitative analyses only. Colocalization of NeuN and
Runx2 immunostaining in cells was determined based on overlapping fluorescence
detected in overlays of images captured from the same Z-stack images with each
fluorescence filter. Images were viewed using Zeiss LSM Image Browser (Carl Zeiss
MicroImaging GmbH) and were not altered in any way except for adjustment of
brightness.

2.2.8 In vitro monitoring of mPer2Luc bioluminescence

For bioluminescence studies, mPer2Luc+/+/Runx2+/- were mated and pups collected on
embryonic day 19-20 (E19-20). Runx2 expression has previously been described in
neonatal brain tissue (Takarada & Yoneda, 2009). Dames were deeply anesthetised with
CO2, decapitated and uterine sacs containing pups were removed and placed in 4ºC
HBSS (Sigma). Pups were individually dissected out of the uterine sac, brain removed
and encased in 4% low-melt agar (Fisher Scientific). Hypothalamic coronal slices (300
µm) containing the SCN were cut on a vibrotome (ThermoScientific, Burlington, ON) at
4ºC and the SCN was isolated with the aid of a microscope. Tissues were placed on
individual Millicell organotypic culture plate inserts (Millipore, Etobicoke, ON) in a 35
mm Petri dish (BD Biosciences, Mississauga, ON) with 1.2 ml of culture media [DMEM
(Sigma) supplemented with 0.35 g/L sodium bicarbonate (Sigma), 10 mM HEPES (pH
7.2, Sigma) B27 (2%; Invitrogen), 0.1 mM luciferin (Promega, Madison, WI), and
antibiotics (1000 U/ml penicillin, 1000 µg/ml streptomycin; Gibco, Burlington, ON)] For
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additional methodological details, see (Yamazaki & Takahashi, 2005). Livers from each
animal were dissected out and sections ~1-2mm3 were cut by hand and cultured
separately. Cultures were maintained at 36.5ºC and bioluminescence was measured using
a LumiCycle (Actimetrics, Evanston, IL).

Bioluminescence data analyses were performed using the LumiCycle Analysis
Program (Actimetrics, Wilmette, IL). Cycle 0 data (slice preparation start through
midnight of the first day) were excluded from the period analyses and only recordings
containing at least three mPer2Luc peaks were used for analyses. Significant rhythms were
determined by χ2 periodogram analyses conducted following subtraction of a baseline
determined by fitting a low-order polynomial to each data set. Statistical analyses of
period length and amplitude of bioluminescence were performed using the baselinesubtracted rhythms. Differences between genotypes were determined using one-way
Anovas and Tukey post hoc analyses were conducted where appropriate. Values were
considered significantly different with p < 0.05. Genotype of pups was determined using
gDNA extracts from tail biopsies performed during brain dissection (see Animals section
for genotyping details).

2.2.9 Behavioral analysis of Runx2+/- mice

Behavioral entrainment of Runx2+/- mice to a LD schedule and ability to establish stable
free-running activity rhythms in constant darkness (DD) were assessed and compared to
age and sex-matched Runx2+/+ littermates. Behavioral analyses of Runx2-/- mice could not
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be evaluated because these animals lack proper ossification and do not survive past postnatal day 1 (Otto et al., 1997). For phase shifting studies, animals were subjected to an
Aschoff type II phase shifting paradigm (Mrosovsky, 1996). In brief, animals were
initially housed under a strict 12h:12h LD schedule for 7 days, subsequently released into
constant dim red illumination at ZT12 (lux <5), and left undisturbed (control) or given a
15 min light pulse (same intensity as for light period during 12h:12h LD entrainment) at
CT6, CT15, or CT21. Following each manipulation, the animals remained in DD for 7
days. All animals were exposed to each treatment and were allowed to stably re-entrain
for at least 7 days prior to the each photic pulse.

Phase shift responses to light were calculated from running wheel activity records.
CLOCKLAB software (Actimetrics) was used to detect the daily onset of wheel running
and to fit a regression line to the 7 daily onsets prior to the photic manipulation. Phase
shift magnitude (hours ± SEM) was calculated by subtracting the observed activity onset
on day 6 (phase advance) or day 3 (phase delay) of DD from the predicted onset prior to
light treatment. Positive values represent phase advances, negative values represent phase
delays. To control for individual variability in free-running period, the magnitude of the
phase shift produced by the pulse treatments was subtracted by the inherent shift
observed in each animal following the no light control condition. Mean normalized phase
shift values for each treatment and genotype group were determined and comparisons
between genotypes for a given photic manipulation were conducted using one-way
Anova analyses.
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2.3 – RESULTS

2.3.1 Expression of Runx2 in the mouse brain

Given the limited description of the expression of Runx2 in the adult mammalian brain
(Jeong et al., 2008), we first established whether detectable levels of Runx2 are expressed
in the adult C57BL/6 mouse SCN. Qualitative RT-PCR assays validated expression of
Runx2 in this brain region (Figure 2.1A). Consistent with previous observations that
expression of Runx1 is ubiquitously expressed in the mammalian central nervous system
in contrast to Runx3, another member of this transcription factor family, RT-PCR assays
detected expression of Runx1 in SCN samples; however, Runx3 was undetectable. In
addition, Osteocalcin, a known target of Runx2 transcription factor activity (Sato et al.,
1998), was detected in the SCN (not shown). However, a second well established target
of Runx2 in osteoblasts, Osteopontin (Harada et al., 1999), was not found to be expressed
in the SCN. These findings suggest that the Runx2 gene product might have distinct
functionality in the murine SCN compared to bone.

Next, we determined whether Runx2 protein was detectable in the SCN of
C57BL/6 mice. Western blot analyses of protein extracts from the SCN of adult mice
resulted in a band of immunoreactivity at the predicted molecular weight of Runx2 (~57
kDa) (Figure 2.1B) with a corresponding band also present in tissue isolated from mouse
calvaria on embryonic day 15 mice (Ducy & Karsenty, 1995; Banerjee et al., 1996; Choi
et al., 2001). In order to determine if Runx2 is expressed by neurons, coronal sections of
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Figure 2.1. Runx2 gene and protein expression is detectable in neurons of the
suprachiasmatic nucleus (SCN). A) Qualitative PCR analysis of Runx2 mRNA (289bp)
expression in the SCN of adult mice. Lane 1: 100bp molecular weight standard ladder
(black arrowhead: 300bp). Lane 2-4: Runx2 (289bp) PCR product from reactions
performed using E15 mouse calvarial bone mRNA extracts and Runx2-specific primers.
Lane 5-7: Runx2 (289bp) PCR product from reactions performed using adult mouse SCN
mRNA extracts and Runx2-specific primers. Sequencing confirmed the identity of all
positive PCR amplification products. B) Western blot analysis of Runx2 protein
(~60kDa; black arrowhead) expression in the SCN of adult mice. Lane 1: Molecular
weight standard ladder. Lane 2-3: protein isolated from E15 mouse calvarial bone. Lane
4-5: protein isolated from SCN of adult mice. GAPDH (~37kDa; grey arrowhead) protein
detection served as a loading control. C) Immunolabelling of Runx2 (green) and NeuN
(red) in the frontal cortex. Overlay image: co-localization of Runx2 and NeuN (yellow).
Scale bar: 50 µm.
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fixed mouse brain tissue were immunolabeled for Runx2 protein and the neuronal nuclei
marker, NeuN (Mullen et al., 1992). Confocal analysis revealed that Runx2-positive
staining was exclusively localized to NeuN-positive cells in all brain areas (Figure 2.1C).
As others have observed Runx2 promoter activity in several brain structures including the
cortex and hippocampus (Jeong et al., 2008), we also determined whether Runx2 protein
was detectable in these and other brain areas. A qualitative analysis of Runx2 distribution
in the brain revealed that Runx2 is not homogenously expressed. Specifically, dense
immunolabeling was observed in all areas of the cortex (Figure 2.2A), except piriform
cortex, where labeling was light to moderate. Dense labeling was also observed
throughout the thalamus (Figure 2.2D) and in numerous areas within the hypothalamus,
including the paraventricular nucleus of the hypothalamus (PVN), SCN, ventromedial
hypothalamus (Figure 2.2F), preoptic area, anterior and later hypothalamus, but was
absent in the arcuate nucleus and light in dorsomedial nucleus of the hypothalamus.
Moderate labeling was evident in the amygdala (Figure 2.2E), but was light or absent in
the bed nucleus of the stria terminalis and lateral septum. Runx2 immunolabeling was
absent or light throughout the dorsal and ventral striatum (Figure 2.2B), including
caudate putamen, nucleus accumbens, and globus pallidus. Runx2 was present in the
hippocampus, with dense labeling in CA3, and light scattered labeling in CA1-2 and
dentate gyrus (Figure 2.2C). Finally, immunolabeling for Runx2 was dense in most areas
of the midbrain and brainstem, including ventral tegmental area and substantia nigra,
dorsal raphe and red nucleus.
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Figure 2.2. Examples of Runx2 immunolabeling in cortex (A), ventral striatum (B),
hippocampus (C), thalamus (D), amygdala (E), and hypothalamus (F) in a
representative male mouse at CT9. Scale bar indicates 250 µm. Abbreviations: aco:
anterior commissure; AM: anteromedial nucleus of the thalamus; ARC: arcuate nucleus;
BLA: basolateral nucleus of amygdala; cc: corpus callosum; CeA: central nucleus of
amygdala; DB: diagonal band of Broca; DG: dentate gyrus; lv: lateral ventricle; M: motor
cortex; MeA: medial nucleus of amygdala; MS: medial septum, NAc: nucleus
accumbens; ot: optic tract; PVA: paraventricular thalamic nucleus, anterior; Re: reuniens
thalamic nucleus; RS: retrosplenial cortex, S1: somatosensory cortex; sm: stria medularis;
Tu: olfactory tubercle; VMH: ventromedial nucleus of hypothalamus.
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2.3.2 Runx2 gene expression is rhythmic in the mouse brain

To examine the circadian regulation of Runx2, gene expression was examined in the SCN
and several other brain regions previously shown to be rhythmic under both LD and DD
conditions (Abe et al., 2002). In the SCN, under LD conditions, there was a significant
main effect of time of day upon Runx2 expression (F (5, 20) = 5.652; p < 0.01) (Figure
2.3). Post hoc analyses revealed significantly greater expression of Runx2 during the
early to mid-day than during the night (ZT1-5 vs. ZT17-21, p = 0.001-0.03; Figure
2.3A). The rhythmic expression of Per2 (F (5, 21) = 6.439; p < 0.005) was in phase with
the Runx2 rhythm, with peak levels observed during midday (ZT5 vs. ZT13-21, p =
0.001-0.005; Figure 2.3A). Rhythmic expression of Bmal1 (F (5, 21) = 14.171; p < 0.05)
was in antiphase compared to the expression of both Per2 and Runx2, with greater levels
of Bmal1 expression occurring during the night than day (ZT5 vs. ZT17-21, p=0.002;
ZT5 vs. ZT13, p = 0.05; Figure 2.3A).
Under DD conditions, Runx2 expression in the SCN was also rhythmic (F (5, 21)
= 6.117; p < 0.005) with peak levels in the early to midday (CT1-5) and a nadir in the
mid to late night (CT1-5 vs. CT17-21, p = 0.002-0.005; Figure 2.3B). Likewise, the Per2
expression rhythm (F (5, 20) = 16.509; p < 0.001) was similar in phase to that observed
for Runx2 (peak levels observed during early to midday; CT1-5 vs. CT13 and 21, p =
0.0001-0.0003; CT5 vs. CT17, p = 0.07) and antiphase to the rhythm of Bmal1 (peak in
late night; CT1-5 vs. CT13-21, p = 0.00002-0.01; CT9 vs. CT13-17, p = 0.0002-0.007;
Figure 2.3B). In addition, another member of the period gene family, Per1, was also
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Figure 2.3. Runx2 gene expression is rhythmic in the SCN of wild type mice. Fold
changes in levels of gene expression (± SEM) in the SCN for Runx2 (red circle, ●), Per2
(green triangle, ▲; A and B), Bmal1 (blue square, ■; A and B) and Runx1 (black
diamond, ♦; C and D) and OC (blue circle, ●; C and D) determined by real-time qRTPCR under 12h: 12h LD (A and B) and 24hr DD (C and D). Values represent the level of
normalized gene expression relative to the mean overall normalized gene expression
across the day. In 12:12h LD conditions, time of day is represented by white and black
horizontal bars indicating periods of day (light) and dark (night), respectively, with dark
onset marking ZT12. In 24h DD conditions, black horizontal bars represent darkness
during subjective day and night with running wheel activity onset marking CT12. Runx2
gene expression data for 12:12h LD and 24h DD were plotted in both panels to allow for
comparison with multiple gene profiles. Significant peaks levels of expression (*)
compared to nadir points (#) for given gene presented in respective color (p < 0.05).
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expressed in phase with Runx2, with peak levels observed during early to midday (CT1
vs. CT13-21, p=0.004-0.04; CT5 vs. CT13, p = 0.003).

To address whether other genes associated with Runx2 are also rhythmic, gene
expression of Runx1 and Osteocalcin was examined under LD and DD. Rhythmic
expression of Runx1 (F (5, 20) = 6.209; p < 0.005) and Osteocalcin (F (5, 20) = 11.881; p
< 0.05) was evident under 12:12h LD conditions with peaks in early to midday (ZT1 vs.
ZT17-21, p = 0.01-0.007; ZT5 vs. all other times of day, p = 0.016-0.029; Figure 2.3C).
Rhythmic gene expression was also observed in DD for Runx1 (F (5, 22) = 12.883; p <
0.05) and Osteocalcin (F (5, 21) = 7.113; p < 0.001) with significant peaks in expression
in midday, approximately 4h following the observed initial rise in Runx2 expression
observed under DD conditions (Runx1: CT5 vs.CT9-21, p = 0.0005-0.02; Osteocalcin:
CT5 vs.CT9-21, p = 0.01-0.03; Figure 2.3D).

Expression of Runx2 and the clock genes Per2 and Bmal1 were also examined in
the PVN, olfactory bulb (OB) and hippocampus (HP) under LD and DD conditions.
Rhythmic Runx2 gene expression was observed under both lighting conditions in the
PVN (LD: F (5, 21) = 7.364, p < 0.05; DD: F (5, 21) = 3.914, p < 0.05), OB (LD: F (5,
20) = 1.535, p < 0.001; DD: F (5, 22) = 16.455, p < 0.01) and HP (LD: F (5, 22) =
74.407, p < 0.01; DD: F (5, 20) = 14.074, p < 0.05; Figure 2.4). In the PVN, expression
of Per2 was rhythmic under LD (F (5, 19) = 4.683, p = 0.01) and DD conditions (F (5,
19) = 3.940, p = 0.021; Figure 2.4A and B). Per2 expression mirrored that of Runx2 with
greatest levels detected during mid to late day and nadirs observed during the night under
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Figure 2.4. Runx2 gene expression is rhythmic in the brain regions outside of the
SCN. The paraventricular nucleus, the olfactory bulb and the hippocampus tissues were
assayed fewer than 12:12h LD (A, C and E) and 24h DD (B, D and F) conditions. Fold
changes in levels of gene expression (± SEM) for Runx2 (red circle, ●), Per2 (green
triangle, ▲) and Bmal1 (blue square, ■) determined by real-time qRT-PCR. In 12h:12h
LD conditions, time of day is represented by white and black horizontal bars indicating
periods of day and night, respectively, with dark onset marking ZT12. In 24h DD
conditions, grey and black horizontal bars represent subjective day and night,
respectively, with running wheel activity onset marking CT12. Significant peaks levels of
expression (*) compared to nadir points (#) for given gene presented in respective color
(p < 0.05).
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both conditions (Figure 2.4A and B). The peaks in Runx2 and Per2 expression in the
PVN were phase delayed by 4 h compared to the SCN (Figure 2.3A and B, 2.4A and B).
In contrast to the SCN, Bmal1 expression was not rhythmic in the PVN under LD
conditions (F (5, 20) = 1.856, p = 0.162) with a trend for rhythmicity in DD (F (5, 19) =
3.041, p = 0.058; Figure 2.4A and B). As in the SCN, Bmal1 appeared to be in antiphase
to Per2 and Runx2 in the PVN under DD conditions (Figure 2.4B).

The phase relationship between Runx2 and Per2 expression observed in the OB
under LD conditions was similar to that seen in the SCN and PVN but was not as tightly
linked when examined under DD. Specifically, the rhythmic expression of Per2 rhythm in
the OB under LD conditions (F (5, 22) = 8.455, p < 0.001) was similar to that of Runx2
(Figure 2.4C). However, the Per2 expression peak was phase delayed by 4 h compared
to the SCN while the Runx2 peak did not shift (Figure 2.4C). In DD, Runx2 expression
was shifted by 4 h compared to detected levels in the SCN and elevated levels were
extended over the mid day to the early night in the OB in DD (Figure 2.4D). In contrast,
the peak in Per2 rhythm (F (5, 21) = 7.406, p < 0.001) was delayed by 8 h under DD
compared to its peak expression detected under LD conditions (Figure 4C and D) and 12
compared to its peak in the SCN (Figure 2.3A and B). Rhythmic expression of Bmal1
(LD: F (5, 21) = 18.066, p < 0.001; DD: F (5, 23) = 28.053 p < 0.001) also displayed
differing shifts in expression under LD and DD conditions in the OB and maintained an
antiphase relationship with Runx2 and Per2 under both conditions.
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In the HP, Per2 was rhythmic under LD (F (5, 23) = 15.902, p < 0.01) and DD
conditions (F (5, 19) = 8.206, p < 0.001; Figure 2.4E and F). As observed in the PVN,
the peak in Per2 expression was shifted by 4 h in the HP compared to the SCN. This peak
was 4 h earlier than the peak in Runx2 expression, demonstrating a difference in phase
between Per2 and Runx2 in the HP under LD conditions (Figure 2.4E). Bmal1
expression appeared to be in antiphase to Per2 under LD conditions but displayed only a
trend toward rhythmicity in this brain area (F (5, 20) = 2.675, p = 0.06; Figure 2.4E).
Per2 expression was also rhythmic in the HP under DD conditions (F (5, 20) = 8.206, p <
0.001) and displayed a similar phase in expression to Runx2, with shifts in peak levels of
expression by 4-8 h compared to the SCN. Expression levels of Runx2 remained elevated
for a longer interval than Per2 levels (Figure 2.4F). This was opposite of what was
observed under LD conditions wherein Per2 had prolonged elevated levels of detectible
expression compared to a single clear peak for Runx2 (Figure 2.4E). Under DD
conditions, Bmal1 expression was rhythmic (F (5, 20) = 13.226, p < 0.05) with peak
levels in late night and was antiphase to Runx2 and Per2 rhythms (Figure 2.4F).

2.3.3 Runx2 protein expression is rhythmic in the mouse SCN

Next, immunohistochemistry was used to determine whether Runx2 protein, like its
mRNA, was rhythmic in the SCN. In the SCN, there was a significant effect of time of
day on Runx2 immunoreactivity (F (5, 43) = 17.563, p < 0.05; Figure 5), under DD
conditions. Optical density levels were significantly greater at CT9 than at any time
assessed during subjective night (CT9 vs. CT13-21, p = 0.003-0.03). The time of greatest
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optical density of Runx2 immunoreactivity corresponded to ~4h following peak Runx2
gene expression levels in the SCN of animals housed in either LD or DD conditions
(Figure 2.3). Overall protein concentration of Runx2 in the SCN at the peak and nadir
times of immunoreactivity density were also found to be significantly different as
determined by western blot analyses (CT9 vs. CT21, p = 0.023).

Rhythms in the optical density of Runx2 immunostaining were also observed in
the PVN (Figure 2.5). In the PVN (F (5, 31) = 11.019, p < 0.01), peaks in optical density
were seen in the early and late night compared to all times during the subjective day (p =
0.002-0.0001; Figure 2.5). As in the SCN, the initial peak in optical density of Runx2
immunostaining in the PVN occurred ~4h following the observed peak in Runx2 gene
expression (Figure 2.4).
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Figure 2.5. Runx2 protein immunoreactivity is rhythmic in the SCN and PVN of
wild type mice. Fold change (mean ± SEM) in Runx2 protein levels measured by
immunodensity analyses in the SCN (A) and PVN (D) of mice housed in 24h DD. Data
are expressed as the fold change (mean ± SEM) relative to the overall mean across times
of day for all animals for each brain region. Significant peaks levels of expression (*)
compared to nadir points (#; p < 0.05). Representative images of sections through the
SCN (B and C) and PVN (E and F) at peak (B and E) and nadir (C and F) time points.
Traces represent area of analyses. 3V: third ventricle; oc: optic chiasm. Scale bar: 100
µm.
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2.3.4 Rhythmic expression of Runx2 is absent in the SCN of Bmal1 knockout mice

The similarity in phase observed between Runx2 and Per1/2 gene expression rhythms
suggested that Runx2 may be a clock-controlled gene in neurons. Therefore, to determine
whether rhythmic Runx2 expression was dependent on a functional molecular clock
system, gene expression within the SCN of mice lacking one or both functional Bmal1
alleles were assayed at ZT/CT5 and ZT/CT17. Specifically, animals were transferred into
DD at ZT12 and sacrificed at 17 h and 29 h later, reflecting ZT/CT5 and ZT/CT17 in the
following circadian cycle. True circadian time cannot be established in these animals
because their behavior becomes arrhythmic in the absence of a daily light cue. Since
photic stimulation of the SCN may itself stimulate expression of Runx2, animals were
sampled within the first day of DD without photic stimulation in an effort to sample
tissues prior to the breakdown of entrained rhythms. The times selected represent times of
peak and nadir levels of expression of Runx2 and clock genes as observed in WT animals
(Figure 2.3).

In homozygote Bmal1-/- mice, the time of day difference in Runx2 gene
expression was completely absent (CT5 vs. CT17, p=0.147; Figure 2.6). As expected,
time of day differences in gene expression of Per1 and Per2 were also absent in the SCN
of Bmal1-/- mice (p = 0.388 and 0.867, respectively; Figure 2.5). In contrast, time of day
differences in fold changes in gene expression of Per1, Per2 and Bmal1 observed in
heterozygote Bmal1+/- mice mirrored those observed in WT animals (Bunger et al.,
2000). Similar to previous reports, expression of both Period genes, Per1 and Per2, were
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Figure 2.6. Diurnal changes in Runx2 gene expression are absent in Bmal1-/- but not
Bmal1+/- mouse SCN. Fold changes in mRNA levels (± SEM) of Per1, Per2, Runx2 and
Runx1 determined by real-time qRT-PCR under DD conditions. Values represent the
level of normalized gene expression relative to the mean overall normalized gene
expression at observed times of day. *: significant difference in levels of gene expression
between times of day; p < 0.05.
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significantly greater at ZT5 than ZT17 (p = 0.012 and 0.00001, respectively) and the
expression of Runx2 was observed to be greater at ZT5 compared to ZT17 (p = 0.0007) in
the SCN of Bmal1+/- mice (Figure 2.6) (Bunger et al., 2000). Together, these findings
suggest that the circadian rhythms in Runx2 gene expression within the mouse SCN are
dependent on expression of a functional Bmal1 gene.

2.3.5 Circadian rhythms of mPer2Luc-mediated bioluminescence in isolated SCN
from E19/20 Runx2+/+, Runx2+/- and Runx2-/- mice

In order to determine whether a complete absence of Runx2 alters SCN circadian clock
gene rhythms, Runx2+/- mice homozygous for the mPer2luc allele were generated in order
to measure molecular rhythms using real-time monitoring of in vitro bioluminescence
from the SCN.

Tissues were isolated on embryonic day 19-20 (E19/20) thus

circumventing the neonatal lethality of the homozygote Runx2-/- genotype (Otto et al.,
1997).

Overall, there was a significant difference in the mean period length of mPer2Luc
rhythms in SCN cultures from Runx2+/+, Runx2+/- and Runx2-/- mice (F (2, 28) = 3.537, p
< 0.05; Figure 2.7). Post hoc analyses confirmed that the mean period of the mPer2Luc
rhythms in the SCN of Runx2-/- E19/20 mice (n = 7, 25.3 ± 0.26h) was significantly
longer than those observed in the SCN of either Runx2+/- (n = 13, 24.20 ± 0.26h, p =
0.039) or Runx2+/+ (n = 11, 23.92 ± 0.34h, p = 0.047) littermates (Figure 2.7A and B).
No significant difference in the mean period of the mPer2Luc rhythms was seen between
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Figure 2.7.

Mean period of mPer2Luc-mediated bioluminescence rhythms is

lengthened in the SCN of Runx2 deficient mice. A) Mean period (± SEM) of mPer2Luc
rhythms in SCN cultures of Runx+/+ (black), Runx2+/- (grey) and Runx2-/- (white)
determined from real-time monitoring of bioluminescence from isolated E19/20 mice.
Inlayed number represents n value of experimental group. B) Representative trace of
mPer2Luc-mediated bioluminescence observed over several cycles from Runx2+/+ (black),
Runx2+/- (grey) and Runx2-/- (dashed) SCN cultures. *: significant difference in levels of
gene expression between times of day; p < 0.05.
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Runx2+/- and Runx2+/+ littermates (p = 0.328). We did not observe a difference in the
mean amplitude of bioluminescence levels between genotypes (p > 0.1). Moreover, in
liver tissue which does not express Runx2, there was no difference in the mean period of
bioluminescence between genotypes (data not shown; p = 0.473).

2.3.6 Runx2+/- mice display lengthened period of free-running activity

To determine whether Runx2 deficiency leads to in vivo consequences in circadian
behavior, the wheel-running rhythms of Runx2+/- mice were compared to those of
Runx2+/+ mice. As noted above, heterozygote animals were used since homozygous
Runx2-null mutants are postnatal lethal (Otto et al., 1997).

In free-running conditions, Runx2+/- mice displayed a significantly longer mean
free-running period (n = 72, 23.78 ± 0.03h) than that of Runx2+/+ males (n = 74, 23.54 ±
0.04h, p < 0.001) (Figure 2.8A and C). The mean total wheel revolutions per day were
not significantly different between Runx2+/+ (2959.73 ± 126.40) and Runx2+/- mice
(3120.60 ±166.68, p = 0.126; Figure 2.8B), indicating that differences in free-running
period are not due to differences in overall locomotor activity.

Exposure to environmental cues, such as light, can induce phase-dependent shifts
in activity rhythms. To investigate whether Runx2 plays a role in photic resetting of the
clock, Runx2+/+ and Runx2+/- mice were subjected to phase shifting light pulses during
either subjective day, or early or late subjective night. As expected, running wheel
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activity was significantly shifted following exposure to a light pulse during late (CT21 vs.
no pulse; p = 0.000003) or early subjective night (CT 15 vs. no pulse; p = 0.0005) but not
to light exposure during subjective day (CT6 vs. no pulse; p = 0.704) (Table 2.1).
Genotype comparisons revealed that direction and amplitude of phase shifts in response
to light pulses at these different circadian times did not differ between Runx2+/- and
Runx2+/+ littermates (p > 0.5; Table 2.1).

Table 2.1. Runx2+/- mice display responses to phase shifting light pulses
indistinguishable from Runx2+/+ mice. Mean phase shifts (h ± SEM) for wild-type and
Runx2+/- mice exposed to a light pulse at CT6, CT15 or CT21.

Genotype
Runx2+/+ (n=6)
Runx2+/- (n=6)

Light Pulse at CT6
-0.140 ± 0.491 h
0.270 ± 0.377 h
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Light Pulse at
CT15
-1.136 ± 0.378 h
-0.933 ± 0.209 h

Light Pulse at
CT21
2.362 ± 0.667 h
2.088 ± 0.578 h

Figure 2.8. Free-running period of running wheel activity is lengthened in Runx2+/mice. A) Mean (± SEM) free-running period of Runx2+/+ (grey) and Runx2+/- (white)
mice. Inlayed number represents n value of experimental group. B) Mean ± SEM wheel
revolutions of male Runx2+/+ (grey) and male Runx2+/- (white) entrained to a 12:12h LD
schedule. Inlayed number represents n value of experimental group. C) Representative
running wheel activity records (upper panels) for Runx2+/+ (left panels) and Runx2+/(right panels) mice. Activity records are in single-plotted format with each horizontal line
represents a 24h period. In 12h:12h LD conditions, time of day is represented by white
and black horizontal bars indicating periods of day and night, respectively, with dark
onset marking ZT12. Black arrow with white asterisk: transition into 24h DD.
significant difference between genotypes; p < 0.05.
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2.4 – DISCUSSION

We found that Runx2 mRNA and protein expression is rhythmic and under the control of
circadian clock network in the SCN, as well as in several other brain regions previously
shown to exhibit rhythmic clock gene expression (Abe et al., 2002; Jilg et al.). In
addition, Runx2 appears to play a functional role in the regulation of cellular and
behavioral rhythms, with lengthened free-running period being observed in Runx2
mutant SCN tissues and animals.

In the SCN, the phase of peak Runx2 expression was similar to that of Per1 and
Per2 suggesting the possibility that Runx2, like Per1 and Per2, may be a target for
Bmal1/Clock transactivation. Indeed, in the absence of a functional Bmal1 gene product,
a rhythm in Runx2 mRNA in the SCN of mice housed under DD conditions was
undetectable, again mirroring the effects on Per1 and Per2. This effect of the Bmal1
knockout on Runx2 gene expression suggests that Runx2 is a clock-controlled gene
dependent on Bmal1 activity. Consistent with this, a putative Bmal1-response element
(E-box) has been described in the region upstream of the Runx2 promoter, although the
functionality of this site remains to be validated (Wang et al., 2006). A comprehensive
study of the promoter regions of Runx2 would provide greater insight into the possible
mechanisms of Bmal1-mediated Runx2 expression (Stock & Otto, 2005).

Alternatively, rhythmic expression of the Runx2 gene may not be directly
mediated by Bmal1 but rather under the transcription control of one or several other
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CCGs. One such CCG, known to be rhythmically expressed in the SCN, is transforming
growth factor ß (TGF-ß) (Alliston et al., 2001; Kang et al., 2005; Beynon et al., 2009). In
osseous tissues, Runx2 expression and activity is repressed by the signalling cascade
activated by TGF-ß (Alliston et al., 2001; Kang et al., 2005). Since TGF-β expression
and signalling activity are elevated during the subjective night in the SCN, a time when
Runx2 expression is at its lowest, TGF-β may be having a similar repressive effect on the
Runx2 transcription in the SCN (Beynon et al., 2009). Given the evidence for the nonphotic phase shifting properties of TGF-ß signalling in peripheral tissues (Kon et al.,
2008), it is interesting to speculate its capacity to do so in the SCN is attributable to its
effects on Runx2.

The results of the in vitro and in vivo experiments reported here suggest that
Runx2 participates in regulating circadian period length through its influence on
molecular and/or signalling pathways occurring at the level of the SCN. Within the SCN
and other tissues, period length is largely due to the timing of intracellular molecular
rhythms (Welsh et al., 2010), and there are several possible mechanisms by which Runx2
may act to lengthen the period of cellular rhythms. First, the timing of the intracellular
rhythms may be modified by actions of Runx2 on transcription of clock genes or their
regulators leading to a lengthened period of the individual cellular oscillators comprising
the SCN. The runt-domain of the Runx2 protein binds DNA in a site-specific manner by
recognizing sequences identified as of 5’-puACCpuCA-3’ (Kamachi et al., 1990). A
cursory analysis identified a number of putative Runx2 binding sites within the sequences
of clock genes including Bmal1 and Per2 (NCBI reference sequence: AC_000029.1,
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NC_000067). Further studies are needed to identify functional Runx2 binding sites in
clock gene sequences and to determine the influence of Runx2 on the expression of these
genes. Runx2 also contains a number of protein-protein interaction domains that act to
recruit proteins to downstream gene targets, including transcription activators (i.e. p300,
CCAAT/enhancer binding proteins) and repressors (i.e. histone deacetylases) (McCarthy
et al., 2000; Sierra et al., 2003; Jensen et al., 2008). The diversity of the multi-protein
complexes formed through Runx2-mediated scaffolding is further increased by a number
of potential post-transcriptional modifications to Runx2 (Lian et al., 2003; Bae & Lee,
2006). Thus, in addition to acting directly through its DNA-binding sequences, Runx2
may act indirectly to regulate transcription of clock genes and/or CCGs by facilitating
recruitment of other factors that, in turn, serve to facilitate or repress target genes.

The period lengthening effect of Runx2+/- observed in vivo was also observed in
the period of the bioluminescence rhythms detected from cultured SCN tissues collected
from Runx-/- mice. Unlike activity rhythms measured in vivo, no significant change in the
period length was detected in Runx2+/- SCN cultures. However, when the mean period
length value of in vitro bioluminescence rhythms measure from the SCN tissues of
Runx2+/- mice is compared to the mean period of free-running rhythms of Runx2+/- mice,
both show a similar magnitude of period lengthening (16.8 min in vitro vs.14.4 min in
vivo). The lack of statistical significance between the periods of molecular rhythms
measured from Runx2+/+ and Runx2+/- SCN tissues therefore likely lies in the variability
of the measured bioluminescence rhythms in vitro. This variability could be due to a
number of factors including lack of sensitivity of the detection method or a relatively
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smaller sample number for each group under in vitro conditions versus the in vivo sample
sizes (Mickman et al., 2008; Foley et al., 2011). Previous studies correlating period in
behavioral rhythms in vivo to molecular rhythms in vitro have examined animals
harboring mutations with dramatic differences in period length (Vitaterna et al., 2006;
Godinho et al., 2007; Meng et al., 2008) and under conditions where both gene alleles are
compromised. Another factor may have been the differences in age of the mice in the in
vivo (adult) and in vitro experiments (embryonic). Thus it is possible that the effects we
observed in haplodeficient animals are only manifested in adulthood perhaps due to
compensatory mechanism(s) during development that either wane or are insufficient later
in life.

Beyond the SCN, detectible expression levels of Runx2 were rhythmic in the
PVN, OB and hippocampus. The phase of the Runx2 rhythm was shifted by ~4 h in each
of these brain regions under DD conditions compared to its phase in the SCN. This phase
lag may be of physiological importance since the synchronization of oscillators to one
another may be critical in coordinating neural activity and responses to external cues (i.e.
light, food). Such a phase lag (3-9 h) relative to their maximal expression in the SCN is
typical of genes expressed in peripheral tissues whose circadian oscillations are driven
and/or synchronized by a signal led by the circadian pacemaker (Zylka et al., 1998; Yoo
et al., 2004). Support for SCN-influenced expression of Runx2 in these peripheral tissues
can be derived from the observation that shifts in the phase of Runx2 oscillations were
similar to the lag observed for the circadian clock gene, Per2. Whether the oscillations of
Runx2 in these brain regions are driven and/or synchronized by the SCN remain to be
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elucidated. It may be that the rhythmic expression of Runx2 in the PVN, a target of SCN
efferents, is driven by the SCN and would become arrhythmic in its absence (Berk &
Finkelstein, 1981; Kalsbeek et al., 1993; Vrang et al., 1995; Dai et al., 1997; Abe et al.,
2002). In contrast, the OB has been convincingly shown to contain independent, selfsustained oscillators that do not rely on the SCN (Granados-Fuentes et al., 2004a;
Granados-Fuentes et al., 2004b). Since rhythms in the OB are synchronized rather than
driven by the SCN, oscillations in Runx2 in the OB would likely persist in SCN-lesioned
animals (Granados-Fuentes et al., 2004a). Rhythmic expression of clock genes, including
Bmal1 and Per2, has previously been described within the HP; however, the dependency
of these rhythms on the SCN has not been thoroughly evaluated (Shieh, 2003; Jilg et al.,
2010). Finally, Runx2 protein was found to expressed in numerous other areas within the
brain, as are clock genes suggesting that Runx2 may influence circadian modulation of a
variety of physiological and behavioral functions (Shieh, 2003; Webb et al., 2009; Jilg et
al., 2010).

Runx2 deficiency is known to have clinical consequences in skeletal development
and bone homeostasis. Cleidocranial dysplasia (Online Mendelian Inheritance in Man
#119600) is a rare genetic disorder resulting from an autosomal dominant mutation(s) or
complete loss of a functional Runx2 gene copy (Mundlos et al., 1997). In general,
patients with this disorder have abnormal osteogenic development and present with a
number of skeletal and dental deformities which vary in severity depending on the causal
gene mutation (Yoshida et al., 2003). To date, no circadian or sleep disorders have been
linked with CCD. Given our findings on the effects of Runx2 on period length, it would
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be worthwhile to assess the status of circadian biomarkers and sleep patterns in
individuals with CCD to determine if the effects of Runx2 haplodeficiency we observed
in mice translate to humans.

In summary, Runx2 appears to be a circadian clock-controlled gene that is
expressed rhythmically in the SCN and other regions of the murine brain. This expression
occurs in a circadian fashion with greatest levels of expression occurring during the
subjective day and this rhythm is dependent on the expression of Bmal1 suggesting that
Runx2 is a circadian controlled gene. Decreased Runx2 gene expression leads to
significant lengthening of the period of behavioral rhythms in vivo and lengthened
mPer2Luc rhythms in vitro. Future studies will be needed to identify the precise
mechanisms by which Runx2 is regulated by circadian clock genes within the SCN as
well as in bone and other peripheral tissues, and its potential impact on other clockcontrolled genes.
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CHAPTER III:

The Molecular Clock Directly Regulates Rhythmic Expression of Runx2
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3.1 – INTRODUCTION

In the previous chapter (Chapter II), we demonstrated rhythmic expression of Runx2
(runt-related transcription factor 2) in the suprachiasmatic nucleus of the hypothalamus
(SCN), where its pattern of expression was in phase with the circadian clock genes, Per1
and Per2; while in anti-phase with Bmal1. Moreover, the functional relevance of Runx2
rhythms was demonstrated in animals harboring a mutation in one of the Runx2 alleles,
which resulted in an elongation of the period of behavioral circadian rhythms. This
prolonged period of behavioral rhythms appeared to be due to altered molecular rhythms
at the level of the SCN (Chapter II). Finally, the temporal variation in Runx2 gene
expression in the SCN was blunted in animals lacking functional Bmal1 expression
(Chapter II), indicating that rhythmic expression of Runx2 is dependent on a functional
circadian clock, namely the transcriptional activity of the Bmal1/Clock heterodimer
(Reppert & Weaver, 2001).

At a molecular level, the timing of circadian oscillations is based on an autoregulatory transcriptional-translational feedback loop (Figure 1.1). The feed forward arm
of the transcriptional-translational feedback loop driving circadian oscillations consists of
the Bmal1/Clock complex, promoting the rhythmic expression of core clock genes,
Period 1 and 2 (Per1 and 2) and Cryptochrome 1 and 2 (Cry1 and 2) genes. The protein
products of these genes feedback to negate the transcriptional drive of Bmal1/Clock
complex, forming the negative feedback arm of the loop. In addition to core clock genes
essential to the generation of circadian oscillations, the molecular machinery of the
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circadian clock promotes transcription of gene required for rhythmic biological
processes, known as clock-controlled genes. Expression of clock-controlled genes can be
driven directly by the Bmal1/Clock transcriptional complex or indirectly by transcription
factors that are themselves regulated by the feed forward mechanism of the circadian
clock. Based on the observation made in Chapter II that the phase of Runx2 expression
mirrors that of the Per genes, known targets of the Bmal1/Clock transcriptional complex,
it can be postulated that Runx2 is a clock-controlled gene.

Bmal1/Clock-mediated gene expression is selectively driven through recognition
of E-box (5’-CACGTG-3’) and E’-box (5’-CACGTT-3’) elements within the promoter
region of core clock genes as well as clock-controlled genes (Yoo et al., 2005; Fustin et
al., 2009). Indeed, a canonical circadian E-box sequence as well as several divergent
sequences are present in the promoter region of the Runx2 gene (Appendix A).
Moreover, there are several divergent E-box sequences of which five (5’-CACATG-3’)
have been shown to be activated by the clock transcription complex when they located
adjacent to the canonical E-box favored by Bmal1/Clock (Triqueneaux et al., 2004).
Thus, there are several putative Bmal1/Clock binding regions in the Runx2 promotor
region, which may represent functional sites at which the circadian clock can exert
influence on Runx2 expression. Taken together with the observations made in the
previous chapter, I hypothesize that the Bmal1/Clock heterodimer directly promotes
rhythmic transcription of Runx2 by physically binding to the promoter region of the gene.
To date, this notion has not yet been explored and is the basis of the current studies.
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In order to dissect the molecular mechanisms by which the components of the
circadian clock network regulate the rhythmic expression of Runx2, experiments were
conducted using a cell line known to express RUNX2 under native conditions. The
U2OS-B6 cell line features several characteristics which make it a favorable model
system to be used for these studies: 1) U2OS-B6 cells exhibit robust circadian
oscillations under cell culture conditions, with detectible rhythms in expression of core
clock genes (i.e. BMAL1, PER2, REV-ERBα) (Hughes et al., 2009), 2) U2OS-B6 cell line
dependent on RUNX2 function, and originates from osteosarcoma, cells that have human
osteoblastic lineage (Ducy et al., 1997); 3) they are an easily transfectable cell line
facilitating genetic manipulations.

The current study presents findings in support of the hypothesis that rhythmic
expression of RUNX2 is driven by direct interaction of the BMAL1/CLOCK heterodimer
complex with the promoter region of the gene. First, rhythmic RUNX2 gene expression
in synchronized U2OS cultures is shown to be in antiphase to that of BMAL1, mirroring
observations made in vivo in the SCN (Chapter II). Second, the expression of RUNX2 is
ablated in synchronized U2OS cells in which BMAL1 gene expression was transiently
silenced. Finally, chromatin immunoprecipitation was conducted to demonstrate the
physical interactions of BMAL1 to the RUNX2 promoter region at two circadian
intervals.
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3.2 – MATERIALS AND METHODS

3.2.1 U2OS-B6 cell culture

The U2OS-B6 cell line has previously been described (Vollmers et al., 2008). Cell
cultures were maintained under standard cell culture conditions (incubated at 37ºC with
5% CO2) in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA)
supplemented with 10% FBS, 1% Penicillin/Streptomycin and 2 µg/mL puromycin. For
time course studies, cells were synchronized using a cocktail of 0.1µM dexamethasone
and 1µM forskolin (Sigma, St. Louis, MO). Dexamethasone is a potent activator of
glucocorticoid-mediated signaling pathways acting at the level of transcriptional
regulation. Several core circadian factors mediating the circadian transcription-translation
feedback loop (PER1, CRY1, and BMAL1) harbor glucocorticoid response elements
(GRE) within the promoter region of their genes and are sensitive to dexamethasone
treatment (Reddy et al., 2007). Consequently, activation of the glucocorticoid-mediated
signaling pathway can reset the phase of the molecular clock. In contrast, forskolin
directly activates adenylyl cyclase leading to raised levels of cyclic AMP (cAMP) and
activation of the protein kinase A (PKA) signaling pathway. In turn, PKA phosphorylates
and activates the Ca2+/cAMP responsive element binding protein (CREB) thus eliciting
circadian gene expression (i.e. Per1, Per2) leading to phase resetting of the molecular
clock (Yagita & Okamura, 2000; O'Neill et al., 2008). Using two different factors to reset
the molecular clock in culture ensured that all the cells in the plate were synchronized
within the time span of the experiments.
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3.2.2 Total mRNA collection and quantitative real-time PCR

Media was removed by vacuum and cells were washed once with cold phosphate buffer
supplemented with saline (PBS; pH7.4). Cells were lysed using TRIzol reagent
(Invitrogen) and harvested using a silicon cell scraper. The cell lysate was passed through
a pipette several times to homogenize sample and incubated for 5 min at room
temperature (RT). Chloroform was added to each sample (1/5th volume of TRIzol
reagent), samples were shaken vigorously by hand for 15 sec, incubated for 3 min at RT
and centrifuged at 13 200RPM for 20 min at 4ºC. The colorless aqueous upper phase
containing the RNA of each sample was transferred to individual fresh eppendorf tubes.
Ice cold isopropanol (1/2 volume of TRIzol reagent) was added to each sample, tubes
were inverted several times and sample incubated at -20ºC overnight. RNA was pelleted
by centrifugation at 13 200RPM for 20min at 4ºC. Supernatant was removed, pellet
washed with ice cold 70% ethanol and centrifuged at 13 200 RPM for 20 min at 4ºC.
Supernatant was discarded and RNA pellet was air dried for 5 min. RNA was redissolved
in RNAse-free H2O by pipetting. RNA concentration for each sample was determined by
spectrophotometry (Nanodrop). Reverse transcription of total RNA was performed using
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems Inc., Foster
City, CA) according to the manufacturer’s instructions.

For quantitative analysis of gene expression, qRT-PCR reactions were performed
using 2µL of cDNA, 10µL of TaqMan Universal PCR Master Mix 2X (Applied
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Biosystems, Inc), 0.8µL of 25mM MgCl2 (Invitrogen), 6.2µL DEPC and 1µL of TaqMan
gene expression assay solution for the gene of interest. QRT-PCR reactions were
performed

for

BMAL1

(Hs00154147_m1),

PER1

(Hs00242988_m1),

PER2

(Hs00256143_m1), RUNX2 (Hs00231692_m1), REV-ERBα (Hs00355782_m1) and
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Hs02758991_g1). Triplicate
reactions for each sample were performed using a Rotor-Gene RG-6000 thermocycler
and software (Corbett Life Sciences, San Francisco, CA). Each reaction was performed
using the following PCR conditions: hold at 50ºC for 2 min and 95ºC for 10 min, 40
cycles of 95ºC for 15 sec and 58ºC for 1 min.

Data analysis for time series experiment was performed as follows: The cycle
threshold (Ct) values were determined from an optimal threshold line generated from
standard curve dilutions for each gene analyzed. In brief, a series of 5-log dilutions of
cDNA reverse transcribed from RNA isolated from U2OS cells was used to perform
qPCR reactions for each probe to be used for analyses. Standard curves were deemed
optimal when the line of best fit through the Ct values of the dilutions had a R2 > 0.99 and
an efficiency value between 0.8-1. The Ct of each experiment sample was determined
from the intersection between the baseline subtracted amplification curve of the sample
and the threshold line established by the optimal standard curve. The gene of interest
levels of expression within a sample was normalized to their respective levels of the
expression of the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), within each sample; this value corresponds to the ΔCt value. In the current
study, the ΔΔCt value represents the difference between gene expression in an individual
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sample at a given time of day and the overall average level of gene expression measured
at all-time points sampled rather than a comparison to a control group as typically
performed (ΔCt(average) - ΔCt(sample) = ΔΔCt). Relative mean fold changes for each sample
were calculated relative to the average ΔΔCt across samples at all times of day sampled
with the value 1 representing a baseline level of expression. One-way Anovas and twotailed t-tests for post hoc analyses were conducted to identify significant daily rhythms
p< 0.05.

3.2.3 Total protein isolation and western blotting

Cell culture plates were transferred from incubator and kept on ice. Media was removed
by vacuum and cells were washed once with cold PBS (pH7.4). Cells were lysed in
culture plates by lysis buffer (150mM NaCl, 50mM Tris pH8.0, 1mM EDTA, 1%
Nonidet P 40) supplemented with 1X protease inhibitor cocktail (aprotinin, leupeptin,
pepstatin A and trypsin inhibitor; Roche, Germany) for 2 min on ice. Cells were
harvested using a silicon cell scraper, transferred to an Eppendorf tube and kept on ice for
10 min to complete lysis. Samples were centrifuged at 12 000 RPM for 15 min and
supernatant containing protein was transferred to a clean tube and concentrations were
determined by BCA assay (ThermoScientific, Il) according to manufacturer’s instructions
and

spectrophotometry

(NanoDrop

1000).

Methodology

applied

for

PAGE,

electrophoretic blotting and immunodetection of proteins of interest has previously been
described (Webb et al., 2009). In brief, equal volume and concentrations of protein (10
µg/µL) were combined with an equal volume of 2X SDS loading buffer (100mM Tris
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pH6.8, 25% glycerol, 2% SDS, 0.01% bromophenol blue, 10% β-mercaptoethanol) and
heated at 94ºC for 4 min. Equal volumes of sample were loaded onto 10%
polyacrylamide gel and separated under reducing conditions (Webb et al., 2009). All
experimental samples were run in duplicate and balanced by time point across individual
gels. Precision Plus Protein All Blue Standards (Bio-Rad Laboratories Ltd.) were used as
molecular weight markers. Protein samples separated on gels were transfered onto
Millipore Immobilon-FL polyvinylidene difluoride membranes (Millipore, Billerica,
MA), which were individually incubated for 16h on a shaker at 4ºC with an antibody
raised against the loading control protein, GAPDH (mouse anti-GAPDH; 1:20,000;
MAB374, Chemicon International), and rabbit anti-mRunx2 antibody (1:200; M-70,
Santa Cruz Biotechnology Inc.,). The following secondary antibodies were used to
visualize immunolabeled blots: IRDye 800CW-conjugated polyclonal goat anti-mouse
(1:20,000; LI-COR Biosciences, Lincoln, NE) and Alexa 680-conjugated polyclonal goat
anti-rabbit (1:5000; Invitrogen). Images were captured using an Odyssey 2.1 scanner (LICOR Biosciences). Quantification of protein concentration was performed by
determining ratios of protein of interest/GAPDH intensity levels for each lane and
averages of the replicates were calculated for each protein sample. The overall fold
change in protein across the day was determined by normalizing the ratios for each
sample to the mean protein level across all time points.

All primary antibodies resulted in single bands of immunoreactivity at their
respective expected molecular weights. The specificity of the RUNX2 antibody used in
the current study has been previously documented (Luppen et al., 2003; Barski &
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Frenkel, 2004; Gutierrez et al., 2004) and labeling of western blots of protein isolated
from U2OS cells with the RUNX2 antibody resulted in a single band at the predicted
molecular weight for RUNX2 (~57kDa; Figure 2.1). In accordance with published
evidence for detectible RUNX2 protein levels (both isoforms) in U2OS-B6 cells, we
were able to detect robust levels of RUNX2 gene expression and protein levels within this
cell line (Sudhakar et al., 2001).

3.2.4 Cell culture transfection

U2OS cells were plated in 35mm dishes at 80% confluency the day of transfection.
BMAL1 silencing experiments in U2OS cells were performed by transient transfection of
cells with plasmids constructed to express either short hairpin BMAL1 (shBMAL1; n =
3) or short hairpin negative control sequences (shControl; n = 3). Plasmids (1µg of DNA
per well) were transfected into U2OS cells using Lipofectamine 2000 reagent
(Invitrogen) in OptiMEM (Gibco, Carlsbad, CA). Cells were maintained under standard
tissue culture conditions in DMEM (Gibco) supplemented with 10% fetal bovine serum
(Gibco), 1% Penicillin/Streptomycin and 2 µg/mL puromycin at 37ºC in a humidified
atmosphere supplemented with 5% CO2 (Thermo Scientific, Waltham, MA).U2OS cells
were synchronized with dexamethasone and forskolin as described above and harvested
at either 24 or 44h post-synchronization for total RNA and total protein collection (as
described above). Quantitative real-time PCR analyses were used to determine levels of
gene expression and protein extracts were prepared for western blot analyses to determine
effects of gene silencing on protein levels (as described above).
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3.2.5 Chromatin Immunoprecipitation

Cultures were exposed to 1% formaldehyde for 15 min at RT to crosslink protein to DNA
at either 24 (n = 2) or 40h (n = 2) post-synchronization. Crosslinking was quenched with
0.14M glycine at room temperature for 5 min and cells were washed five times with cold
PBS (pH7.4). Cells were harvested from plate using a silicon scraper. Cells were
centrifuged at 1000 RPM for 2 min at 4ºC and the pellet washed with PBS five times.
Following the final wash, all supernatant was removed and cells were resuspended in
hypotonic lysis buffer (100mM Tris pH 8.0, 10mM NaCl, 3mM MgCl2, 30mM sucrose,
0.1% Nonidet P 40) supplemented with 1X protease inhibitor cocktail (Roche) and
incubated on ice for 10 min. The cells were pelleted by centrifugation at 3000 RPM for 5
min at 4ºC, buffer removed and pellet resuspended in 500µL of RIPA buffer (50mM Tris
pH7.5, 150mM NaCl, 0.1% SDS, 0.5% deoxycholate, 0.2% Nonidet P 40, and 5mM
EDTA) supplemented with 1X protease inhibitor cocktail and 50mM NaF. The cells were
sonicated to shear DNA fragments into sizes ranging from 100-1000bp. The cells were
kept on ice for 10 min and centrifuged at 13 200 RPM for 10min at 4ºC. Gel
electrophoresis using 1% agarose gel supplemented with EtBr was used to verify DNA
fragment sizes ranged from ~100bp to 1000bp in length. DNA concentration of the
supernatant was determined using spectrophotometry (NanoDrop). Samples with equal
concentrations of DNA (60µg in 800µL of RIPA buffer) were incubated for 1h at 4ºC
with 60µLof pre-washed Protein A sepharose 4B conjugate beads (Invitrogen). Samples
were centrifugated at 13 200 RPM for 5 min at 4ºC. Supernatant from samples were
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rotated overnight at 4ºC with one of the following antibodies: RUNX2-specific rabbit
antibody (M-70; Santa Cruz Biotechnology, Inc), BMAL1-specific rabbit antibody (Santa
Cruz), or control antibody mix consisting of normal rabbit IgG (1:800; sc-2027, Santa
Cruz Biotechnology, Inc) and normal mouse IgG (1:800; sc-2025, Santa Cruz
Biotechnology, Inc). Following the overnight incubation, 30µL of sepharose beads were
added to each sample and rotated for 1h at 4ºC. Samples were centrifuged at 3000RPM
for 2 min at 4ºC. A fraction of the supernatant was set aside as the input sample. The
beads were washed twice with a low salt buffer (0.1% SDS, 0.1% Triton X-100, 2mM
EDTA, 20mM Tris pH8.0, 150mM NaCl), once with a high salt buffer (0.1% SDS, 0.1%
Triton X-100, 2mM EDTA, 20mM Tris pH8.0, 500mM NaCl), then with a lithium buffer
(0.25M LiCl, 1% Nonidet P 40, 1% deoxycholate, 1mM EDTA, 10mM Tris pH8.0) and a
TE wash (Fisher Scientific, Fair Lawn, NJ). Each wash was followed by 5 min
incubation, 2 min centrifugation at 3000 RPM at 4ºC and supernatant was discarded.
Beads were resuspended in 100µL of TE wash supernatant following the final wash,
rotated for 5 min, centrifuged for 2 min at 3000 RPM at 4ºC and supernatant was
discarded. Elution was conducted in 200µL of elution buffer (50mM Tris pH8.0, 10mM
EDTA, 200mM NaCl, 1% SDS) containing 1µL of protease K and 200mM of DTT for
1h at 42ºC. Crosslinking was reversed for both the immunoprecipitate (IP) and loading
samples (supplemented with 200mM of NaCl) by heating at 65ºC overnight. Following
reversal of crosslinks, samples were centrifuged at 13 200 RPM for 2min at 4ºC. The
DNA from the supernatant was purified by phenol:chloroform:isoamyl alcohol and
ethanol purification. Purified DNA pellets were resuspended in TE buffer and DNA
concentration was determined by spectrophotometry (NanoDrop).
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Qualitative PCR reactions were performed using equal concentration of DNA for
each reaction. The primers used to amplify three distinct fragments of the human RUNX2
promoter regions containing putative BMAL1 binding sites (Appendix A): fragment 1
forward, 5’-TCA AGA GCT TTA TTT GCA TTG A -3’, reverse, 5’-TGC ACT TTT
TGT CCT CTG TGA -3’; fragment 2 forward, 5’-CAC ATG AAA CCA TGT TTG GAA
-3’, reverse, 5’-CCA GAA ATA CAT TTT GGT GTT TT -3’; and fragment 3 forward,
5’- CAC ATG ATT CTG CCT CTC CA -3’, reverse, 5’- CAT GTG AAA AGC AAA
GAA ACA A -3’Primers used for control reactions were designed to identify a promoter
region of the housekeeping gene GAPDH (negative control for all ChIP experiments):
GAPDH forward, 5’- AAT GAA GGG GTC ATT GAT GG -3’, reverse, 5’- AAG GTG
AAG GTC GGA GTC AA -3’. .Each reaction was performed using equal concentrations
of DNA and the following PCR conditions: hold at 95ºC for 5 min, 45 cycles of 95ºC for
45 sec 60ºC for 30 sec, 72ºC for 30 sec, 72ºC for 10 min (MyCycler Thermo Cycler;
BioRad). PCR products were separated by electrophoresis on a 1% agarose gel in 1X
TAE (40mM Tris, 40mM EDTA, 20mM acetic acid; final pH 8.0) buffer. Gels were
visualized and images captured using the MultiImage Light Cabinet (BioRad). The
genomic identity of amplified sequences having predicted lengths were confirmed by
molecular sequencing (GeneWiz).
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3.3 – RESULTS

3.3.1 Runx2 expression is rhythmic in U2OS cell cultures

To determine whether expression of RUNX2 was rhythmic in U2OS cells, cultures were
synchronized and sampled every 4h (24-48h post-synchronization). We observed a
rhythm in the expression of RUNX2 in U2OS cultures (F = (6, 19); p < 0.001). Over this
24h window of time sampled, we observed nadir levels of expression between 24-36h
and a rise to peak levels between 40-48h following culture synchronization (Figure 3.1).
BMAL1 levels were also rhythmic in the cell cultures (F = (6, 18); p < 0.001) with the
highest expression detected between 28-40h and declined to nadir levels between 44-48h
(Figure 3.1), displaying an antiphase relationship with RUNX2 expression. Levels of
RUNX2 expression were significantly greater than those of BMAL1 at the 44-48h time
points (p = 0.002-0.00004), but significantly lower at the 28-40h intervals (p = 0.0110.021).

Western blot analyses of protein samples Protein samples were collected from
U2OS cultures revealed a rhythmic pattern of expression in RUNX2 protein levels in
U2OS cells, although the small sample size did not allow statistical analysis. Specifically,
over the same 24h window described above, we observed nadir levels of expression
between 32-40h with peak levels expressed at 24-28h and 44-48h (Figure 3.1). This peak
in protein expression could be predicted by the rise in RUNX2 gene expression we
observed at 40h post-synchronization.
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Figure 3.1. RUNX2 gene and protein expression levels are rhythmic in U2OS-B6 cell
cultures. A) Mean representative percent fold change in gene expression levels of
RUNX2 (black) and BMAL1 (grey) in synchronized U2OS-B6 cells sampled over 24h
(n=3 per time point). Significant peaks levels of expression (*) compared to nadir points
(#) for given gene presented in respective color. Significant differences in gene
expression (§) between genotypes in red. B) Mean representative percent fold change in
RUNX2 protein levels in synchronized U2OS-B6 cells sampled over 24h measured by
western blot (n=2 per time point).
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3.3.2 Expression of RUNX2 is down regulated by silencing BMAL1 gene expression
in U2OS cells

To determine whether the expression of the RUNX2 gene is sensitive to changes in
BMAL1 expression levels in U2OS-B6 cells, culture were transfected with an expression
plasmid encoding either a shBMAL1 (5’– GCC UUC AGU AAA GGU UGA AGA – 3’)
or a scrambled control sequence (Clontech Laboratories Inc, CA, USA) (generated and
validated by Dr. Lei Yin, University of Michigan), synchronized and total mRNA
collected at 44h post-synchronization. At this time, RUNX2 levels are known to be
elevated under control conditions while BMAL1 levels are tapering from its peak levels of
expression in U2OS cells (Figure 3.1). Transfection of a shRNA targeting BMAL1 in
U2OS cultures resulted in approximately 60% knock down of its expression compared to
the control plasmid (p = 0.0005; Figure 3.2). This level of BMAL1 knockdown was
accompanied by a significant down regulation of RUNX2 expression levels (p = 0.002;
Figure 3.2). Levels of PER2, a known target of BMAL1 transcription activity, were also
assayed in these samples. As expected, knockdown of BMAL1 led to dampening of PER2
expression (p = 0.0002; Figure 3.2). Together with the unaltered levels of the
housekeeping gene, GAPDH, (Ct values for controls: 18.53, 18.62, 18.39; shBmal1treated samples: 18.72, 18.21, 18.55) we conclude that the observed effects on RUNX2
gene expression are due to attenuated levels of BMAL1 gene product levels in these cells.

3.3.3 BMAL1 transcription factor binds to the RUNX2 promoter in U2OS cells

To determine if the effects of BMAL1 silencing on RUNX2 gene expression are due to
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Figure 3.2. RUNX2 expression levels are dampened by transient BMAL1 expression
knockdown in U2OS-B6 cultures at 44h post-synchronization. Mean representative
percent fold change in gene expression of BMAL1, RUNX2 and PER2 in U2OS-B6
cultures transfected with either a shBMAL1 expressing plasmid (n=3; white bar) or
control plasmid (shNC, n=3; grey bar). Asterisk: significant difference in levels of gene
expression between samples transfected with shNC vs. shBMAL1; p<0.05.
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direct regulation by BMAL1, the promoter region of RUNX2 was scanned for E-box
sequences known to be putative BMAL1 binding regions over the 3kbp region upstream
of the promoter start site. Within this region, we localized three blocks of sequences
which contained one or several putative BMAL1 binding sites (Appendix A). Genomic
DNA (gDNA) was used to validate primers designed to recognize the promoter region of
the human RUNX2 gene sequence. The sequences from PCR reactions were confirmed
using both sequence alignment and the human genome BLAST tool (Basic Local
Alignment Search Tool, NIH; http://blast.ncbi.nlm.nih.gov/Blast.cgi).

Chromatin immunoprecipitation (ChIP) assays were performed to determine
whether BMAL1 binds to the putative E-box sequences identified in the RUNX2
promoter region. U2OS cells were grown to confluency (~95% confluent) and
synchronized. BMAL1-bound gDNA was isolated from U2OS cultures sampled at 24h
and 44h post-synchronization, times of nadir and peak levels of RUNX2 expression in
these cells (Figure 3.1). Qualitative PCR analyses using primers specifically designed to
identify the three blocks of the RUNX2 promoter containing putative E-box regions and
the gDNA collected by BMAL1-directed ChIP revealed positive results were observed
for all three primer sets specific for the RUNX2 promoter (Figure 3.3). In contrast, very
little or no detectible product was visualized in PCR amplifications utilizing the control
ChIP samples (Figure 3.3). As a negative control, PCR assays using primers designed to
detect the promoter region of GAPDH yielded an absence of PCR product as visualized
by agarose gel.
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Figure 3.3. Fragments of the RUNX2 gene promoter region containing putative Ebox sequence(s) are detectible in U2OS-B6 genomic DNA isolated by BMAL1directed chromatin immunoprecipitation (ChIP). A) Schematic representation of 3kbp
upstream of the RUNX2 gene transcription start site (arrow). Grey boxes represent loci of
putative BMAL1 binding sites (E-boxes). Sequences of the putative E-boxes located
along the RUNX2 promoter region. See text for references. B) PCR amplification
products detected using primers designed to detect the three distinct fragments of the
RUNX2 promoter region containing putative E-box(es) and gDNA isolated by BMAL1directed (B-1) or control (NC) ChIP experiments. Experiments were performed using
U2OS-B6 sampled either 24 or 44h post-synchronization. Lane 1: 100bp molecular
marker ladder. Lane 14: 1kbp molecular marker ladder.
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3.4 – DISCUSSION

The present results demonstrate that RUNX2 is a clock-controlled gene under direct
regulation of BMAL1-mediated transcription. We demonstrated that the gene expression
of RUNX2 in U2OS cells oscillates over a 24h period and is expressed in antiphase to the
BMAL1 rhythm (Figure 3.1). Transient silencing of BMAL1 expression in U2OS cells
resulted in a significant dampening of RUNX2 expression, suggesting that BMAL1
directly regulates RUNX2 expression (Figure 3.2). Finally, we provide evidence that
BMAL1 interacts directly with the promoter region of the RUNX2 gene (Figure 3.3).
Collectively, our observations support the notion that rhythmic expression of RUNX2 is
mediated by the molecular elements of the circadian clock network.

The autonomous cellular oscillatory features of the U2OS cell system including
rhythmicity of core clock genes such as BMAL1 are well established (Vollmers et al.,
2008; Hughes et al., 2009). Using the U2OS culture system as a conventional in vitro
model to investigate circadian characteristics of RUNX2, we observed an antiphase
relationship in gene expression to the BMAL1 expression. This was a notable observation
for several reasons. First, oscillations in RUNX2 expression are consistent with
observations previously made for Runx2 expression in vivo in murine bone (Zvonic et
al., 2007); however, the phase relationship of its expression compared to core clock genes
had not previously been investigated in bone in an in vivo model. Second, the phase
relationship between RUNX2 and BMAL1 expression rhythms mirrors that of these genes
in the SCN of adult mice (Chapter II). Moreover, it suggests that the molecular
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mechanisms interlocking Runx2 and the circadian clock could be similar in both the SCN
and the cell culture system.

Further evidence for BMAL1/CLOCK directed regulation of RUNX2 stems from
observations made when BMAL1 expression was transiently silenced in the U2OS cells.
As we hypothesized, following transient silencing of BMAL1 expression, a dramatic
decrease in RUNX2 expression was detected at a circadian time when its expression was
shown to be at its peak in untreated cells (Figure 3.1 and 3.2). This finding mirrors the
reduction in Runx2 expression we previously observed in the SCN of mice lacking both
functional Bmal1 genes (Chapter II). This negates the possibility that the down
regulation of Runx2 expression that was observed in the Bmal1 knockout rodent model in
our previous chapter is a secondary or indirect consequence of circadian dysfunction.
Therefore, it appears as though the level of RUNX2 expression is dependent on BMAL1
activity both in vivo and in vitro. One caveat of the present study is that our findings are
based on analysis from samples collected at a single time point coinciding with a time
RUNX2 was demonstrated to be expressed at peak levels in untreated U2OS cultures.
Unlike in our previous in vivo studies in which multiple time points were sampled from
animals completely lacking functional expression of Bmal1, approximately 40% BMAL1
expression remains detectable in culture. Therefore, we cannot exclude the possibility
that silencing BMAL1 in U2OS cells affected the phase of molecular rhythms in vitro,
and thus that control and silenced cultures were sampled at different circadian times
despite cell synchronization. Nonetheless, our findings support the impact of down
regulation of RUNX2 by silencing of BMAL1. Specifically, the level of detectible RUNX2
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expression is ~40% lower than those during nadir times in untreated cells and ~70%
lower than those during peak expression (Figure 3.1 and 3.2).

Down-regulation of expression following silencing of BMAL1 suggests that the
regulation of RUNX2 expression levels may be downstream of the circadian transcription
factor. A number of genes are known to be affected by loss of BMAL1; however, in most
cases this effect of BMAL1 loss on gene expression levels are the consequence of
arrhythmicity (Bunger et al., 2000; McDearmon et al., 2006). In contrast, the reduction in
expression levels of RUNX2 following the silencing of BMAL1 expression appears to be
due to the lack of transcriptional drive provided by direct binding of BMAL1 to the
promoter region of the RUNX2 gene. First, several putative BMAL1 binding consensus
sequences were identified along the promoter region of RUNX2, allowing for direct
interactions (Appendix A). Moreover, we demonstrated that BMAL1 binds directly to
several of these E-box consensus sequences (Figure 3.3). Thus, the ability of BMAL1
levels to modulate RUNX2 expression appears to occur via BMAL1 protein binding to
the RUNX2 promoter at one or more of these E-box sites (Figure 3.3). It is not
uncommon for genes directly regulated by the transcriptional activity of BMAL1 to
harbor more than one E-box sequence, with one or several of these sites being necessary
and/or sufficient for proper rhythmicity of the target gene (Triqueneaux et al., 2004; Yoo
et al., 2005; Ripperger & Schibler, 2006; Fustin et al., 2009). To date, it is unknown
whether one or more of the identified E-box sites within the RUNX2 promoter is
necessary and/or sufficient for BMAL1 to maintain proper RUNX2 expression levels.
This could be addressed with reporter gene assays in vitro using a series of promoter
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sequences harboring mutations in one or multiple E-box regions. The activity of each
RUNX2 promoter::Luciferase construct would be transfected into cell cultures along with
BMAL1 and CLOCK expression constructs. The degree of bioluminescence detected in
the mutated constructs compared to that of an unaltered promoter reporter construct
would reveal which E-box sites within the RUNX2 promoter are necessary and/or
sufficient for BMAL1/CLOCK-mediated transcriptional activation. The time of day
dependency of BMAL1 binding at each E-box locus was not determined so we can only
speculate as to whether there is a time of day variation in E-box binding in the RUNX2
promoter that mirrors the variation in RUNX2 expression levels.

Future studies

addressing these questions will be crucial in furthering the understanding of circadian
clock regulation of RUNX2 expression.

Reduction or knock out of Bmal1 gene expression resulted in a significant
damping of Runx2 expression in U2OS cultures and in the mouse SCN, respectively.
These observations contrast with findings derived from bone formation studies conducted
using the Bmal1 knock out animal model (Bunger et al., 2005; Fu et al., 2005). These
animals display progressive arthropathy attributable to significant greater number of
osteoblasts present in their bone tissues (Bunger et al., 2005; Fu et al., 2005). Since
Runx2 is an essential factor in the differentiation of osteoblasts from precursor cells, it
appears its expression is increased in these cells in the absence of functional Bmal1
expression ((Otto et al., 1997). There are several likely explanations for this discrepancy.
The first possible explanation is based on an elegant series of studies conducted by Fu et
al., which demonstrate that the molecular circadian clock negates bone formation by
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suppressing cell cycle progression and osteoblast proliferation (Fu et al., 2005).
Therefore, in the absence of Bmal1 the intracellular clock mechanism cannot hold back
osteoblast differentiation, thus activating bone-specific pathways to increase expression
of Runx2. The Runx2 gene is believed to be the target of a number of bone-specific signal
transduction pathways that are regulated by extracellular cues (reviewed by (Komori,
2011)). Such cues would likely be deregulated or arrhythmic in the absence of a
functional circadian clock system. Thus, it is possible that increased expression of Runx2
is an indirect consequence of a lack of circadian coordination between tissues. Finally,
Bmal1 may directly or indirectly promote expression of factors involved in the regulation
of intracellular Runx2 levels. In this case, unimpeded expression and/or activity of Runx2
would result in the increased number of osteoblasts present under conditions of circadian
dysfunction. Overall, the difference in findings derived from the SCN and U2OS cells
compared to native osteoblasts under conditions of Bmal1 deficiency suggests that the
context of the cellular makeup plays a role in how Runx2 expression is affected
(McDearmon et al., 2006).

The biological significance of Bmal1-mediated rhythmic expression of Runx2
remains to be determined. In Chapter II, we addressed this question by examining the
overall effects of Runx2 on behavioral rhythms as well as on the intracellular molecular
clock rhythms. The findings from these studies suggest a role for Runx2 in regulating the
period of circadian rhythms. Specifically, animals harboring mutations in Runx2
demonstrated longer running-wheel activity rhythms and lengthened rhythms in
mPer2::Luciferase-driven bioluminescence in the SCN. Thus, Runx2 appears to have a
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role in supporting the timing of the core molecular circadian clock mechanism. Indeed,
the expression profile of Runx2 mimics that of core clock components (Chapter II)
suggesting that it can act as a regulator of the core molecular clock machinery and not
simply a clock-controlled gene. However, it remains to be determined whether Runx2
acts directly on components of the circadian clock to affect the timing of rhythms. This
hypothesis will be investigated in Chapter IV.

In summary, the present studies demonstrated that rhythmic RUNX2 expression is
directly regulated by the circadian transcription complex, BMAL1/CLOCK. Using a
model cell culture system for circadian investigations, the blunting of rhythmic Runx2
expression observed in vivo in Bmal1 mutant mice was mimicked by silencing BMAL1
expression in vitro. The relationship between Runx2 expression and Bmal1 functionality
appears to be direct since several putative BMAL1 binding sequences were identified in
the promoter region of the Runx2 gene. Moreover, BMAL1 was found to physically
interact with the DNA sequences encoding these binding elements. Together, these
findings support the notion that Runx2 is a clock-controlled gene directly regulated by the
core circadian clock network and further implicates Runx2 as an important molecular
component of circadian rhythms.
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CHAPTER IV:

RUNX2 Regulates Rhythmic Expression of the
Molecular Clock Transcription Factor, BMAL1
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4.1 – INTRODUCTION

The basis for circadian timing at the cell level is a network of transcriptional-translational
auto-regulatory feedback loops. The central feed forward drive for this network is the
transcriptional activity of the Bmal1/Clock heterodimer complex. In addition to
promoting expression of the core clock elements required for maintenance of daily
molecular oscillations, the Bmal1/Clock transcription factor promotes the expression of
clock-controlled genes required for rhythmic biological processes. In the studies outlined
in preceding chapters, I have presented evidence in support of the hypothesis that Runx2
is a clock-controlled gene directly regulated by Bmal1-mediated transcription. First, I
revealed a circadian pattern of gene expression of Runx2 in the SCN of adult mice
observed under a strict light-dark cycle and under constant dark conditions as well as in
U2OS cultures. Next, I demonstrated that expression of Runx2 is blunted in the absence
or partial silencing of Bmal1 expression in the SCN of mice and in U2OS cells,
respectively. Lastly, I described several putative BMAL1 consensus sequences present in
the RUNX2 gene promoter. Moreover, I demonstrated that BMAL1 does indeed bind to
these regions of the RUNX2 promoter suggesting that these sites are functional binding
regions exploited by the BMAL1 transcriptional complex to regulate RUNX2 expression.
Collectively, these observations indicate Runx2 to be a target for transcriptional
regulation by the core molecular circadian clock.

A number of clock-controlled genes have been shown to influence the pace of the
core molecular circuitry of the clock, for example Dec1 and 2 and ID2 (Honma et al.,
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2002; Ward et al., 2010). By interacting with core circadian elements like Bmal1, these
additional interlocking loops appear to be important for the stability and precision of
intracellular rhythms (Shearman et al., 2000; Reppert & Weaver, 2001; Brown et al.,
2012). The identification of many of the factors involved in regulating circadian rhythms
has been based on animal models harboring gene mutations resulting in obvious circadian
alterations such as shortened or lengthened period of behavioral rhythms (for examples
see (Vitaterna et al., 1994; van der Horst et al., 1999; Vitaterna et al., 1999; Zheng et al.,
1999; Lowrey et al., 2000; Cermakian et al., 2001)). In Chapter II, I demonstrated that
the circadian period was modestly but significantly lengthened in mice harboring Runx2
gene mutations. Specifically, the period of running wheel activity rhythms were longer in
Runx2+/- mice than their wild type littermates when housed in constant dark conditions.
The lengthened period for behavioral rhythms was attributed to the lengthened period of
the molecular clock feedback loop, measured by mPer2Luc-driven bioluminescence, in the
SCN of Runx2 deficient mice. Based on these observations, I hypothesized that Runx2
acts as a regulator of the circadian clock to coordinate the speed of rhythms at the levels
of the molecular network and, consequently, output processes.

Factors able to modify the functioning of the primary transcriptional-translational
feedback loop underlying biological rhythms exert their effects through a number of
different mechanisms. Kinases and phosphatases regulate the rate of translocation and
degradation of period and cryptochome gene products which act to negate the
transcriptional activity of the Bmal1/Clock complex. Other gene products, like those of
the Dec family, block the ability of Bmal1 to bind to E-box sequences in the promoter
127

regions of target genes. The first known example of factors able to regulate the core
molecular clock loop form what is known as the auxillary loop of the circadian clock
network. In brief, Bmal1/Clock promotes the expression of Rev-erbs and Retinoid-related
orphan receptors (RORs), members of the retinoic acid-related orphan nuclear receptors
family. The Rev-Erbs and RORs gene products influence the rate of transcription of the
Bmal1 gene by binding to retinoid-related orphan receptor elements (RORE) within its
promoter region. Binding of RORs to these elements promotes Bmal1 expression while,
Rev-Erbs binding at these sites blocks Bmal1 gene transcription (Preitner et al., 2002;
Sato et al., 2004; Crumbley et al., 2010; Crumbley & Burris, 2011; Cho et al., 2012).
Similar to Bmal1 and the orphan nuclear receptors, Runx2-mediated transcriptional
regulation is specified through a consensus binding sequence, 5’-puACCpuCA-3’
(Kamachi et al., 1990). Analysis of the Bmal1 promoter sequence for both mouse and
human revealed a conserved putative Runx2 binding site (Appendix B and C). This
suggests Bmal1 expression may be targeted by the transcriptional activities of Runx2.
Together with observations that the period of circadian rhythms is lengthened in animals
harboring Runx2 mutations, it can be postulated that deficits in Runx2 gene expression
result in decreased expression of Bmal1.

The present studies were designed to examine whether Runx2 acts a regulator of
the circadian system by directly influencing the expression of the core clock gene,
Bmal1. First, expression of clock genes in the SCN of Runx2+/- revealed the dampened
amplitude of rhythmic Bmal1 expression. Second, expression of BMAL1 following
silencing of RUNX2 expression in U2OS cells demonstrated that RUNX2 deficits impact
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the level of BMAL1 gene expression in this culture model as it does in the SCN. Third,
chromatin immunoprecipitation was conducted to demonstrate the physical interactions
of RUNX2 to the BMAL1 promoter region at two different circadian intervals. Finally,
the U2OS cell line used throughout these studies has been genetically modified to stably
express a luciferase gene under the regulation of the mouse Bmal1 promoter
(mBmal::Luciferase) ((Appendix F and (Vollmers et al., 2008)). This reporter of cellular
circadian oscillations was exploited to show the impact of varying degrees of RUNX2
silencing on circadian period and amplitude of rhythms in U2OS cells.

4.2 – MATERIALS AND METHODS

4.2.1 U2OS-B6 cell culture

U2OS-B6 cell cultures were maintained as described in Chapter III. In brief, cells were
incubated at 37ºC with 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen).

Culture

medium

was

supplemented

with

10%

FBS,

1%

Penicillin/Streptomycin and 2 µg/mL puromycin. For all circadian studies, cells were
synchronized using a cocktail of 0.1µM dexamethasone and 1µM forskolin (Sigma).

4.2.2 Animals
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All animal care and experimental procedures were approved by the Canadian Council of
Animal Care and the Animal Use Subcommittee of the University of Western Ontario.
(Appendix F).

Breeding and genotyping of Runx2 deficient (Runx2+/-) mice was described in
Chapter II. In brief, Runx2+/- mice were genotyped by PCR using the following primers:
Neo5-neu2, 5’-GATGATCTGGACGAAGAGCATCAGG-3’;
GGGTGACCAGTCTCTTACCTTG-3’;

MCBFA3-korr,

Cbfa11-neu,

5’-

5’-AGCGACGTGAG-

CCCGGTG -3’. DNA for genotyping was collected from tail biopsies rather than toe
clips to prevent any impairment which could affect running wheel activity.

Prior to experimental manipulations, animals were group housed and kept under a
12h:12h light-dark cycle. For circadian studies, animals were individually housed at in
cages equipped with running wheels (MiniMitter) and food and water available ad
libitum. Running wheel activity was recorded using VitalView software (MiniMitter) and
analyzed using CLOCKLAB software (Actimetrics) as described in Chapter II. Animals
were housed under a strict 12h:12h light-dark schedule until activity rhythms were stably
entrained (10-14 days) and subsequently housed under constant dim red illumination (lux
<5) until stable free-running behavior was established (10-14 days). As previously stated,
circadian time 12 (CT12) marks the onset of daily when running activity.

4.2.3 Total RNA collection and quantitative real-time PCR
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4.2.3.1 Animals
Runx2+/- and wild type littermate mice were sacrificed at one of six defined circadian
times of day: CT 1, 5, 9, 13, 17 and 21 (n = 12 per time of day). RNA from the SCN was
collected by microdissection from fresh frozen mouse brains collected using methods
described in Chapter II. Samples for each genotype were generated by pooling the
micropunched tissue from three mice in the same circadian time group to produce a total
of n = 4 per time point investigated. Preparation of cDNA samples for real-time qRTPCR, namely RNA extraction, isolation from tissue samples and reverse transcription
reactions, was described in Chapter II.

Real-time qRT-PCR was used to quantify gene expression in SCN samples
collected from the Runx2+/- and wild type littermates. Reactions were performed as
described in Chapter II, using the following TaqMan gene expression assay solutions
(Applied Biosystems): Bmal1 (Mm00500226_m1), Per2 (Mm00478133_m1), Runx2
(Mm00501578_m1), Osteocalcin (OC;

Rn01455285_g1) and Glyceraldehyde-3-

phosphate dehydrogenase (GAPDH; Rn99999916_s1). Triplicate reactions for each
sample for each gene of interest were performed with a thermocycler using the following
PCR conditions: hold at 50ºC for 2 min and 95ºC for 10 min, 40 cycles of 95ºC for 15 sec
and 58ºC for 1 min (see Chapter II for detailed methodology).

Analyses of qRT-PCR results were performed using the cycle threshold (Ct)
values as outlined in the methods section of Chapter II. In brief, the Ct value of each
sample for each reaction was determined using the optimal threshold established for each
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individual gene. This sample value was normalized to the Ct value for the loading control
gene, GAPDH, within each individual sample to generate the ΔCt value. The difference
between expression of a gene in a given sample and the overall average level of gene
expression measured across all time points is represented by ΔΔCt, specifically ΔCt(average)
- ΔCt(sample)

=

ΔΔCt. The fold change for each sample was determined relative to the

average ΔΔCt across all time points, with 1 representing the baseline level of gene
expression. One-way Anovas and two-tailed t-tests were conducted to identify significant
daily rhythms. Values were considered significantly different with p < 0.05.

4.2.3.2 Cell Culture
The RNA from U2OS cultures was extracted, isolated and reverse transcribed using
protocols outlined in Chapter III. In brief, cells in culture plates were lysed using TRIzol
reagent (Invitrogen), homogenized and harvested on ice. Chloroform and centrifugation
methods were used to extract the RNA fraction of the cell lysates. RNA was isolated by
isopropanol precipitation over night and RNA pellet was washed with 70% ethanol.
Equal concentrations of RNA were reverse transcribed using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Inc.) following the manufacturer’s
instructions. Reactions were performed using the following TaqMan gene expression
assay solutions (Applied Biosystems, Inc.): BMAL1 (Hs00154147_m1), PER1
(Hs00242988_m1),

PER2

(Hs00256143_m1),

RUNX2

(Hs00231692_m1),

and

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Hs02758991_g1). Triplicate
reactions were performed using a thermocycler with the following PCR conditions: hold
at 50ºC for 2 min and 95ºC for 10 min, 40 cycles of 95ºC for 15 sec and 58ºC for 1 min.
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Analyses of qRT-PCR data was performed by determining the Ct value for each
sample and normalizing the value to its loading control Ct value to generate the ΔCt value
for each gene of interest for each sample as described above. Differences between siRNA
treatments were determined using one-way Anova and Tukey post hoc analyses were
conducted where appropriate. Values were considered significantly different when p <
0.05.

4.2.4 Cell culture transfection

U2OS cells were plated in 35mm dishes and maintained under standard tissue culture
conditions (see 4.2.1) until cultures reached ~80% confluency. At this point, cells were
transfected with small interfering RNA (siRNA) using a cocktail of Lipofectamine 2000
reagent (Invitrogen) and OptiMEM (Gibco). Forty-eight hours post-transfection, cells
were synchronized as described in section 4.2.1. Cells were harvested at two times, 24h
(n = 3 per treatment) or 44h (n = 3 per treatment) post-synchronization and total RNA
was extracted and isolated as described in section 4.2.3.2. Quantitative real-time PCR
was performed on reverse transcribed RNA samples to measure the effects of RUNX2
gene expression silencing on the level of BMAL gene expression in U2OS cells.

4.2.5 Chromatin Immunoprecipitation

Genomic human DNA was used to validate primers designed to recognize the promoter
region of the human BMAL1 gene sequence containing RUNX2 binding sites. The
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sequences from PCR reactions were confirmed and validated using both sequence
alignment

and

the

human

genome

BLAST

tool

(NIH;

http://blast.ncbi.nlm.nih.gov/Blast.cgi). RUNX2 directed chromatin immunoprecipitation
was performed as outlined in Chapter III with several modifications. First, pull down of
chromatin was conducted at two different circadian intervals (n = 2 per time point) using
RUNX2-specific rabbit antibody (M-70; Santa Cruz Biotechnology, Inc). Qualitative
PCR reactions were performed using the following primers to amplify the fragment of the
human BMAL1 promoter containing the transcription start site and a putative RUNX2
binding site (Appendix B): forward, 5’- AAT GAT TGG TGG CAG GAA AG -3’, and
reverse, 5’- ACC TCC GTC CCT GAC CTA CT -3’. A negative control was performed
using primers designed to identify a promoter region of GAPDH (negative control for all
ChIP studies): GAPDH forward, 5’- AAT GAA GGG GTC ATT GAT GG -3’, reverse,
5’- AAG GTG AAG GTC GGA GTC AA -3’. As with the previous ChIP experiments
described, PCR products were separated by electrophoresis on a 1% agarose gel in 1X
TAE (40mM Tris, 40mM EDTA, 20mM acetic acid; final pH 8.0) buffer and visualized
using the MultiImage Light Cabinet (BioRad). The identity of amplified PCR products
with expected sequence lengths were confirmed through sequence analysis (GeneWiz).

4.2.6 Real-time recording of mBmal1::Luciferase-mediated bioluminescence in
U2OS cells

Generation of U2OS cell line harboring the mBmal1::Luciferase gene construct has been
previously described (Vollmers et al., 2008). Cells were plated in 35mm plates and

134

maintained as described above until cells reached >90% confluency. Cells were
transfected with 0.5µg, 1 µg or 2µg of siRNA specific for RUNX2 transcripts or control
siRNA sequence (n = 3 per dose per treatment) as described above in Cell Culture
Transfection (Santa Cruz Biotechnology, Inc).

Forty-eight hours after transfection,

cultures were viewed and images captured with a 20X objective using an inverted
microscope to ensure cells were not compromised by the treatments. Cell morphology
and viability was assessed immediately prior to synchronization; no differences were
observed suggesting these observations are the result of effects occurring at the molecular
level within cells (Figure 4.1).

For bioluminescence recording, media was replaced with sterile, luciferincontaining synchronization media (glucose and phenol-red free DMEM, 5% FBS, 25mM
glucose, 20mM HEPES, 1X non-essential amino acids, 1X antibiotic antimycotic, 10µM
forskolin, 10µM dexamethasone, 0.1mM luciferin). Plate lids were replaced with cover
slips sealed by vacuum grease to prevent media evaporation. Cultures were maintained at
37ºC and bioluminescence was measured using a LumiCycle (Actimetrics, Evanston, IL).
Bioluminescence data analyses were performed using the LumiCycle Analysis Program
(Actimetrics). Cycle 0 data (cells start through midnight of the first day) were excluded
from

the

period

analyses

and

only

recordings

containing

at

least

three

mBmal1::Luciferase-mediated bioluminescence peaks were used for analyses. Significant
rhythms were determined by χ2 periodogram analyses conducted following subtraction of
a baseline determined by fitting a low-order polynomial to each data set. Statistical
analyses of period length and amplitude of bioluminescence were performed using the
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Figure 4.1. U2OS cell cultures 48h following transfected with varying doses of
RUNX2-specific siRNA or scramble sequence control siRNA.
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baseline-subtracted rhythms. The period of a rhythm is defined by the time elapsed to
complete a single oscillation (time elapsed for the occurrence of two consecutive peaks or
troughs of a recurring wave). The amplitude of a rhythm refers to the difference between
the peak value (or trough value) and the mean value of the oscillation. Differences
between siRNA dosages were determined using pair wise analyses were conducted where
appropriate. Values were considered significantly different when p < 0.05.

4.3 – RESULTS

4.3.1 Bmal1 gene expression is altered in Runx2+/- mice

To determine whether Runx2 acts as a regulator of the circadian clock system in vivo,
rhythms in clock gene and protein expression in the SCN was examined in mice lacking a
functional Runx2 gene copy (Runx2+/-). Since animals lacking Runx2 do not survive
following birth (Komori et al., 1997), clock gene and protein expression was determined
at several times of the circadian day in adult Runx2+/- mice housed in DD conditions.

As previously demonstrated in Chapter II, gene expression of Runx2 was
rhythmic in the SCN of WT (Runx2+/+) mice (F (5, 21) = 6.117; p < 0.005). The levels of
Runx2 expression peaked in the early subjective day and dropped to nadir levels in mid to
late subjective night (CT1-5 vs. CT17-21, p = 0.002-0.005; Figure 4.2A). In contrast,
there was no time of day effect for the expression of Runx2 in the SCN of Runx2+/- mice
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(F (5, 18) = 1.682; p = 0.208). Hence, the rhythmic expression pattern of Runx2 is lost in
the SCN of Runx2+/- mice.

Next we examined how this lack of rhythmic Runx2 expression affected the core
clock gene, Bmal1. Rhythmic expression of Bmal1 in the SCN of WT is well documented
and was previously described in Chapter II. The rhythmic pattern of expression for Bmal1
(F (5, 21) = 20.706, p = < 0.001) was antiphase to that of Runx2, with peak levels reached
during the subjective night compared to the early subjective day (CT1-5 vs. CT13-21, p =
0.00002-0.01). In the SCN of Runx2+/- mice, expression of Bmal1 was rhythmic (F (5,
18) = 5.398, p = 0.007). However, the Bmal1 rhythm displayed significantly dampened
amplitude compared to its expression rhythm in the Runx2+/+ SCN (Figure 4.2B). Post
hoc analyses comparing levels of Bmal1 expression between genotypes revealed
significantly reduced levels of Bmal1 expression at CT1, CT9, CT13 and CT17 (p =
0.044, 0.03, 0.048 and 0.044, respectively), with a trend for dampened expression at CT5
(p = 0.059), in the SCN of Runx2+/- mice compared to Runx2+/+ mice. Thus, deficits in
Runx2 appear to reduce the overall level of Bmal1 gene expression without eliminating
its rhythmicity.

To determine whether dampened expression of Bmal1 would impact downstream
clock genes, the expression of Per2 in Runx2+/- was assessed. The rhythmic expression of
Per2 in the SCN of Runx2+/+ (F (5, 20) = 16.509; p < 0.001) was shown to be in phase
with that of Runx2, with peak levels of gene expression observed in early to mid
subjective day and nadir levels observed during the night (CT1-5 vs. CT13-21, p =
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0.0001-0.0003). A similar pattern of expression was observed in Runx2+/- mice, wherein
Per2 expression was rhythmic (F (5, 20) = 13.69, p = < 0.001) with a peak in expression
in mid subjective day and nadir levels observed from mid subjective night until early
subjective day (CT5 vs. CT17-1, p = 0.03 - 0.001; Figure 4.2C). These observations
indicate that the dampened rhythmic gene expression of Bmal1 in the SCN of Runx2+/does not appear to dramatically alter Per2 gene expression.

To determine the effects of Runx2 deficits on target gene expression in the SCN,
Osteocalcin (OC) expression was measured and compared to WT. Rhythmic expression
of OC (F (5, 21) = 7.113; p < 0.001) was first described in Chapter II and shown to have
its greatest levels of expression at CT5 (CT5 vs.CT9-21, p = 0.01-0.03). Expression of
OC in the SCN of Runx2+/- was also rhythmic (F (5, 20) =18.816; p < 0.001) (Figure
4.2D) with peak expression levels observed in early and mid-subjective day (CT1-5) and
nadir levels reached across subjective night (CT1-5 vs. all other times of day; p = 0.0120.002). Compared to expression in the SCN of WT mice, there was a significant decrease
in OC gene expression levels observed at CT1 (p = 0.009). These findings suggest an
altered regulation of Runx2 gene and protein expression lead to altered regulation of
downstream gene targets.
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Figure 4.2. Expression of core clock genes is altered in the suprachiasmatic nucleus
of adult Runx2+/- mice (white) compared to Runx2+/+ (black) mice. Normalized mean
representative fold changes in mRNA levels (± SEM) of Runx2 (A), Bmal1 (B), Per2 (C)
and Osteocalcin (OC; D) determined by real-time qRT-PCR (n = 4 per time point).
Values represent the level of normalized gene expression relative to the mean overall
normalized gene expression across the day. In 24h DD conditions, grey and black
horizontal bars represent subjective day and night, respectively, with running wheel
activity onset marking CT12. Significant peaks levels of expression (*) compared to
nadir points (#) for given gene presented in respective color. (§) Significant differences in
gene expression between between genotypes in green.
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4.3.2 Down-regulation of RUNX2 expression reduces expression of BMAL1 and
lengthens period of molecular rhythms in U2OS cells

To determine whether the dampened levels of Bmal1 expression observed in Runx2
deficient conditions is associated with changes in the periodicity of circadian rhythms;
clock gene expression was first examined in the U2OS culture model following
incremental Runx2 gene expression silencing. Gene expression was analyzed from cells
transfected with one of two concentrations of control siRNA or RUNX2-specific siRNA
(siRUNX2). Cells were collected at 44h post-synchronization, a time at which RUNX2
gene expression levels are elevated while BMAL1 expression levels are declining from
peak levels in U2OS cells (Figure 3.1). Overall, there was a treatment effect of siRUNX2
treatment on detectible RUNX2 expression in U2OS cultures (F (2, 8) = 13.216, p =
0.006; Figure 4.3). Cells treated with 1µg of siRUNX2 had a 20% decrease in detectible
levels of RUNX2 expression compared to control treatments (p = 0.022), while those
treated with 2 µg of s siRUNX2 displayed 70% of control expression levels (p = 0.007).
The difference in RUNX2 levels was not significant between the two siRUNX2 doses
used (Figure 4.3).

There was a treatment and dose-dependent effect of siRUNX2 treatment on
BMAL1 expression in U2OS cultures (F (2, 7) = 21.771, p = 0.003; Figure 4.3). There
was no significant effect of the low dose of RUNX2-specific siRNA on BMAL1
expression when compared to the control treatment (p = 0.713). A large variability
between samples was observed of which the cause is not clear. However, detectible levels
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Figure 4.3. BMAL1 expression levels are dampened by transient RUNX2 expression
knockdown in U2OS cells at 44h post-synchronization. Fold change in gene
expression of RUNX2 (left) and BMAL1 (right) in U2OS cultures transfected with either
control siRNA (black; n = 6), 1µg (grey; n = 3) or 2µg (white; n = 3) of RUNX2-specific
siRNA (siRUNX2). (*) Significant differences between siRUNX2 and control conditions.
(#) Significant differences between 1µg and 2µg siRUNX2 dose.
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of BMAL1 expression was reduced by approximately 80% in cells treated with the higher
siRNA dosage, significantly less than control (p = 0.004) or low dose treatment
conditions (p = 0.004). Notably, expression levels of the housekeeping control GAPDH
were unaltered between treatments (Ct values for 1 µg Control samples: 22.86, 22.56,
23.7 and siRUNX2: 23.54 and 23.67; Ct values for 2 µg Control samples: 18.79, 19.8; and
siRUNX2 samples: 19.84, and 19.07). Together, these results demonstrate a negative
correlation between gene expression levels of RUNX2 and detectible BMAL1 gene
expression.

To determine whether RUNX2 also regulates the period of Bmal1 expression,
real-time recording of bioluminescence in U2OS cultures under conditions of RUNX2
silencing were conducted. The U2OS cultures used for these studies are derived from a
native U2OS cell line which was transfected with a plasmid harboring a firefly luciferase
construct downstream of ~600bp of the mouse Bmal1 promoter sequence (mBmal1; see
(Vollmers et al., 2008) for construct details). This stably expressed construct serves as a
reporter of mBmal1 promoter activation in this cell line. Within the mBmal1 promoter
sequence of this construct lays a putative RUNX2 binding consensus sequence (see
Appendix C and (van der Deen et al., 2011).

To first determine whether the mBmal1::Luciferase gene construct was as
sensitive to the silencing effects of RUNX2 down-regulation as is the native BMAL1
gene, we assayed luciferase activity in the protein samples collected from U2OS cultures
transfected with 2µg of siRUNX2 or a control sequence. At 44h post-synchronization,
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total protein samples were collected and assayed for luciferase-based bioluminescence.
Virtually no promoter reporter activity was detected while untreated cells displayed clear
luciferase-based luminescence (Figure 4.4).

To determine whether silencing the expression of RUNX2 affects the amplitude
and/or period of mBmal1::Luciferase rhythmicity in vitro, bioluminescence was
measured in U2OS in real-time. Compared to untreated cells, the amplitude of rhythms
was significantly dampened in all three siRUNX2 treatment dosages (NT vs. 0.5 µg, p =
0.001; NT vs. 1 µg, p = 0.010; and NT vs. 2 µg, p = 0.012; Figure 4.4A). Pair-wise
comparison on bioluminescence amplitude between negative control and siRUNX2
treatments revealed similar results. Specifically, the amplitude was significantly
dampened by all three siRUNX2 doses compared to their controls (0.5 µg, p = 0.049; 1
µg, p = 0.0048; 2 µg, p = 0.036; Figure 4.5A). No treatment effect of the control siRNA
on rhythm amplitude observed when compared to untreated cells (p = 0.222). Moreover,
there were no differences in amplitude between siRUNX2 treatment doses (p = 0.093).

The period of the bioluminescence rhythm was significantly lengthened in Runx2
siRNA-treated cells, regardless of the siRUNX2 dosage compared to control treatments
(0.5 µg, p = 0.037; 1 µg, p = 0.027; 2 µg, p = 0.035; Figure 4.5B). Compared to
untreated cells, only the higher two doses of siRUNX2 had significantly period
lengthening (NT vs. 1 µg, p = 0.037; 2 µg, p = 0.030), with the lowest dose only having a
tendency for lengthened period (p = 0.068; Figure 4.5B).
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Figure 4.4. Normalized mBmal1::Luciferase-driven bioluminescence activity levels
are attenuated by RUNX2-specific siRNA (siRUNX2) in U2OS cultures at 44h postsynchronization compared to control conditions (n = 3 per treatment). Significant
difference (*) in levels of gene expression between samples transfected with control vs.
siRUNX2.

145

Figure 4.5. mBmal1::Luciferase-driven bioluminescence rhythms are lengthened
and display dampened amplitudes in U2OS cultures transfected with RUNX2specific siRNA compared to control conditions. Mean amplitude (A) and period length
of rhythms (B) of bioluminescence in U2OS cultures transfected with 0.5, 1 or 2µg of
RUNX2-specific siRNA (siRUNX2, white) or scrambled negative control siRNA (NC,
grey). Observations were compared to untreated cultures (black). Numbers in each bar
represent the n value for each experimental group. (*) Significant difference between
samples transfected with siNC vs siRUNX2. (#) Significant difference between samples
transfected with no treatment vs. siRUNX2. Numbers in each bar represents n value.
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There was no treatment effect of the control siRNA on the period length compared to
untreated cells (p = 0.106 – 0.352). Together, the observations support the hypothesis that
the deficiency of RUNX2 expression dampens the expression of BMAL1 as seen in the
SCN of mice and lengthens the period of circadian rhythms as observed from behavioral
and molecular assays conducted using Runx2+/- mice (Chapter II).

4.3.3 RUNX2 transcription factor binds to the BMAL1 promoter region in U2OS
cells

Chromatin immunoprecipitation (ChIP) assays were performed to determine whether
RUNX2 binds to its putative consensus sequence identified in the BMAL1 promoter
region. U2OS cells were grown to confluency (~95% confluent) and synchronized.
RUNX2-bound gDNA was isolated from U2OS cultures sampled at 24h and 44h postsynchronization; times at which RUNX2 protein expression in these cells is elevated
(Figure 4.6).

Qualitative RT-PCR analyses using primers specifically designed to

identify the BMAL1 promoter sequence the putative RUNX2 consensus binding region
revealed PCR product amplification using the RUNX2-directed ChIP samples (Figure
4.6). In contrast, very little or no detectible product was visualized in PCR amplifications
utilizing the control ChIP samples (Figure 4.6). PCR amplification of the BMAL1
promoter containing the RUNX2 consensus sequence does appear to be greater at 44h
than at 24h post-synchronization. However, it should be noted that quantitative RT-PCR
methods would be needed to draw firm conclusions between the two time-points at which
cells were sampled.
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Figure 4.6. Fragment of the BMAL1 gene promoter region containing putative
RUNX2 binding sequence is detectible in U2OS genomic DNA isolated by RUNX2directed chromatin immunoprecipitation (ChIP). A) Schematic representation of
~500bp upstream of the BMAL1 gene transcription start site (arrow). Grey box represent
locus of putative RUNX2 binding site and sequence of the putative RUNX2 consensus
along the BMAL1 promoter region. B) PCR amplification products detected using primers
designed to detect the BMAL1 promoter region containing putative RUNX2 binding site
and gDNA isolated by RUNX2-directed or control ChIP experiments. Experiments were
performed using U2OS sampled either 24 or 44h post-synchronization (n = 2 per time
point).
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4.4 – DISCUSSION

A major functional role of BMAL1-mediated transcription is to regulate gene
transcription in a rhythmic manner so that cellular functions are regulated across the 24 h
day. Stability of the transcriptional-translational feedback loops (TTL) underlying the
molecular clockwork in cells is facilitated by the number of factors whose expression is
driven by the transcriptional activity of BMAL1, and which feed back onto the TTL in
either a positive or negative feedback manner. The findings made from the current series
of experiments support the proposition that RUNX2 is a clock-controlled gene able to
feed back onto, and thereby impacting the functionality of the molecular network
underlying circadian rhythms. First, we demonstrated the dampened amplitude of
rhythmic Bmal1 expression in the SCN of Runx2 haplodeficient mice. Second, transient
silencing of RUNX2 expression resulted in a dose dependent reduction of BMAL1
expression levels suggesting that levels of RUNX2 are correlated with expression of this
clock gene. Using a luciferase reporter gene driven by a fragment of the mouse Bmal1
promoter, silencing RUNX2 gene expression led to the dampening of rhythm amplitude
and lengthened period of circadian oscillations. Lastly, we identified a putative RUNX2
binding site within the BMAL1 (and mBmal1) promoter region and revealed that RUNX2
interacts directly with this sequence. Together with the findings presented in the
preceding chapters, our observations support the notion that RUNX2 is a clock-controlled
gene involved in the regulation of the TTL network. Thus, RUNX2 is both an output and
input to the core molecular machinery that controls circadian rhythms.
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The question of whether RUNX2 feeds back into the network of auto-regulatory
loops’ sustaining cellular rhythms was first addressed by examining the expression of
core clock genes in the SCN of mice lacking one functional Runx2 allele (see Chapter II
for description). In both Runx2+/+ and Runx2

+/-

mice, Bmal1 expression was rhythmic;

however, the amplitude of the rhythm in Runx2+/- was blunted and overall levels of
expression were lower than those observed in Runx2+/+ littermates (Chapter I).
Observations made in vivo were similar to those observed under controlled in vitro
conditions in which RUNX2 was down regulated. There was a direct correlation between
expression levels of BMAL1 and RUNX2; specifically, the greater the down-regulation of
RUNX2 expression, the greater the decrease in detectible BMAL1. Moreover, as we
increased the degree to which RUNX2 was silenced in vitro, we observed greater
variability in levels of RUNX2 expression which mirrors findings made in vivo. The
detectible levels of Runx2 in the SCN were even more variable than those of WT animals,
suggesting a loss of tightly orchestrated regulation that exists under single allele
conditions. In contrast, the effects of RUNX2 silencing on BMAL1 expression were
observed at the circadian time having the highest levels of RUNX2 expression in
untreated U2OS cultures. Based on earlier observations that animals lacking functional
copy of Runx2 gene allele showed lengthened behavioral rhythms and molecular rhythms
within the SCN, we cannot discount the possibility that silencing RUNX2 in U2OS cells
affected the period of molecular rhythms. Thus, there is a possibility that the cells
collected from control samples were at a different phase of the rhythmic cycle than in
those samples when RUNX2 was silenced. Unlike measures of behavior and molecular
rhythms observed in real-time using Runx2+/- and Runx2-/- mice in Chapter II, the
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observations from the current gene expression assays demonstrate only a glimpse of
gene expression activities. Thus, it can be postulated that the observations made in vivo
are due to the altered Bmal1 levels observed in animals with Runx2 deficits.

To further investigate the effects of RUNX2 down-regulation on molecular
rhythms in U2OS cells, we took advantage of the transgenic properties of a cell line that
expressed the luciferase reporter gene under the control of the mBmal1 promoter
fragment. Once the sensitivity of the mBmal1::Luciferase gene to the silencing effects of
RUNX2-specific siRNA was confirmed to be similar to that of the native human BMAL1
gene in U2OS cells, RUNX2 was silenced incrementally and the bioluminescence
rhythms of the cultures were monitored in real-time. Similar to the observations based on
in vivo samples collected from the SCN of mice (Chapter II), we observed a significant
dampening in the amplitude of rhythms in cells following RUNX2 silencing regardless of
dosage used compared to all control treatments and untreated cells. In contrast, we did
not observed a difference in rhythm amplitude for the mPer2Luc-driven bioluminescence
rhythms monitored from the SCN of Runx2+/+ and Runx2+/- mice (Chapter II). This is not
surprising given that we observed very little difference in gene expression levels for
mPer2Luc in the SCN of Runx2+/- compared to Runx2+/+ mice. Had the luciferase gene
been under regulation of the Bmal1 promoter in the Runx2 transgenic animals as it was in
the U2OS cells, we predict a similar decrease in the amplitude of bioluminescence
rhythms would have been observed. As in the behavioral rhythms and molecular rhythms
in the SCN, we observed a significant period lengthening of the molecular rhythms in
U2OS cells treated with RUNX2-specific siRNA regardless of dosage used compared to
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all control treatments. These findings suggest that RUNX2 plays a key role in regulating
the period of molecular rhythms in U2OS cells. As such, it would be intriguing to
monitor real-time molecular rhythmicity in these cells following transient up-regulation
of RUNX2 expression. Based on our findings under conditions of RUNX2 deficiency, it
can be predicted that over-expression of RUNX2 would lead to a shortening of the
period. Future studies will be needed to address this question.

The actions of RUNX2 on the regulation of BMAL1 expression levels appear to
occur at the level of the BMAL1 gene promoter. RUNX2 was found to bind to a DNA
sequence containing a putative RUNX2 consensus binding site identified in the promoter
region of both the human and mouse Bmal1 gene (Appendix D). Based on qualitative
analysis, there does appear to be a time of day difference in the presence of RUNX2 on
the BMAL1 promoter with greater occupancy occurring at the 44h than at the 24h
circadian time point. This fits with observations that the 44h time point follows a period
of heightened BMAL1 expression whereas the 24h time represents the end of the nadir
period of BMAL1 expression. RUNX2 protein levels were found to be similar at both
these times suggesting that any differences observed at the level of the BMAL1 promoter
may be attributed to transcriptional regulation at this site. However, additional
quantitative analyses will be needed to confirm this hypothesis. Unlike in the RUNX2
promoter analyses in the previous chapter, we focused on a single consensus site within
the BMAL1 (and mBmal1) promoter region. It is possible that RUNX2 does indeed
localize to this DNA sequence but it may do so as a complex with other transcription
factors which are binding to the BMAL1 promoter. The best way to address this
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possibility would be to monitor the activation of a reporter gene construct harboring
mutations in the RUNX2 consensus sequence within the BMAL1 promoter region. The
degree of reporter activity as well as its rhythmic pattern of expression would reveal
whether identification of the RUNX2 consensus sequence is necessary for RUNX2mediated regulation of BMAL1 expression. Delineating the mechanism by which RUNX2
regulates BMAL1 gene activity will be essential in understanding the regulatory role of
RUNX2 in the molecular clock network.

In summary, the present studies demonstrated that RUNX2 expression is
positively correlated with the expression of the core circadian transcription factor,
BMAL1. Moreover, using a real-time bioluminescence reporter to observe expression of
BMAL1 under conditions of varying levels of RUNX2 expression, the period of the
mBmal1 promoter driven luciferase rhythm was significantly lengthened. This parallels
with observations of the lengthened period of behavioral rhythms in vivo and molecular
SCN rhythms in vitro from animals harboring mutations in the Runx2 gene. The
relationship between the level of Runx2 expression and Bmal1 appears to be direct.
Specifically, Runx2 was found to physically interact with a sequence in the BMAL1
promoter region containing a putative Runx2 binding element. Together, these findings
support the notion that Runx2 acts directly on a core element of the circadian clock
network, namely Bmal1, to regulate its function. Given the essential role for Runx2 in
osteogenesis and bone homeostasis, as well as a currently undefined role in the central
nervous system, future studies are warranted to delineate the range of functional
consequences of its direct association with the circadian clock.
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CHAPTER V:

CONCLUSIONS AND GENERAL DISCUSSION
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5.1 – SUMMARY OF RESULTS AND GENERAL DISCUSSION

5.1.1 Runt-related transcription factor 2 (Runx2) is expressed in a rhythmic manner
in the murine brain, including the suprachiasmatic nucleus of the hypothalamus
The initial discovery of Runx2 expression in the central circadian pacemaker, the SCN,
served as the basis for the global hypothesis of this dissertation. Rhythmic Runx2 was
observed in the SCN, paraventricular nucleus (PVN), the hippocampus (HP), the
olfactory bulb (OB; Chapter II) as well as in U2OS cell cultures (Chapter III). These
findings, namely that Runx2 is rhythmically expressed in the central circadian
pacemaker, suggest that expression of Runx2 is regulated by the molecular circadian
clock network driving daily cellular oscillations and may therefore be categorized as a
clock-controlled gene.

In order to be able to characterize Runx2 as a clock-controlled gene and not
simply a rhythmic gene, our next aim was to identify whether a direct relationship
between the core circadian clock molecular network and the regulation of Runx2
expression exists.

5.1.2 Expression of Runx2 is dependent on the core molecular circadian clock
network, namely the transcription factor Bmal1
The circadian pattern of expression for Runx2 mirrored that of the Period family of core
clock genes, Per1 and Per2 (Chapter II), leading to the hypothesis that Runx2 and Per
genes are regulated by a common circadian transcription factor. In animals lacking
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functional expression of the core circadian transcription factor, Bmal1 (Chapter II), as
well as in cells in which BMAL1 expression was transiently silenced (Chapter III),
expression of Runx2/RUNX2 was significantly reduced. Moreover, BMAL1 bound to Ebox sequences within the RUNX2 promoter region (Chapter III) revealing that the
activity of this circadian factor directly regulates expression of Runx2.

Circadian regulation of clock-controlled genes occurs for biologically significant
purpose such as rhythmic output or regulation of the molecular clock network itself.
Investigating the effects of Runx2 deficiency on circadian behavior and molecular events
may help elucidate the biological relevance of rhythmic Runx2 expression.

5.1.3 Runx2 plays an important role in regulating the period of molecular and
behavioral circadian rhythms
Studies monitoring rhythmic animal behavior (Chapter II) and molecular events in SCN
(Chapter II) and U2OS cell cultures (Chapter IV) revealed that Runx2 is an important
component in regulating the period of circadian rhythms. Mice lacking a functional
Runx2 allele displayed significantly longer periods in running wheel activity rhythms
under constant dark conditions compared to wild type littermates (Chapter II). This can
be attributed to changes occurring at the level of the SCN where mPer2::Luciferasedriven bioluminescence rhythms are lengthened in tissues collected from mice lacking
the Runx2 gene (Chapter II). Similar results obtained using in vitro methods to control
the degree of RUNX2 deficiency (Chapter IV) further support the notion that Runx2
plays an important role in coordination of circadian timing.
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The mechanism(s) by which Runx2 influences circadian physiology and timing of
the molecular clock would deepen understanding of the role it plays in supporting
circadian rhythms at the cell level.

5.1.4 Runx2 regulates the amplitude of rhythmic Bmal1 expression
The effects of Runx2 deficiency on circadian parameters revealed that this clockcontrolled gene was able to feedback onto the core molecular network underlying
biological rhythms. In animals harboring Runx2 gene mutations, gene expression assays
revealed that rhythmic expression of Bmal1 was significantly dampened amplitude
compared to their wild-type littermates (Chapter IV). Real-time measures of
bioluminescence driven by the Bmal1 promoter revealed that the dampened amplitude of
Bmal1 promoter activity caused by decreased RUNX2 expression results in a significant
lengthening of circadian period (Chapter IV). Moreover, RUNX2 bound to a region of
the BMAL1 promoter encoding a putative consensus sequence (Chapter IV)
demonstrating that the effects of RUNX2 on circadian timing are, at least in part, due to
direct regulation of the transcriptional activity of this circadian factor.

5.1.5 Proposed model for the feedback regulation of Runx2 and the molecular
circadian clock
The observations gathered from the present studies support the notion that there is a
reciprocal relationship between the clock-controlled gene, Runx2, and the circadian
transcription factor, Bmal1 (Figure 5.1). Specifically, Bmal1 in concert with Clock
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promotes the rhythmic expression of the Runx2 gene through direct interaction with Ebox elements in its promoter. Runx2 subsequently feeds back into the molecular clock
network by acting as a positive driver of Bmal1 transcription at least in part by directly
binding to a consensus sequence located in the Bmal1 promoter region. The positive
drive both Bmal1 and Runx2 exert on the transcriptional activity of the other’s gene is
substantiated by the decreased expression levels of one gene resulting from silencing the
other. Disruption of this relationship does appear to have biological consequences.
Specifically, the dampened amplitude of rhythmic Bmal1 expression under conditions of
Runx2 deficiency is thought to be causal factor for the lengthened period observed in
molecular and behavioral rhythms. A similar phenotype is observed in animal models
lacking RORβ gene function. Comparable to observations for Runx2, RORβ normally
enhances transcription of Bmal1 and, in its absence the period of circadian activity is
lengthened by 0.5 h (Andre et al., 1998; Guillaumond et al., 2005). Therefore, this effect
of a transcription factor on Bmal1 expression and period regulation is not unprecedented
and the RORβ model could serve as a basis for understanding the mechanisms by which
Runx2 influences the circadian clock. Nevertheless, further investigations will be needed
to fully comprehend the functional consequences of the direct association of Runx2 with
the circadian clock.
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Figure 5.1. A) Proposed model and findings supporting a putative reciprocal
feedback relationship between Runx2 and Bmal1 and B) summary of effects on
circadian parameters in conditions of Runx2 deficiency
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5.2 – FUTURE DIRECTIONS

The collection of experiments outlined in this dissertation reveal the underlying
framework of a reciprocal relationship between the Runx2 transcription factor and the
mammalian circadian rhythms system. Beyond the basic interactions delineated by the
current findings, many questions regarding the mechanisms and functional consequences
of the association of these factors remain to be addressed.

First, we demonstrated that rhythmic expression of Runx2 was dependent on
Bmal1 which binds to the promoter sequences containing E-boxes. The functionality of
these sites needs to be validated to confirm which one or several of these E-box
sequences are necessary and/or sufficient to promote rhythmic Runx2 expression.
Moreover, the studies examining the interaction of Bmal1 to the Runx2 gene in Chapter
III focused on one (Promoter 1) of the two known promoter sequences for Runx2
(reviewed by (Stock & Otto, 2005)). The second promoter sequence (Promoter 2) is not
as widely studied and believed to be less tightly regulated than Promoter 1 (Stock & Otto,
2005). Nevertheless, it will be important to determine whether expression through this
second promoter is also directly or indirectly regulated by the circadian clock.

Next, we showed that rhythmic expression of Runx2 has a biological consequence
on behavioral and molecular rhythms indicating that it influences the molecular network
underlying circadian rhythms. The feed forward drive of Runx2 on the amplitude of
rhythmic Bmal1 expression appears to be based on its binding to a consensus sequence in
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its promoter. However, the functionality of this site and whether additional factors play a
role in this positive drive warrants further investigation. Moreover, the effect of Runx2
over-expression on clock gene expression and circadian function could shed light on the
molecular interactions it has with the circadian clock network in cancer. Specifically,
Runx2 has been proposed to be a pivotal player and potential tool to diagnose clinical
outcome for a number of human malignancies including breast cancer (Pratap et al.,
2006). Malignant cell growth is known to be associated with disruptions in circadian
regulation at the molecular level (Lahti et al., 2012). Therefore, understanding the
mechanisms of actions contributing to the interaction between Runx2 and the circadian
clock network under normal and over-expression conditions could serve to better our
understanding of the pathogenesis of cancer.

A number of gene products impinging on the molecular clock do so by directly
interacting with clock factors to enhance or inhibit their function. For example, the clock
gene products Per and Cry translocate into the nucleus as a complex and associate with
the Bmal1/Clock heterodimer to negate its transcriptional activity (Reppert & Weaver,
2001). To date, Runx2 has been found to directly interact with factors having a broad
spectrum of cellular functions including basic helix-loop-helix-containing transcription
factors similar to Bmal1 (Kim et al., 2003; Lian et al., 2003). In addition to interacting
with its gene promoter, Runx2 may promote the amplitude of Bmal1 expression by
supporting or inhibiting the function and/or expression of factors that enhance or suppress
Bmal1 expression, respectively.
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A number of neurotransmitters including glutamate, neuropeptide Y (NPY) and
serotonin may be regulating the expression and/or activity of Runx2 in the SCN.
Glutamate, one of the main neurotransmitter signaling photic information from the retina
to the photoreceptive neurons in the core of the SCN, represses the activity and
expression of Runx2 in osteoblasts (Takarada-Iemata et al., 2010). Based on observations
made in mice lacking a functional copy of the Runx2 allele, Runx2 does not appear to
play a role in regulating the circadian behavioral response to acute photic light exposure
(Chapter II). However, it is possible that the levels of Runx2 expression present in this
animal model are sufficient to compensate for its role in photic responsiveness. Indeed,
the molecular impact of Runx2 deficiency on circadian periodicity was only clearly
perceived in the Runx2-/- SCN tissue despite observed behavioral period in Runx2+/- mice
suggesting a difference in sensitivity between the molecular and behavioral impacts of
Runx2 deficiency. In additions, the experimental design tested the effects of an acute
exposure and did not determine whether the Runx2 deficiency would have an impact on
the ability to re-entrain behavioral rhythms to a strict light-dark schedule following a
large photic phase shift (i.e. 6 hours). Performing these investigations will serve to
elucidate how recovery from phase shifting insults such as shift work and jet-lag have on
the circadian clocks relationship with Runx2 and whether it plays a role in recovering
from the dramatic photic change. Thus, it will be important to test these and other
circadian parameters in animals in which Runx2 expression is silenced to a greater degree
by specifically in the SCN using an siRNA technique. Localizing the decreased
expression of Runx2 to the SCN will also serve to validate our observation that its role in
the SCN is important in coordinating circadian behavioral rhythms.
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The possible involvement of Runx2 in the regulation of non-photic phase shifting
was not considered in the studies presented. Serotonin plays an important role in nonphotic phase shifts in circadian rhythms and has been associated with arousal and
locomotor activity (Dudley et al., 1998). In osteoblasts, serotonin acts to promote gene
expression of Runx2 thus it can be postulated that the serotonin-induced phase shifts in
circadian rhythms are in part mediated by stimulating Runx2 expression (Hernandez et
al., 2012). Expression of Runx2 was found to be significantly elevated in osteoblasts of
NPY-deficient mice, suggesting NPY-mediated non-photic phase shifts may be executed
through regulation of Runx2 levels (Baldock et al., 2009).

Together, the collection of studies and observations reported in the present
dissertation serve as a critical basis for understanding the reciprocal relationship between
the molecular circadian clock, circadian behaviors and Runx2. This foundation presents
many avenues for further investigations including the proposed future studies outlined
and contributes to our ever growing comprehension of circadian rhythms.
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The promoter sequence ~3.5 kb upstream of the transcription start site
of the Homo sapiens RUNX2 gene (Promoter 1; Type 2; MASNSL).
NCBI Reference Sequence: NT_007592.15; Homo sapiens chromosome 6

Red base: Transcription start site
Underlined bases: Predicted bmal1 binding site
Dashed underlined bases: Predicted runx2 binding site
Italicized bases: bases overlapping two consensus DNA-binding sequences

5’- ATAAAATTTTATGGGTCTTTAAAAAGCAAAAATAAAAATAAAAATAAATC
TGTGGTTTTCAATTTCTGATTATAACCATGGTATAAATCTATAATCAAGAGCT
TTATTTGCATTGACTTTTCTAAATCAGTATCTCTTCACCACGTGTAGTAAGCT
ATTTCTAATGAAACACACTGTTATCAAATGTGTACCAATTATCAAATGTGCCC
CAGTTGTCATTGTTTTTTAAATTTTTACAACAAAGTAATATTTGCTCCAAAGA
GGATATATTTTCGTTTTAGGAAAAAAATTCATGTGGATAATGAATATACTAA
CTTAAAGCACATGATTTCACTATCTTTCTCCTGCTAGAATTTGATAGGCCTCA
CAGAGGACAAAAAGTGCATATATAACAATATCTACTAAACTCTCAAATCCTG
GTCCAAAAATTACATGCAGGAGGATTACCTGCAAAAAGTGAACAGGTAATTA
AATGACAAATAGATGTTAAAAATTACTTAAATTCTTATCAGGTCAATTTGAAG
AGCCAAAGTTTACATAAAGAAGATTTTAAGGAAGAAAATAGCAAAATGTTGG
GTTTGTAAGATGTTTCAGTGAATGCTAATGTAGAAACTATAAGCTTATTTGAA
AAGAAGAAAACCATTTGCTGATCATACTACAGCAGCTACCTACATATTTTCA
ATTAAGTGATTCTGCTATTATAGGTACACATGAAACCATGTTTGGAAATCCC
ACAAGCTATAAGGACAAAACCCTCCTTTTGTTTACTTTGGATACTAATTAGAG
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ATACAGATAATATGGATACGACTTATTTATAAAAGAGAAAAAATAATTTTTC
TCTCCTTCACATGAATAACTGCATGTTAAATGAACGCTTTTACCTTTCAATGT
AAAATCTGTTTACACATACAATAAGGCATGATAAATCCATAGTTAAAATAAA
ACACCAAAATGTATTTCTGGTTTTTTATCACTAAAAGTTTATTCTGAAAAGGT
TCTGGACATTTGAAAAATAAAGGACTAGAATCATTCCCATACCCTACCAGTG
TATTTTGGGAAAATCAAATTTTCTGTAAAGAAACTTATGAACATATTTGTACA
GTTATTGTGATCTAATATGAACCAAAAGCAGATAATGAATAGCACTAGGAAG
AACACAGGGATATTTTAGTTCTAACACCCTCCTGTCTCCCTAGCCCTTACCTC
CCTGCACATTCCAAATAATCTTTTGTAATTCACTGTCTCCGCCCACCCCATTTA
CTTTATGCCACTCCTAGTTACTGTCACACTAGGAAGAAGTCTAACATGCAGAT
TTAGAGTGGCATGGATAAATGGCAAAAAAATGCCTAGAAAATTGGTCTGTTC
GCCTTTATAATTTTGGTTGAAAAATACTCCATCGCTCCCAACTGATGAAAACA
GGAAGCTCTATTCATAAATATAAAATTCACTGCCTATGATATATAATCATCCT
AATAAGAAAATGAGTTCTATACATACTTGTCCAAAGGGGCAAAAAAGGAGAT
AGTTTCCCAAAGATGTTTCCAATTTTCTTCTGAATCAGAATTAGCAAATCGAG
ACGACTAACATACTCTGTCTGTGGGCATTATTCCTTACTACACACAGCATTTT
GTAATTTATTTCAAAGCTTCCATTAGAAACAAAAAAATACATAGCTTCTGTTA
ACCCACTCTATTCTAAGCTCATAGAATCAAATACTGAACAATCTACATTATAA
CATAAGCATTTTACTTTATAGAAGATCTGCTATCAGAAACTCTATTAATGTCT
AAACTACTTAAAGAACTATATAAACTGAATACACTTCAATGAAAGACAAAAA
ATATTACAATCATAAAGAAAACTAAGATTCATCCAATAAACTATATTACAAT
CCCTGTCATTCATTTTTTTAAGATCTTCAAACTAGGCATGAGATAATGGTATA
CATGAAACATTACATTTAATCTTTATTGTAAAGGCCGCCATCTAATAGATTGA
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TAATAAACTAGACAGACGTGATTTAAAATTTGTAAAAGAATGCCCAGACTAA
CACTTTCATGACAGCCAATTATAGTCAAGCCTAGCAAGCAGTTTGCAACCAG
ACCTTAAGGTAAACTTTTTTTTTTTTTACAATGAGTTACAGATTCACAAGTTTA
AGAAGACAAGAAAAAGGAAAACAGAAGGAATCCAGCCACCCAGCAAATATG
AAGCAGACCCCAGAATGTGATACAGTCCAAAGATGTGAATTATTGTATATCA
TCACTGTTGTTCAGAATTTCACACAGACTCTTGAGCCAATTTTGTTCATTTTTC
CACAGACACAATAATGAACTAAAAAGAGGAGGCAAAAAGGCAGAGGTTGAG
CGGGGAGTAGAAAGGAAAGCCCTTAACTGCAGAGCTCTGCTCTACAAATGCT
TAACCTTACAGGAGTTTGGGCTCCTTCAGCATTTGTATTCTATCCAAATCCTC
ATGAGTCACAAAAATTAAAAAGCTATATCCTTCTGGATGCCAGGAAAGGCCT
TACCACAAGCCTTTTGTGAGAGAAAGAGAGAGAGAGAAAGAGCAAGGGGGA
AAAGCCACAGTGGTAGGCAGTCCCACTTTACTTAAGAGTACTGTGAGGTCAC
AAACCACATGATTCTGCCTCTCCAGTAATAGTGCTTGCAAAAAAAAGGAGTT
TTAAAGCTTTTGCTTTTTTGGATTGTGTGAATGCTTCATTCGCCTCACAAACAA
CCACAGAACCACAAGTGCGGTGCAAACTTTCTCCAGGAGGACAGCAAGAAG
TCTCTGGTTTTTAAATGGTTAATCTCCGCAGGTCACTACCAGCCACCGAGACC
AACAGAGTCAGTGAGTGCTCTCTAACCACAGTCTATGCAGTAATAGTAGGTC
CTTCAAATATTTGCTCATTCTCTTTTTGTTTTGTTTCTTTGCTTTTCACATGTTA
CCAGCTACATAATTTCTTGACAGAAAAAAATAAATATAAAGTCTATGTACTC
CAGGCATACTGTAAAACTAAAACAAGGTTTGGGTATGGTTTGTATTTTCAGTT
TAAGGCTGCAAGCAGTATTTACAACAGAGGGTACAAGTTCTATCTGAAAAAA
AAAGGAGGGACTATG – 3’
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The promoter sequence 2 kb upstream of the transcription start site of
the Homo sapiens BMAL1 gene.

NCBI Reference Sequence: NC_000011.9; Homo sapiens chromosome 11

Red bases: Transcription start site (+1)
Underlined bases: Predicted runx2 binding site
Bolded bases: Sequence targeted by primer sets

5’-TCATCTGGACATGTGATGCGAATCTTCTGGATTTTCCTTCAGAACACTGA
TAAAAGTTCTGATGTCTGGACCTGGGAGAGAGGCTTCTGTCATTCTGAGGGT
AACTGGTGTGGTATAGAGGCTTTGAAATAAAAAGAAAAAGTCTAGTTTGAAT
CACGGCTCTGCCACCTACTGTGTGACCTTTGGCCAGCTAGCTAAATTCTGAGT
TTCAGTTTCCCCATCTGTAAAATGGGGCAATAAAAGCTTCCTCACAGTGTGGT
TATAAAGATTAAGGGAGAACATGAGGGGAAAGTACTTAGCACAGTGTCTGGT
ACGTAGTAGGTGCTGCTGGAATGCTGACTCCCTGCAATCTTCTTTTCGGTCAA
CGTCGACTCATCAATCAGCATCTTTAGGTTATGGTTACTTAACCAGTTATTAG
TCCAATTAATGATACTAGCATCCAGCCCATATTTCTTCATCTTGTCTATGATAT
CTTGTCAAGTGCTTCGCTTAAGTCCCACTTACCTAGAGTGATCTCCTCATGAA
ATGGGGGCAGAGACAAAGGAGCAATAAGATTCCACCTGCGTGTAAACTTCGG
AAAAATAGCAAGCTACCGACGGAATTGCTTGACCTCGAAAACAGTCAGCATT
CAGACCACAAGCACATATTGGGCACTCCGTGCCTGTCAATGAGCTGGGGATG
GGCAATGGTGTTACAGAGATTAAAAAACGCAGTGTCTGTGTTCAAGGAACTT
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ACCAGGCTAGAAGTCTAGAGTCACGGGGGCCAGTCTGGGTAACAGAATTAGG
CCAATTTATTTAATTCCATTTGTTCATGTATCCAGCCAACAGATATTTATGGTG
CACTTGTTGGGTGCCAGCCCCGCCCCCACCACTCCACCCTACCCCAGCAGGC
GCTAAAGGAGAGCTGACATGATGGATAACGAAAAAGAAGACGCTGTCCTTCT
ATTCAGGGAGTTTAACATCTGGAAGAGCCGGGAGTTCTTTGTGCTAAAGGCC
CTCTACAAAGTGCCTGAGATGCAAAAATAAGTCACTTTCTCTGTCCTCTCAGC
AACCGAGTCGCATGTCGTTATCAAATTTTTATTTTCTGTAACTGTTTCCTTCCG
TCTTGCTCCGTAGACAGCTTTTTGCAGCAGAGAGCGCTGCCGCGGGGCTGGT
GTCTACTCTTCAGTAAGTGGTCAAAACCTGGCTACTGGAAGGAAATGCAATG
GAATCGCTCCGCGCTCGAGTATTCTCTTTGGAACTACGGGAATGACAGCTCCA
GTGGGACACTTGGAGGTCATGATGAACGCAAAGAACGTGAGAACACTTGCA
GTCCTCGGGGTGGAAATGCCTTCTAGAAATACTAAGTATCCGTTCTCTCGTTG
AGACTTTGGCAAACCAGGGATTTTAGGAAGGGTCTGGCACTCAACGTTCCTA
AAATTGGTTTCCTAGATGGAGCCGGAGGGAGAGAGGGAGTCAGGAACTGCT
GCTTTTCGTCGGAATGCCCGGAGGGGAGAAGAAGAAGGAGGAGGGGTGAGG
GCGGGCGGCCAAACGCCAGCCGGCAGGGGACCCAGAGAAGAGGGACATCCC
GGGCGACCCCGAGGAGCGCGGCTTGGGCACCGCAGTGGCCGCGGCTAGTGG
GAGACCTGAGGGGAAAGGGAGAGGGCAGGGGCGAGGAACCCAGGGAGCGC
GCGCGGATTGGTCCTCTCCTCGGGGCGTGCGCTCCTGTGCGCCAAATGATTGG
TGGCAGGAAAGTAGCAGGTAAACCGGCTCCCGCCGCCTCGCCATTGGTCAGC
GGCCTCTCTAGCCGCCACACAACTGGCCAGCGGGCTGCCGAGCCGCGCGCGG
ATTGGCTGGGGGCGGCCGCCGGGACCGGCTCCCTTCGGGCGTTCGGATTGGC
TGGCGGGAAGAGGCAGGTATCCGGGCGCTGCGGCTCCTCCATTGGTGGGCGG
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GGAAGGGGGGTTGGGCACAGCGATTGGTGGGCGGGGGGCCGGGCCTGGGCC
GGCGGGGAGCGGATTGGTCGGAAAGTAGGTTAGTGGTGCGACATTTAGGGA
AGGCAGAAAGTAGGTCAGGGACGGAGGTGCCTGTTTACCCGCGCCGGACTTG
CCGCCGCCGCCGCCGCGGGATCCGAGTGCGGGTGCGGGCGCGGGCGCTCGCA
GCGAGCCACGGTGAGTGTCGGCATGGCTGCGGGCAGCAGCCGTCTCGGGG- 3’
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mBmal1 promoter sequence upstream of the firefly luciferase gene
construct stably expressed in U2OS cells
Red base: Transcription start site
Underlined bases: Predicted runx2 binding site

5’- ACTAGCCAGGGACGCGGCTGAGGAGCAGGGGACAACGGCGAGCTCGCAG
AGTCCGCAACGCAGTGGCCTCAGCGAGCTTTAGACCTGAGGGGGAAAACCG
AGGGCTGGGGCAAGAAATCCACAGAGCGTGCCAATTGGTCCACTCCTCGGGG
CGTGTGCTTCTGTGCGCCAAATGATTGGTGAAGGGAAAGTAGCAGGTAAACC
AGCCCTGCCGTCTTGCCATTGGTCAGAGGCTTTCCTATCGGTCACTCGATTGG
CTAGCCTAACGCAGAGCAGAACGCGAATTGGTTTGGGTTGTCCGCCAAGACA
ACTCCGTTCGCTCTCTCTGATTGGCTAACGGGAAGAGGCAGGTATCCGGGCT
GCGCGGCTCCTCCATTGGTGGGCGGGGAAGGGGGGTTGGGCACAGCGATTGG
TGGGCGGGGGGCCGGGCCTGGGCCGGCGGGGAGCGGATTGGTCGGAAAGTA
GGTTAGTGGTGCGACATTTAGGGAAGGCAGAAAGTAGGTCAGGGACGGAGG
TGCCTGTTTACCCGCG - 3’

REFERENCES:
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Vollmers, C., Panda, S. & DiTacchio, L. (2008) A high-throughput assay for siRNAbased circadian screens in human U2OS cells. PLoS One, 3, e3457.
Runx2 consensus sequence:
van der Deen, M., Akech, J., Lapointe, D., Gupta, S., Young, D.W., Montecino, M.A.,
Galindo, M., Lian, J.B., Stein, J.L., Stein, G.S. & van Wijnen, A.J. (2011) Genomic
promoter occupancy of runt-related transcription factor RUNX2 in osteosarcoma cells
identifies genes involved in cell adhesion and motility. J Biol Chem.
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Sequence comparison of the mBmal1 promoter region driving Luciferase
gene expression construct in U2OS cells to the hBMAL1 promoter region.
NCBI reference sequences: Mus musculus Chromosome 7 (NT_039433.7); Homo
sapiens Chromosome 11 (NT_009237.18)
Highlight: Putative Runx2 binding site

Mouse GCAACGCAGTGGCCTCAGCGAGCT-TTAGACCTGAGGGGGAAA-ACCGAGGGCTGGGGCA
||| |||||||||| | || || |
|||||||| |||||||
|||||| |||||
Human GCACCGCAGTGGCCGCGGCTAG-TGGGAGACCTGA-GGGGAAAGGGAGAGGGCAGGGGCG

Mouse AGAAATCCACAGAGCGTGC-C-AATTGGTCCACTCCTCGGGGCGTGTGCTTCTGTGCGCC
|| || ||| ||||| || | |||||||| |||||||||||||| ||| |||||||||
Human AGGAACCCAGGGAGCGCGCGCGGATTGGTCCTCTCCTCGGGGCGTGCGCTCCTGTGCGCC

Mouse AAATGATTGGT-GAAGGGAAAGTAGCAGGTAAACCAGC-CCTGCCGTCTTGCCATTGGTC
||||||||||| | | ||||||||||||||||||| || || |||| || ||||||||||
Human AAATGATTGGTGGCA-GGAAAGTAGCAGGTAAACCGGCTCCCGCCGCCTCGCCATTGGTC

Mouse AGAGG-CTTTCCTATCGGTCACTCGATTGGCTAGCCTAAC-GCAGAGCAGAACGCGAATT
|| || || | ||| | | ||| | | |||| || |
| || |||| | |||| |||
Human AGCGGCCTCT-CTAGCCGCCACACAACTGGCCAG-CGGGCTGCCGAGCCGCGCGCGGATT

Mouse GGTTTGGGTTGTCCGCCAAGA-CAACTCCGTTCGCTC-TCTCTGATTGGCTAACGGGAAG
|| | ||| | ||||| || | |||| |||| | | || |||||||| |||||||
Human GGCTGGGGGCGGCCGCCGGGACCGGCTCCCTTCGGGCGT-TCGGATTGGCTGGCGGGAAG

Mouse AGGCAGGTATCCGGGCTGC-GCGGCTCCTCCATTGGTGGGCGGGGAAGGGGGGTTGGGCA
|||||||||||||||| || ||||||||||||||||||||||||||||||||||||||||
Human AGGCAGGTATCCGGGC-GCTGCGGCTCCTCCATTGGTGGGCGGGGAAGGGGGGTTGGGCA

Mouse CAGCGATTGGTGGGCGGGGGGCCGGGCCTGGGCCGGCGGGGAGCGGATTGGTCGGAAAGT
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human CAGCGATTGGTGGGCGGGGGGCCGGGCCTGGGCCGGCGGGGAGCGGATTGGTCGGAAAGT

Mouse AGGTTAGTGGTGCGACATTTAGGGAAGGCAGAAAGTAGGTCAGGGACGGAGGTGCCTGTT
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human AGGTTAGTGGTGCGACATTTAGGGAAGGCAGAAAGTAGGTCAGGGACGGAGGTGCCTGTT

Mouse TACCCGCG
||||||||
Human TACCCGCG
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The University of Michigan
University Committee on Use and Care of Animals (UCUCA)

PI: Lehman, Michael
Protocol Number: #10507
Approval Period: 02/14/2011 ‐ 02/14/2014
Funding Agency: Canadian Institutes of Health Research
Title: Interactions Between the Eye and Central Circadian Clock
funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
DRDA Number:
Date: 02/14/2011
Dear Principal Investigator,
The University of Michigan Committee on Use and Care of Animals (UCUCA) has
reviewed your application to use vertebrate animals (Application #10507). This project
has been approved. The proposed animal use procedures are in compliance with
University guidelines, State and Federal regulations, and the standards of the "Guide for
the Care and Use of Laboratory Animals."
When communicating with the UCUCA Office please refer to the Approval Number
#10507. The approval number must accompany all requisitions for animals and
pharmaceuticals.
The approval date is 02/14/2011. The approval period is for three years from this date.
However, the United States Department of Agriculture (USDA) requires an annual
review of applications to use animals. Therefore, each year of this application prior to
the anniversary of its approval date, you will be notified via email to submit a short
annual review. Your continued animal use approval is contingent upon the completion
and return of this annual review. You will also be notified 120 days prior to the
expiration of the approval period so that your renewal application can be prepared,
submitted and reviewed in a timely manner in the eSirius program and an interruption
in the approval status of this project avoided.
UCUCA approval must be obtained prior to changes from what is originally stated in the
protocol. An amendment must be submitted to the UCUCA for review and approved
prior to the implementation of the proposed change.
The University's Animal Welfare Assurance Number on file with the NIH Office of
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Laboratory Animal Welfare (OLAW) is A3114‐01, and most recent date of accreditation
by the Association for the Assessment and Accreditation of Laboratory Animal Care
International (AAALAC, Intl.) is November 06, 2009.
If you receive news media inquiries concerning any aspect of animal use or care in this
project, please contact James Erickson, News and Information Services. If you have
security concerns regarding the animals or animal facilities, contact Bill Bess, Director of
Public Safety.
Sincerely,

Richard Keep, Ph.D.
Professor, Neurosurgery
Chairperson, University Committee on Use and Care of Animals

184

CURRICULUM VITAE
Name: Meghan Elizabeth Reale

Educational Background:
PhD in Neuroscience
University of Western Ontario, London, ON, Canada
Started September 2007
University of Michigan, Ann Arbor, MI, USA
Visiting scholar in the Department of Molecular and Integrative Physiology
December 2010 – July 2012
Bachelor of Medical Sciences: Honors Specialization in Biochemistry and Cell
Biology
The University of Western Ontario, London, ON, Canada
September 2003 – May 2007

Teaching Experience:
Department of Anatomy and Cell Biology
The University of Western Ontario, London, ON, Canada
September 2007- April 2008:
Graduate student supervisor for fourth year thesis research project.

Scholarships:
2009-2012: Alexander Graham Bell Canada Graduate Scholarship for Doctoral
Studies (NSERC, CGS-D3).

2008-2009: NSERC PGS-M
2008-2009: Ontario Graduate Scholarship (declined).
2007-2012: Western Graduate Research Scholarship
2007-2012: Schulich Graduate Research Scholarship
2007-2008:
- Ontario Graduate Scholarship ($15,000).
- CIHR Stategic Trainin Program in Neurobiology and Behaviour
Graduate Student Scholarship at the University of British
Columbia ($20,000; declined).
- Distinguished Academic Incentive, Graduate Entrance
Scholarship awarded by the Department of Anatomy and Cell
Biology of the Schulich School of Medicine and Dentistry at the
University of Western Ontario ($2,000).
185

Honours and Awards:
2011: Symposia of Circadian Rhythms Research in Canada Research Merit
Award
2007: Top Ranked Honours Research Thesis in Biochemistry and Cell Biology,
Department of Biochemistry of the Schulich School of Medicine and
Dentistry at the University of Western Ontario.
2004-2007: Dean’s Honors List

Publications:
Accepted
Glickman, G., Webb, I.C., Elliott, J.A., Baltazar, R.M., Reale, M.E., Lehman,
M.N. & Gorman, M. R. Winter photoperiods increase sensitivity of circadian
photoreception. Journal of Biological Rhythms, 2012.

Submitted Manuscript
Reale, M.E., Coolen, L.M., Webb, I.C., Baltazar, R.M., Wang. X. & Lehman,
M.N. The transcription factor Runx2 is under circadian control in the
suprachiasmatic nucleus and functions in the control of rhythmic behavior.
Submitted to the Public Library of Science (PLoS). Manuscript number: PONED-12-30032.

In preparation
Webb, I.C., Baltazar, R.M., Reale, M.E., Coolen, L.M. & Lehman, M.N. Evidence that a
daily rhythm of glutamate release from retinal terminals is responsible for circadian
rhythms in a subdivision of the suprachiasmatic nucleus.

Baltazar, R.M., Webb, I.C., Reale, M.E., Coolen, L.M. & Lehman, M.N.
Prefrontal cortex modulates diurnal rhythms in cfos immunreactivity in the
mesolimbic reward system.

Seminar Presentations:
The transcription factor, Runx2, is a circadian clock-controlled gene and
contributes in the control of rhythmic behaviour. Presented as part of the Sleep
186

and Circadian Biology Data Blitz organized by the NIH National Center on Sleep
Disorders Research and the Program at the Society for Neurosciences Conference,
(2011)
The transcription factor, runx2, is a circadian clock-controlled gene and participates in
the control of rhythmic behaviour. Presented as part of the Symposia of Canadian
Circadian Rhyhtms Research (2011).
Bone heads Can Keep Time: Runx2 in the Central Circadian Pacemaker. Presented to the
Department of Anatomy and Cell Biology (2010).

Abstracts:
Reale M.E., Coolen L.M., Webb I.C., Wang X. and Lehman M.N. (2011) The
transcription factor, Runx2, is a circadian clock-controlled gene and contributes in
the control of rhythmic behaviour. Abstract accepted July 31st, 2011. Poster
presented at the Society for Neuroscience annual meeting in November in
Washington, DC [International Conference].
Reale M.E., Coolen L.M., Webb I.C., Wang X. and Lehman M.N. (2011). The
transcription factor, Runx2, is a circadian clock-controlled gene and participates
in the control of rhythmic behaviour. Poster presented at the Symposia of
Canadian Circadian Rhythms Research held in Montreal, QB [National
Conference].
Reale M.E., Coolen L.M., Wang X. and Lehman M.N. (2009) Rhythmic
expression of runx2 in the SCN and other regions of the adult mouse brain. Poster
presented at the Society for Neuroscience annual meeting in October in Chicago,
IL [International Conference].
Reale M.E., Coolen L.M., Cheng G., Goodman R.L. and Lehman M.N. Sexual
dimorphism of dynorphin A and neurokinin B-containing inputs onto
gonadotropin-releasing hormone neurons in the sheep. Abstract accepted July
31st, 2007. Poster presented at the Society for Neuroscience annual meeting in
November in San Diego, CA [International Conference].
Cheng G., Coolen L.M., Reale M.E., Goodman R.L., Padmanabhan V. and
Lehman M.N. Sex differences in kisspeptin neurons in the sheep hypothalamus.
Abstract submitted May 15th, 2007. Poster presented at the Society for
187

Neuroscience annual meeting in November in San Diego, CA. [International
Conference].
Cheng G., Coolen L.M., Reale M.E., Goodman R.L., Padmanabhan V. and
Lehman M.N. Influence of prenatal androgens on dynorphin and NKB-expressing
neurons in the mediobasal hypothalamus of the sheep. Poster presented at the
Endocrine Society annual meeting in Toronto, ON. [International Conference].
Cheng G., Coolen L.M., Reale M.E., Goodman R.L., Padmanabhan V. and
Lehman M.N. Sex differences in neuronal expression of dynorphin and
neurokinin B in the control of gonadotropin-releaseing hormone secretion in the
sheep. Poster presented at the 1st Annual Meeting of Canadian Association of
Neuroscience in Toronto, ON. [National Conference].

Services:
2010-2011: Student chair (elected), Anatomy and Cell Biology, University of
Western Ontario

188

